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Total knee arthroplasty (TKA) is considered to be the treatment of choice for end-stage 
knee osteoarthritis1–3 with patient satisfaction ranging from 75% to 89%.3–7 Many factors 
contribute to the outcome of TKA, which are disease associated such as preoperative 
severity of osteoarthritis. Secondly, surgical associated factors, such as the implant, sur-
gical technique and complications will have an impact on outcome of TKA in patients. 
Finally, patient associated like patient’s functionality (both preoperative and postopera-
tive) and expectations on outcome.
As for the most commonly treated disease with a TKA, osteoarthritis (OA), it is the most 
common form of arthritis and the most prevalent chronic joint disease. It is a multifacto-
rial, inflammatory and degenerative joint disorder, characterized by degeneration of 
articular cartilage, intra-articular inflammation with synovitis, and changes in the peri-
articular and subchondral bone. It has a complex pathogenesis due to the combination 
of genetic, metabolic and local factors. Nowadays, OA pathogenesis has shifted from a 
classical concept due to age factors, into a multifactorial disease.8–11 The prevalence of 
osteoarthritis is influenced by various factors such as age, sex, race, lifestyle, obesity, 
occupation, and genetics. The population of Indonesia is projected to increase to 268 
million population in 2020. During a regional survey in Indonesia on a small patient 
cohort who had musculoskeletal pain, 36% of those patients had osteoarthritis, gout, or 
spine problems.12 National data on the incidence and prevalence of knee osteoarthritis 
in Indonesia are not available yet. According to the WHO, the worldwide prevalence of 
knee osteoarthritis is 10% in men and 18% in women older than 60 years.
Cytokines play an important role in the expression of osteoarthritis. For that matter secre-
tion of tumor necrosis factor alpha (TNF-a) and interleukin-1β (IL-1β), the active form of 
IL-1 during inflammation, are increased in the OA-affected cartilage and synovial cells.5 
Current concepts define OA as a genetic disease, which is influenced by environmental 
factors. For that matter, 65% of radiographic OA of the knee can be associated with 
multiple gene interactions.8,13 Genes implicated in OA include gene codes for vitamin 
D and its receptor (VDR), iodothyronine-deiodinase enzyme type 2 (DIO2), type II col-
lagen (Col2A), insulin-like growth factor 1 (IGF-1), transforming growth factor β (TGF-β), 
estrogen receptor α (ERα), and others genetic still in research with GWAS (genome-wide 
association studies). However, since environmental factors have a huge impact on OA 
development, research into single-nucleotide polymorphisms (SNPs) became the focus 
area for pharmacological agents. Therefore, OA treatment should be holistic and should 
be addressed in a step-care strategy, starting with conservative treatment using both 
non-pharmacological (exercise, diets, etc.)14,15 as well as pharmacological interventions. 
As a last resort TKA can be used as a treatment for end-stage knee OA.16
Since OA patients usually present with complaints of pain limiting daily living activities, 
treatment is focussed on reducing pain. Therefore, the first choices of medication are 
Acetaminophen, NSAIDs, and COX-2 inhibitors.17,18 Other drugs, such as glucosamine 
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sulfate and chondroitin sulfate claim to have effects on pain and joint space narrowing, 
but placebo-controlled randomized studies show no effects.19,20 Steroid injection is used 
to treat local active joint inflammation but showed no functional improvement either.21 
Newer pharmacological OA treatments focus on decreasing the progression of OA. Oral 
Doxycycline, Strontium ranelate, Cathepsin K inhibitors, Calcitonin, anti-enzyme drugs 
like estrogen, PTH and its analogues Bone morphogenic proteins (BMPs), Sprifermin are 
still being studied. Moreover, anti-inflammatory agents against IL-1, IL-6, and TNF-a have 
not shown a significant effect in OA treatment yet.22,23
Surgical associated factors for outcome in total knee arthroplasty
Surgical treatments considered for late knee OA, include osteotomy around the knee, 
joint distraction procedure, unicondylar knee replacement, and total knee arthroplasty 
(TKA).24
In Indonesia there is an expected increase in TKA surgery due to several factors:
1. increased aging population, the current mean life expectancy is 69 years25
2. since 2016, the National health care insurance coverage includes TKA procedures
3. increased education and training of orthopaedic surgeons in knee arthroplasty 
through Indonesian Hip & Knee Society fellowships from 2 fellows per year to 60 
fellows per year.
Many factors contribute to the outcome of TKA such as preoperative severity of OA and 
knee deformity as well as implant related factors such as optimal fit of the implant and 
surgical correction of the deformity. Several surgical techniques and types of implants 
are designed to improve patient satisfaction and functionality. A wide range of different 
surgical techniques are available to achieve an optimal result for TKA. Optimal implant 
positioning is claimed to be achieved by computer-assisted navigation and patient-
specific instrumentation (PSI), recently accelerometer-based navigation has been added 
to improve TKA positioning.26–29
Implant survival (end-point revision) can be influenced by implant design.30–32 Knee 
implant fit to the patient’s knee anatomy is associated implant longevity.33 Interestingly, 
overhang or under-hang of knee components do not command poorer patient-reported 
outcome.33–35
Patient associated factors are based on the patient’s ability to cope with preoperative 
knee complaints, postoperative pain perception and the interaction with the orthopae-
dic surgeon. Thus, a complex entity, which will be different in different social cultural 
contexts. Patient satisfaction is a very important tool for measuring the success of TKA, 
whether the procedure has attained the goals of TKA in relieving pain and restoring func-
tion. The success of a technical operation in surgeons’ perspective may not be the same 
as their patients. For that matter, a successful surgery by the surgeon’s standard might be 
considered a failure in the patients’ perspective.36 Patient satisfaction is associated with 
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preoperative patient’s expectation, functional outcome, mental health and to a lesser 
extent co-morbidity. The most important factor attributed to a patient’s satisfaction 
is the patient’s expectation and mental health while the most significant predictor for 
dissatisfaction is a pain, pessimism, treatment credibility, and treatment expectancy.37–42 
Therefore, the focus areas of research in the last decade puts more emphasis on the 
patient-reported outcome (PRO) and how to mediate it, next to the physician and gait 
analysis outcome measures.43 Traditionally, TKA success is evaluated by the failure of the 
implant, indicated inversely as the survival of the implant36, postoperative complications, 
morbidity, and mortality.44 Those criteria are considered objective from the surgeon’s 
point of view.45 The modern approach to outcome measures has shifted towards more 
subjective criteria, which are based on the patient’s perception, his or her quality of 
life improvements as a result of the TKA.44 Patients’ opinions on treatment outcome are 
of paramount importance when evaluating the success of TKA procedures.38,40,41,46 The 
International Consortium for Health Outcomes Measurement (ICHOM) Working Group 
has already published a consensus report defining an international standard set of 
outcome measures for patients with hip or knee osteoarthritis that can be used widely 
for monitoring, comparing, and improving healthcare on outcomes that matter most 
to patients. In assessing outcome measurements, ICHOM included a standard set that 
consist of patient-reported health status, surgical outcomes, and disease progression.
Several authors38,39,41,47 studied the predictive factors of outcome in TKA and showed 
that the preoperative functional score, radiological measurement of OA grades as 
well as femorotibial joint angles were associated with the postoperative functional 
score.38,39,41,47 Another study by Matsuda et al showed that the surgical intervention 
itself, such as avoiding varus alignment and achieving a better Range of Motion (ROM), 
increases patient satisfaction and thus meets preoperative patients’ expectations.48 Pa-
tient’s dissatisfaction is usually related to residual pain, less functional outcome or unful-
filled patient’s pre-operative expectation.49,50 Ultimately, the latter is the most important 
factor determining a good result of TKA.37,39,40,51 The most important factor contributing 
to patient dissatisfaction is post-operative residual pain, which in the majority is related 
with the anterior part of the knee (anterior knee pain -AKP). The incidence of AKP is 
20%31,50 and its origin is multifactorial although it seems to be located at the patello-
femoral joint in 40 – 58%. Knowledge of the anatomy of the patella, biomechanics of the 
patellofemoral joint, and implant design are very important to reduce AKP.52 Controver-
sies regarding patellar resurfacing are still unresolved53,54, the decision depends on the 
surgeon’s discretion, influenced by both medical and non-medical reasons.55 Regarding 
the anatomy of the patella, pre-operative patella baja has a higher post-operative patel-
lar fracture compared with patella alta in TKA with the resurfaced patella.56 It is caused 
by an intimate interaction of functional (muscle imbalance, dynamic valgus) and me-
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chanical factors (incorrect component placement, aseptic loosening) as well as patients 
expectations regarding outcome.7
Several patient-associated factors described above, such as preoperative knee com-
plaints and postoperative pain perception, have some fundamental discrepancies 
between different social cultural background. Asians are found to squat and kneel more 
frequently than the Western populations.57 As a lower-to-middle income country, Indo-
nesians have an inferior socioeconomic background that could influence the patient’s 
preoperative status, which in turn determine their subjective satisfaction after TKA.58
In addition, one of the patient-associated factors that could influence the outcome of 
TKA is racial discrepancies on knee anthropometric. Asians are known to have smaller 
knee compared to Caucasian. Since most TKA systems were based on North American 
and European anatomy, implant fit could be a major problem for Asians. It is essential 
to evaluate the difference of implant fit in Asian compared to Caucasian, to encourage 
the need of new TKA system based on Asian knee anthropometric. These anatomic 
differences may influence the alignment goal and intraoperative bone cut. In the end, 
the adjustment of component placement also depends on the knee anthropometric. 
Although knee anthropometric might not directly associated with functional outcome, 
but component incompatibility or implant-bone unfit associated with it. Besides anthro-
pometric, socioeconomic-cultural also contribute to, not only functional outcome but 
also patient’s expectation and perception. In addition, racial differences could harbor 
discrepancy over postoperative complication, especially in VTE. Different approach 
might be needed in VTE prevention for Asian patients.
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Aims of this thesis
This thesis aims to address some of the aforementioned aspects associated with the 
outcome of total knee arthroplasty in Asian patients. These factors can be distinguished 
into patient associated factors (i.e. anthropometry, comorbidity, patient-perceived out-
come) and surgical technique associated factors. Finally, the thesis also reviewed one of 
the devastating complications of TKA, that is, venous thromboembolism.
1. Patient factors
	 •	 	Anthropometric	difference	between	knees	of	Indonesian	Asians	and	Dutch	Cau-
casians and the fit of nine different knee implant systems (Chapter 2)
	 •	 	Patient	perception	of	the	outcome	between	 Indonesians	and	North	Americans	
(Chapter 3)
2. Surgical factors
	 •	 	Effect	of	circumferential	cauterization	in	unresurfaced	patella	in	TKA	(Chapter 4)
	 •	 	The	usefulness	of	accelerometer-based	navigation	in	TKA	(Chapter 5)
3. Consideration on postoperative thromboembolic prophylaxis
	 •	 Review	of	VTE	prophylaxis	in	hip	and	knee	arthroplasty	(Chapter 6)
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ABSTRACT
Purpose. The aim of this study was to evaluate the anthropometric differences between 
knees of Indonesian Asians and Dutch Caucasians and the fit of nine different knee 
implant systems.
Methods. A total of 268 anteroposterior (AP) and lateral knee preoperative radiographs 
of 134 consecutive patients scheduled for total knee arthroplasty at two different cen-
ters in Jakarta and Leiden were included. Both patient groups were matched for age and 
sex and included 67 Asians and 67 Caucasians. We assessed the radiographic difference 
between Asian and Caucasian anthropometric data. The dimensions of the nine knee 
implant designs (Vanguard, Genesis II, Persona Standard, Persona Narrow, GK Sphere, 
Gemini, Attune Standard, Attune Narrow, and Sigma PFC) were compared with the 
patients’ anthropometric (distal femur and proximal tibia) measurements.
Results. The Dutch Caucasian patients had larger mediolateral (ML) and AP femoral and 
tibial dimensions than the Indonesian Asians. The aspect ratios of the distal femur and 
tibia were larger in the Asians. The AP and ML dimensions were mismatched between 
the tibial components of the nine knee systems and Asian anthropometric data. Both 
groups had larger ML distal femoral dimensions than the knee systems.
Conclusion. Knee dimensions significantly differed between and within the patient 
groups. Both groups had knee phenotypes beyond the size ranges of the nine knee 
systems. Increasing the range of the tibial and femoral components for the AP dimen-
sions will increase the percentage of optimal fit for both Asian and Caucasian patients.
23
Anthropometric measurement of Indonesian versus Dutch patients
Ch
at
er
 2
INTRoduCTIoN
An increase in the demand for total knee arthroplasty (TKA) is expected worldwide, 
especially in Asia, within the next 10 years.19,23 Data from national registries with 100% 
coverage and 99% completeness, such as those of the Netherlands, show an average 
increase of 20% during the last 5 years.9 Although these valid data are available for 
most Scandinavian countries, the England and Wales, Australia, New Zealand, and the 
Netherlands, the increase in the number of TKA cases in other populations is only an 
estimate or even unknown. More important is the outcome of these TKA procedures, not 
only for patients but also for determining the economic burden to society. The outcome 
of TKA is determined by patients’ expectations and surgical aspects related to knee 
prosthesis position with respect to the anatomy of the patients.5,38,40 In line with this, pa-
tient expectations and the surgical aspects of implant positioning and functional knee 
phenotypes14 are intricately linked. Adequate coverage of the resected bony surfaces by 
the artificial knee design is important to minimize progressive implant migration, which 
ultimately causes implant loosening.15,25,28,31,37,38 Aside from the lower likelihood of im-
plant loosening due to less than optimal implant positioning, a good component fit to 
the patient’s knee also leads to fewer complaints.11,17,25,40 Anthropometric measurements 
vary between patients’ joints; however, only a few TKA system designs that optimally 
fit the patients’ knees are available. Most knee implants are based on North American 
and European patients. Although these continents have varied ethnic populations, the 
implant designs are mainly based on the average male Caucasian knee.20 An increasing 
demand for TKA in Asia is to be expected. Whether the currently available total knee de-
signs optimally fit Asian patients remains to be elucidated. In a study of approximately 
1000 Asian, Caucasian, and African American subjects, Mahfouz et al. showed significant 
differences in the dimensions of the knee anatomy not only between sexes but also 
among the three ethnicities.24 These anatomical size differences among ethnicities have 
also been substantiated in a systematic review by Kim et al.20
The present study aimed to compare anthropometric knee measurements of Indonesian 
Asian and Dutch Caucasian patients scheduled for TKA with the dimensions of nine com-
monly used total knee systems. We hypothesized that owing to knee anthropometry 
differences between Asians and Caucasians, different TKA systems are needed. To our 
knowledge, this is the first study that compared the Asian and Caucasian populations 
with respect to the optimal fit of nine currently used TKA systems.
MATeRIALS ANd MeThodS
A consecutive retrospective study was performed in 100 consecutive Asian patients 
scheduled for unilateral TKA in Jakarta, Indonesia. The inclusion criteria were knee os-
teoarthritis and absence of other deformity of the lower extremity or bone disease. Only 
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patients with digital preoperative and postoperative knee radiographs were included. 
Therefore, 27 patients with no digital knee radiographs were excluded. Six patients with 
a varus/valgus >20° were also excluded, as the anatomy was too obscured for measure-
ments. A total of 67 knee radiographs from the Asian patients were included for analysis 
(Figure 1). The 67 Asian patients were matched for age and sex with 67 Caucasian patients 
who underwent TKA at the Leiden, the Netherlands. The same inclusion and exclusion 
criteria were applied for the Caucasian patients. Thus, 134 knees with 268 coronal and 
sagittal plane knee radiographs could be used for anthropometric measurements. The 
patients’ height and weight were obtained from their records.
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Fig. 1 Flowchart for patient selection 
 
Overall, 57 women (85%) and 10 men (15%) were included in each group. The mean 
(±standard deviation [SD]) ages of the Asian and Caucasian patients were 67 ± 7.8 and 68 ± 
7.1 years, respectively. The respective mean body height and body mass index (BMI) were 
156 ± 8.0 cm and 29 ± 6.8 kg/m2 for the Asian patients and 166 ± 8.1 cm and 30 ± 6.1 kg/m2 
for the Caucasian patients. 
In both hospitals, standing anteroposterior (AP) and supine lateral knee radiographies on short 
films were performed routinely. All the radiographic measurements were performed on digital 
radiographs with the PACS software from GE Healthcare (Jakarta, Indonesia) and Sectra 
(Leiden, the Netherlands). The measurements were performed by 2 authors on all the 
radiographs of both Asian and Caucasian patients. In all measurements (Figure 2a–2f), a 
100 Consecutive Asian 
patients Assessed for 
eligibility 
Excluded: no digital knee 
radiograph (n = 27) 
n = 73 Asian patients 
Excluded varus/valgus  >20° (n = 6 ) 
n = 67 Asian patients n = 67 Caucasian patients (age, sex matched) 
67 Caucasian patients fulfilled inclusion and 
exclusion criteria (age, sex matched) 
fig. 1 Flowchart for patient selection
Overall, 57 women (85%) and 10 men (15%) were included in each group. The mean 
(±standard deviation [SD]) ages of the Asian and Caucasian patients were 67 ± 7.8 and 
68 ± 7.1 years, respectively. The respective mean body height and body mass index (BMI) 
were 156 ± 8.0 cm and 29 ± 6.8 kg/m2 for the Asian patients and 166 ± 8.1 cm and 30 ± 
6.1 kg/m2 for the Caucasian patients.
In both hospitals, standing anteroposterior (AP) and supine lateral knee radiographies 
on short films were performed routinely. All the radiographic measurements were per-
formed on digital radiographs with the PACS software from GE Healthcare (Jakarta, In-
donesia) and Sectra (Leiden, the Netherlands). The measurements were performed by 2 
authors on all the radiographs of both Asian and Caucasian patients. In all measurements 
(Figure 2a–2f ), a correction for radiograph magnification of 115% was used, according 
to the roentgen tube-table distance in both hospitals, which was identical. The degree 
of radiological osteoarthritis (ROA) was classified using the Kellgren and Lawrence (KL) 
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classification (with 4 being the highest degree of ROA) on the basis of the preoperative 
AP knee radiographs. The femorotibial angle (FTA, i.e., the lateral angle between the 
femur and the tibia; Figure 2a), femoral mediolateral (ML) dimension (fML; Figure 2b), 
and tibial ML dimension (tML; Figure 2c) were measured on the AP radiographs. The 
femoral AP dimension (fAP; Figure 2d) and tibial AP dimension (tAP; Figure 2e) were 
measured on the lateral knee radiographs. The distance from the fibular head to the 
tibial plateau was measured (FiTd; Figure 2f ) on the AP radiographs. The patellar tendon 
length (TL) and patellar bone length (PL) were measured from the lateral radiographs. 
The ML-to-posterior ratio (i.e., aspect ratios) for the femur (fML/AP) and tibia (tML/AP) 
and the patella-to-patella tendon ratio (PL/TL) were calculated.
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Fig. 2 Radiographic anthropometric knee measurements: (a) femorotibial angle, (b) mediolateral dimension of the 
femur, (c) mediolateral dimension of the tibia, (d) anteroposterior dimension of the femur, (e) anteroposterior 
dimension of the tibia, and (f) fibular–tibial distance 
 
The dimensions of the nine different knee implants (Vanguard, Persona Standard, and 
Persona Narrow from ZimmerBiomet, Warsaw, IN, USA; Genesis II from Smith & Nephew, 
London, UK; GK Sphere from Medacta, Castel San Pietro, Switzerland; Gemini from 
Waldemar Link, Hamburg, Germany, and PFC Sigma, Attune Standard, and Attune Narrow 
from DePuy Synthes, Warsaw, IN, USA) were collected from the manufacturers’ brochures. 
 
Statistical analysis 
The descriptive statistics for all anthropometric radiological measurements of the knee, age, 
sex, height, BMI, and degree of ROA (KL score) were recorded. The differences between the 
groups were analyzed using t tests for normally distributed continuous data or the chi-square 
test for ordinal data (KL). The anatomical measurements of both Asian and Caucasian knees 
were calculated and compared with the measurements of the type (brand) of knee implant. 
 
fig. 2 Radiographic anthropometric knee measurements: (a) femorotibial angle, (b) mediolateral dimen-
sion of the femur, (c) mediolateral dimension of the tibia, (d) anteroposterior dimension of the femur, (e) 
anteroposterior dimension of the tibia, and (f ) fibular–tibial distance
The dimensions of the nine different knee implants (Vanguard, Persona Standard, 
and Persona Narrow from ZimmerBiomet, Warsaw, IN, USA; Genesis II from Smith & 
Nephew, London, UK; GK Sphere from Medacta, Castel San Pietro, Switzerland; Gemini 
from Waldemar Link, Hamburg, Germany, and PFC Sigma, Attune Standard, and Attune 
Narrow from DePuy Synthes, Warsaw, IN, USA) were collected from the manufacturers’ 
brochures.
Statistical analysis
The descriptive statistics for all anthropometric radiological measurements of th  knee, 
age, sex, height, BMI, and degree of ROA (KL score) were recorded. The differences be-
tween the groups were analyzed using t tests for normally distributed continuous data 
or the chi-square test for ordinal data (KL). The anatomical measurements of both Asian 
and Caucasian knees were calculated and compared with the measurements of the type 
(brand) of knee implant.
ReSuLTS
The preoperative femoral tibial angle (FTA) in the Asian patients was predominantly 
varus, whereas that in the Dutch patients was slightly valgus in both men and women 
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(Table 1). The ROA KL scores were comparable between the two groups: 88% of the KL 
scores were grades 3 and 4 and 12% were grade 2. The mean femoral and tibial dimen-
sions in the male and female Indonesian Asian and Dutch Caucasian patients and the 
dimensions of the nine TKA systems were smaller in the Indonesian Asian patients and 
mismatched with most knee systems of the smaller sizes (Table 2; Figures 3–8).
Table 1 Anthropometric data of the knee (femur and tibia) of Caucasian and Asian patients
  Sex n Caucasian n Asian P
FTA (dgr)
  67   67    
M 10 174 ± 5.5 10 183 ± 4.8 0.001
F 57 178 ± 5.9 57 183 ± 8.2 0.001
fML (mm)
  67   67    
M 10 84 ± 7.1 10 80 ± 9.0 n.s
F 57 75 ± 7.0 57 70 ± 5.3 <0.0001
fAP (mm)
  67   67    
M 10 66 ± 4.1 10 59 ± 5.6 0.003
F 57 59 ± 4.3 57 52 ± 4.5 <0.0001
tML (mm)
  67   67    
M 10 76 ± 7.8 10 72 ± 6.8 n.s
F 57 69 ± 6.2 57 65 ± 5.5 <0.0001
tAP (mm)
  67   67    
M 10 60 ± 2.6 10 51 ± 7.4 0.003
F 57 51 ± 3.8 57 45 ± 3.6 <0.0001
Aspect ratio 
fML/fAP 
  67   67    
M 10 1.3 ± 0.1 10 1.3 ± 0.1 n.s
F 57 1.3 ± 0.1 57 1.4 ± 0.1 <0.0001
Aspect ratio 
tML/tAP
  67   67    
M 10 1.3 ± 0.8 10 1.4 ± 0.1 0.002
F 57 1.3 ± 0.1 57 1.5 ± 0.1 <0.0001
FTA: femoral tibial angle, tML: tibial mediolateral dimension, fML: femoral mediolateral dimension, tAP: 
tibial anteroposterior dimension, fAP: femoral anteroposterior dimension, tML/tAP ratio: tibial mediolateral 
dimension divided the true anteroposterior dimension, fML/fAP ratio: femoral mediolateral dimension di-
vided by the true femoral anteroposterior dimension.
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Table 2 Knee anthropometric dimension of Asian and Caucasian patients and nine total knee systems 
 
Values are presented as mean ± standard deviation (in millimeters). 
aZimmerBiomet; bSmith & Nephew; cMedacta; dWaldemar Link; eDePuy 
 
 
 
Fig. 3 Anthropometric dimensions of the tibia and matching with nine total knee arthroplasty systems: (a) 
mediolateral (ML) and (b) anteroposterior (AP) 
 
 
fig. 3 Anthropometric dimensions of the tibia and matching with nine total knee arthroplasty systems: (a) 
ediolateral (ML) and (b) anter poste ior (AP)
femoral anthropometric measurements
The Caucasian femur was larger in both the AP and ML dimensions (Table 2; Figure 4a 
and 4b) of both males and females. The mean difference in the AP dimensions of the 
femur between the Caucasians and Asians was 6.6 mm; this was not corrected for the 
difference in height. The female patients had smaller AP and ML femoral widths (i.e., nar-
rower femoral condyles) than the male patients among both the Asian and Caucasian 
patients (Table 2). In terms of ML dimension, the Caucasian distal femur was, on average, 
6 mm larger than the Asian distal femur (Figure 4). The mean ML/AP aspect ratio of the 
femur (Table 2; Figure 7) in the Asian patients was larger than that in Caucasians, but the 
difference was insignificant. The mean fibular–tibial distance (FiTd; Figure 2f ) was com-
parable between the two groups: 10 ± 3.0 mm in Asians and 9.8 ± 3.1 mm in Caucasians.
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Femoral anthropometric measurements 
The Caucasian femur was larger in both the AP and ML dimensions (Table 2; Figure 4a and 
4b) of both males and females. The mean difference in the AP dimensions of the femur 
between the Caucasians and Asians was 6.6 mm; this was not corrected for the difference in 
height. The female patients had smaller AP and ML femoral widths (i.e., narrower femoral 
condyles) than the male patients among both the Asian and Caucasian patients (Table 2). In 
terms of ML dimension, the Caucasian distal femur was, on average, 6 mm larger than the 
Asian distal femur (Figure 4). The mean ML/AP aspect ratio of the femur (Table 2; Figure 7) 
in the Asian patients was larger than that in Caucasians, but the difference was insignificant. 
The mean fibular–tibial distance (FiTd; Figure 2f) was comparable between the two groups: 
10 ± 3.0 mm in Asians and 9.8 ± 3.1 mm in Caucasians. 
 
 
 
Fig. 4 Anthropometric dimensions of the femur (ML) and matching with nine total knee arthroplasty systems: (a) 
mediolateral (ML) and (b) anteroposterior (AP) 
fi . 4 Anthropometric dimensions of the femur (ML) and matching with nine total knee arthroplasty sys-
tems: (a) mediolateral (ML) and (b) anteroposterior (AP)
Tibial anthropometric measurements
The AP and ML tibial dimensions were larger in the Caucasian patients than in the Asian 
patients (Table 2; Figure 3a and 3b) in both males and females. On average, the ML tibial 
dimension of Caucasians was 4.3 mm larger than that of Asians. The mean aspect ratio 
of the tibia (Table 2) was larger in the Asian patients than in the Caucasian patients for 
both male and female patients (Figure 5).
Comparison of the dimensions of the nine different TKA systems with the 
anthropometric data
The largest ML dimensions of the proximal tibia in both populations could be accommo-
dated by all nine TKA systems. However, the smallest ML dimension of the proximal tibia 
in the Asian patients could not be matched with any of the nine TKA systems (Figure 
3a). The largest AP dimension of the proximal tibia in the Caucasian patients could not 
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be matched with any of the nine TKA systems. Only the Persona Standard and Persona 
Narrow TKA systems matched with the largest AP dimension of the proximal tibia in 
the Asian patients. As for the smallest AP knee implant dimension, all nine TKA systems 
could be matched with the smallest dimensions of the Caucasian knees, but none of the 
nine TKA systems matched with the smallest Asian knees (Figure 3b).
With respect to the distal femoral implant dimensions, none of the nine TKA systems 
matched with the largest ML dimension of the distal femur of both the Asian and Cauca-
sian patients. Most of the nine TKA systems matched with the smallest ML dimension of 
the distal femur of both populations (Figure 4a). Most of the nine TKA systems matched 
with the largest AP dimension of the distal femur of the Caucasian (except for Persona 
Narrow and Attune Narrow) and Asian populations (except for Attune Narrow). None 
of the nine TKA systems matched with the smallest AP dimension of the distal femur of 
the Asian patients, whereas most of the nine TKA systems could be matched with the 
Caucasian knees (Figure 4b).
The tibial aspect ratios (ML/AP) of the knee implants showed that the knee systems had 
a smaller AP diameter for the same ML diameter (Figure 6). As for the femoral aspect ra-
tios of the femur in both Asian and Caucasian knees, all nine knee systems had a smaller 
ratio than the patients’ anthropometry (Figure 8).
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patients (Table 2; Figure 3a and 3b) in bot  les and femal s. On average, the ML tibial 
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Fig. 5 Comparison of the tibial dimension between Asian and Caucasian patients 
 
Comparison of the dimensions of the nine different TKA systems with the anthropometric data 
The largest ML dimensions of the proximal tibia in both populations could be accommodated 
by all nine TKA systems. However, the smallest ML dimension of the proximal tibia in the 
Asian patients could not be matched with any of the nine TKA systems (Figure 3a). The largest 
AP dimension of the proximal tibia in the Caucasian patients could not be matched with any 
of the nine TKA systems. Only the Persona Standard and Persona Narrow TKA systems 
matched with the largest AP dimension of the proximal tibia in the Asian patients. As for the 
smallest AP knee implant dimension, all nine TKA systems could be matched with the smallest 
dimensions of the Caucasian knees, but none of the nine TKA systems matched with the 
smallest Asian knees (Figure 3b). 
With respect to the distal femoral implant dimensions, none of the nine TKA systems matched 
with the largest ML dimension of the distal femur of both the Asian and Caucasian patients. 
Most of the nine TKA systems matched with the smallest ML dimension of the distal femur of 
both populations (Figure 4a). Most of the nine TKA systems matched with the largest AP 
dimension of the distal femur of the Caucasian (except for Persona Narrow and Attune 
Narrow) and Asian populations (except for Attune Narrow). None of the nine TKA systems 
matched with the smallest AP dimension of the distal femur of the Asian patients, whereas 
most of the nine TKA systems could be matched with the Caucasian knees (Figure 4b). 
fig. 5 Comparison of the tibial dimension between Asian and Caucasian patients
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The tibial aspect ratios (ML/AP) of the knee implants showed that the knee systems had a 
smaller AP diameter for the same ML diameter (Figure 6). As for the femoral aspect ratios of 
the femur in both Asian and Caucasian knees, all nine knee systems had a smaller ratio than 
the patients’ anthropometry (Figure 8). 
 
Fig. 6 Comparison of the tibial dimension among Asian knees, Caucasian knees, and nine total knee arthroplasty 
systems 
 
 
Fig. 7 Comparison of the femoral dimension between Asian and Caucasian patients 
fig. 6 Comparison of the tibial dimension among Asian knees, Caucasian knees, and nine total knee arthro-
plasty systems
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Fig. 8 Comparison of the femoral dimensions among Asian knees, Caucasian knees, and nine total knee 
arthroplasty systems 
 
Patella dimensions 
The mean length of the patellar bone (lateral knee radiograph) was 39 ± 4.3 mm in Asians and 
40 ± 4.1 mm in Caucasians. The mean patellar tendon length was 42 ± 5.1 mm in Asians and 
52 ± 7.2 mm in Caucasians (p = 0.005). The mean Insall-Salvati index was 1.1 ± 0.15 in Asians 
and 1.3 ± 0.21 in Caucasians (p = 0.001); thus, the Asian patients had patella baja relative to 
the Caucasians patients. 
    
Discussion   
The most important finding of the present study was that the Asian patients had knees with 
smaller AP and ML dimensions of both the distal femur and proximal tibia. Overall, the smallest 
sizes in the Asian patients could not be matched with any of the nine knee systems. The Asian 
patients were, on average, 6% shorter than the Caucasian patients and had smaller distal 
femoral and proximal tibial dimensions. This suggests that to have an optimal fit, the knee 
systems should be available in a wider range of sizes (i.e., more smaller sizes) in accordance 
with the findings from an earlier study.15 However, Asian knees also have a wide range of 
dimensions, with even higher ML/AP ratios than Caucasian knees. This stresses that 
differences in knee shape between the two groups exist, which is supported by an earlier 
study.41 Nevertheless, it also underscores that a mismatch is created when the total knee 
fig. 8 Comparison of the femoral dimensions among Asian knees, Caucasian knees, and nine total knee 
arthroplasty systems
Patella dimensions
The mean length of the patellar bone (lateral knee radiograph) was 39 ± 4.3 mm in 
Asians and 40 ± 4.1 mm in Caucasians. The mean patellar tendon length was 42 ± 5.1 
mm in Asians and 52 ± 7.2 mm in Caucasians (p = 0.005). The mean Insall-Salvati index 
was 1.1 ± 0.15 in Asians and 1.3 ± 0.21 in Caucasians (p = 0.001); thus, the Asian patients 
had patella baja relative to the Caucasians patients.
dISCuSSIoN
The most important finding of the present study was that the Asian patients had knees 
with smaller AP and ML dimensions of both the distal femur and proximal tibia. Overall, 
the smallest sizes in the Asian patients could not be matched with any of the nine knee 
systems. The Asian patients were, on average, 6% shorter than the Caucasian patients 
and had smaller distal femoral and proximal tibial dimensions. This suggests that to 
have an optimal fit, the knee systems should be available in a wider range of sizes (i.e., 
more smaller sizes) in accordance with the findings from an earlier study.15 However, 
Asian knees also have a wide range of dimensions, with even higher ML/AP ratios than 
Caucasian knees. This stresses that differences in knee shape between the two groups 
exist, which is supported by an earlier study.41 Nevertheless, it also underscores that 
a mismatch is created when the total knee prosthesis design is based only on a small 
33
Anthropometric measurement of Indonesian versus Dutch patients
Ch
at
er
 2
range of Caucasians. Long-term success of TKA depends on an optimal match between 
the prosthesis and the resected bone. Therefore, different dimensions of knee design 
should be used in Asian patients to optimize the biomechanical performance of the 
artificial knee joint. Furthermore, the female knee tends to be smaller in width than the 
male knee, which is consistent with the results of other published studies.17,18,29 In addi-
tion to implant fit, functional knee phenotypes also have an impact on knee outcome, as 
implant alignment affects intraoperative bone resection. Therefore, they will influence 
the patients’ AP and ML distal femoral and proximal tibial dimensions, implant size, and 
implant–bone fit during TKA.14 When mechanical alignment in the restricted kinematic 
alignment phenotype is used, the medial or lateral compartment might increase even 
in a normosized component. It will also cause excessive tension on the capsule and 
ligaments, which may eventually lead to the stiffening of the knee or unexplained 
postoperative knee pain.
The mean ranges of the FiTd were 8–11 and 9–12 mm for the Caucasians and Asians, 
respectively, which were comparable. However, because the smallest tibial component 
could not fit the smallest Asian knee, resecting part of the fibular head would be neces-
sary to accommodate the much bigger tibial component.32 Similar to the findings of our 
study, Havet et al. also found no association between FiTd and height.13 With regard to 
the relative patella baja in the Asian patients as compared with the Caucasian patients, 
this should be taken into account when bone resections are planned during TKA.
The Asian knee has a slightly varus alignment1,16,33 with a limited range of motion preop-
erative and more severe varus and flexion contractures.8 Therefore, more extensive soft 
tissue release of the posterior capsule is often required, necessitating the use of a larger 
AP dimension with a certain ML femoral dimension of the knee implant. We found that 
most knee systems did not accommodate the smallest Asian knee sizes; thus, a good 
ML fit of the femoral implant will either have an anterior overhang or cause overstuffing 
of the knee joint. Meanwhile, a good AP fit of the implant may cause undersizing of 
the ML dimension, thereby avoiding both anterior notching and overstuffing. These 
mismatches were also found in Korean, Japanese, and Brazilian patient groups.21,22,36 A 
mismatch between a knee implant and anatomy (e.g., overhang) may cause complaints, 
whereas a mismatch with the tibial component may cause more symptoms than the 
femoral components.11,17,25,27,40 Surgeons have to decide whether to select bigger or 
smaller components when the implant tibial component and the resected proximal 
side of the tibia are mismatched, which in turn will result in either overhanging and 
underhanging, respectively.39 An overhang of either the femur or the tibia might in-
crease capsular tension and ultimately lead to overvolumizing. This will increase joint 
pressure and cause pain and stiffness of the knee.25,26 The overhang also causes popliteal 
impingement of either the femur or the tibia. Even in cases of normosized implants, 
popliteal impingement can still be found, especially in oversized implants or in case 
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of posterolateral overhanging due to rotation of the tibial component. Either way, this 
causes knee pain and stiffening.3 Overhanging of the tibial component, on the medial 
side, causes stress on the soft tissues that envelop during range of motion movements, 
which also results in persistent knee pain after TKA. Furthermore, overstuffing the knee 
with an implant will also cause excessive tension on the capsule and ligaments, which 
may lead to knee stiffening or postoperative knee pain.7 In contrast to oversizing, un-
dersizing the tibial component may eventually lead to earlier mechanical loosening of 
the bone–implant interface due to the overload of the trabecular bone.2 Considering 
the problems associated with both oversizing and undersizing of the tibial component 
of the knee implants, a good implant fit is important because a mismatch between the 
knee bone and implant will lead to early loosening, pain, and subsequent revision.
As for the femoral component, an anterior overhang of the femoral implant might cause 
patella overstuffing, which increases the patellofemoral forces; in turn, these might 
disturb the extensor mechanism and limit knee flexion.17,30 Besides the difference in 
implant size, the native femur also has a different shape (more trapezoidal) as compared 
with the TKA systems. This difference in shape might cause an anterior overhang or 
overstuffing.4 Usually, to avoid anterior overstuffing, some surgeons prefer to undersize. 
The femoral implant shape becomes important and worth considering when choosing 
TKA systems. Another consideration to avoid a femoral implant mismatch is the surgical 
technique. Hence, if the external rotation of the femoral component is too much (≥5°), 
an overhang can be created, even in normosized femoral components.5,34 The femoral 
component should not be externally rotated by >3° unless the extensive valgus has 
been released. Thus, to obtain the best fit for Asian femoral condyles, the patients’ knee 
phenotypes and preoperative measurements, the characteristics of each TKA system 
and sizing, and intraoperative remeasurements are required not only to avoid under-
hang or overhang but also to gain optimal flexion-extension (AP length) and soft tissue 
tensioning (ML width). Preoperative templating is important for guidance on the most 
optimal fit, although a slight discrepancy with the actual size might be present during 
surgery. Even a preoperative computed tomography (CT) or magnetic resonance imag-
ing (MRI) scan will not solve this problem, as intraoperative findings can lead to changes 
in preoperative plans, especially in more severely deformed knees (e.g., varus or valgus, 
osteophytes).
The Asian tibia tended to be narrower in ML width than the tibial components of the nine 
TKA systems for a given AP size. In a previous study, Bonnin et al. found that only 17% of 
patients have similar medial and lateral tibial plateau sizes and most had smaller lateral 
plateaus. For this reason, either asymmetrical plateaus are preferred or the component is 
rotated.6 Three systems had an asymmetrical tibial component design: the Persona Stan-
dard and Persona Narrow knee designs (ZimmerBiomet) and the Genesis II TKA system 
(Smith & Nephew). However, even these asymmetrical plateaus may cause overhang if 
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the smallest size does not accommodate the smallest knee morphological phenotype. 
Technically, the tibial baseplate should be aligned by referencing with respect to the 
anterior tibial tuberosity, thus externally rotating to the posterior margin. This will cause 
loss of coverage on the medial side and some overhang on the posterolateral side if the 
component is too big. Even in normosized implants, tibial baseplate positioning causes 
posterolateral overhang that should be avoided. Therefore, the surgical technique and 
implant sizing also play important roles in avoiding overhang.
The ML/AP aspect ratios of the distal femur in both patient groups were larger than those 
of all nine knee systems. This implies that all nine knee systems minimize overstuffing 
of the joint. As for the proximal tibia, most of these tibial component knee implants are 
larger than the anthropometric tibia ML/AP aspect ratios. It is interesting that some im-
plants have similar ML diameters but smaller AP diameters, whereas others have larger 
AP diameters with the same ML diameter.
This study has some limitations. First, although 268 coronal and sagittal radiographs 
were used in the measurements, the sample size might be too small, which might have 
caused a type II error. So, increasing the number of measurements in a larger cohort 
will increase external validity of our findings. Nevertheless, our results indicate that dif-
ferences existed between the different patient groups, emphasizing the importance of 
preoperative templating. Thus, a specific implant can be selected for a specific knee. A 
larger study group would most probably underscore this, thus reducing the possibility 
of a type II error. Second, we used routine radiographs to assess the anthropometric 
morphology of the knees of both patient groups. Although CT and MRI scans will indeed 
provide more information on the real morphological dimensions, templating of knee 
implants on radiographs reflects daily clinical practice. The intraclass correlation coef-
ficient of the interobserver variability in this study was high at 0.853 (good reliability) 
for the tibial measurements and 0.776 (good reliability) for the femoral measurements. 
The latter has been reported in other studies as well.10,12,35 Finally, only nine knee implant 
systems were used for comparison with the anthropometric measurements of the two 
patient groups.
With the results of this study, surgeons might predict and learn to match the implant 
type and size on the basis of patient sex and ethnicity. Different TKA techniques should 
also be used according to the patient’s anthropometry and knee phenotypes.
CoNCLuSIoN
Absolute and relative differences in knee dimensions exist not only between Asian 
and Caucasian knees but also within both groups. Although Indonesian Asian patients 
are smaller, variations within the same ethnic group exist; furthermore, small Dutch 
phenotype and tall Indonesian phenotype exist and vice versa. As different phenotypes 
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exist, an increase in the range of available knee component sizes will be beneficial for 
patients. Extending the range of the tibial and femoral components with one to two 
smaller sizes in all dimensions for the Asian populations will increase the range of 
optimal fit. Therefore, considering ethnicity and sex is important when planning TKA 
and selecting the optimal fit to the joint. Increases in current implant sizes (one size 
larger and one size smaller) will accommodate a better fit to the different human phe-
notypes. As three-dimensional printing facilities for acetabular implants components 
are becoming increasingly available, the same might happen for the tibial and possibly 
the femoral components of a total knee system. Patient-specific printed implants based 
on preoperative scans or statistical shapes will create implants with the most optimal 
fit. However, the surgical technique to position and place the implant will still be an 
important issue, also with robotic placement. In the end, TKA remains a compromise to 
nature.
37
Anthropometric measurement of Indonesian versus Dutch patients
Ch
at
er
 2
RefeReNCeS
 1. Bellemans J, Colyn W, Vandenneucker H, Victor J. The Chitranjan Ranawat award: is neutral me-
chanical alignment normal for all patients? The concept of constitutional varus. Clin Orthop Relat 
Res. 2012;470:45–53.
 2. Bloebaum RD, Bachus KN, Mitchell W, Hoffman G, Hofmann AA. Analysis of the bone surface area 
in resected tibia. Implications in tibial component subsidence and fixation. Clin Orthop Relat Res. 
1994;302:2–10.
 3. Bonnin MP, de Kok A, Verstraete M, Van Hoof T, Van der Straten C, Saffarini M, Victor J. Popliteus im-
pingement after TKA may occur with well-sized prostheses. Knee Surg Sports Traumatol Arthrosc. 
2017;25:1720–1730.
 4. Bonnin MP, Saffarini M, Bossard N, Dantony E, Victor J. Morphometric analysis of the distal femur 
in total knee arthroplasty and native knees. Bone Joint J. 2016;98-B:49–57.
 5. Bonnin MP, Saffarini M, Nover L, van der Maas J, Haeberle C, Hannink G, Victor J. External rotation 
of the femoral component increases asymmetry of the posterior condyles. Bone Joint J. 2017;99-
B:894–903.
 6. Bonnin MP, Saffarini M, Shepherd D, Bossard N, Dantony E. Oversizing the tibial component 
in TKAs: incidence, consequences and risk factors. Knee Surg Sports Traumatol Arthrosc. 
2016;24:2532–2540.
 7. Bonnin MP, Schmidt A, Basiglini L, Bossard N, Dantony E. Mediolateral oversizing influences pain, 
function, and flexion after TKA. Knee Surg Sports Traumatol Arthrosc. 2013;21:2314–2324.
 8. Budhiparama NC, Gaudiani MA, White PB, Satalich J, Nelissen RG, Ranawat AS, Ranawat CS. A 
comparison of clinical and patient-reported outcome measures of TKR: Comparison of Asian to 
North American patients. J Orthop Surg. 2019;27:230949901984455.
 9. Dutch Arthroplasty Register (LROI) (2018) Online LROI annual report 2018. Available via http://
www.lroi-report.nl. Accessed 09 June 2019.
 10. Ettinger M, Claassen L, Paes P, Calliess T (2016) 2D versus 3D templating in total knee arthroplasty. 
Knee 23:149–151.
 11. Gaillard R, Bankhead C, Budhiparama N, Batailler C, Servien E, Lustig S. Influence of patella height 
on total knee arthroplasty: outcomes and survival. J Arthroplasty. 2019;34:469–477.
 12. Gaizo D, Soileau E, Lachiewicz P. Value of preoperative templating for primary total knee arthro-
plasty. J Knee Surg. 2009;22:284–293.
 13. Havet E, Gabrion A, Leiber-Wackenheim F, Vernois J, Olory B, Mertl P. Radiological study of the 
knee joint line position measured from the fibular head and proximal tibial landmarks. Surg 
Radiol Anat. 2007;29:285–289.
 14. Hirschmann MT, Moser LB, Amsler F, Behrend H, Leclerq V, Hess S. Functional knee phenotypes: a 
novel classification for phenotyping the coronal lower limb alignment based on the native align-
ment in young non-osteoarthritic patients. Knee Surg Sports Traumatol Arthrosc. 2019;27:1394–
1402.
 15. Hitt K, Shurman JR, Greene K, McCarthy J, Moskal J, Hoeman T, Mont MA. Anthropometric mea-
surements of the human knee: correlation to the sizing of current knee arthroplasty systems. J 
Bone Joint Surg Am. 2003;85-A Suppl:115–122.
 16. Hovinga KR, Lerner AL. Anatomic variations between Japanese and Caucasian populations in the 
healthy young adult knee joint. J Orthop Res. 2009;27:1191–1196.
Chapter 2
38
 17. Kawahara S, Matsuda S, Fukagawa S, Mitsuyasu H, Nakahara H, Higaki H, Shimoto T, Iwamoto Y. 
Upsizing the femoral component increases patellofemoral contact force in total knee replace-
ment. J Bone Joint Surg Br. 2012;94-B:56–61.
 18. Kim D-I, Kwak D-S, Han S-H. Sex determination using discriminant analysis of the medial and 
lateral condyles of the femur in Koreans. Forensic Sci Int. 2013;233:121–125.
 19. Kim H-A, Kim S, Seo YI, Choi HJ, Seong S-C, Song YW, Hunter D, Zhang Y. The epidemiology of total 
knee replacement in South Korea: national registry data. Rheumatology. 2008;47:88–91.
 20. Kim TK, Phillips M, Bhandari M, Watson J, Malhotra R. What differences in morphologic features 
of the knee exist among patients of various races? A systematic review. Clin Orthop Relat Res. 
2017;475:170–182.
 21. Kwak D-S, Han S, Han CW, Han S-H. Resected femoral anthropometry for design of the femoral 
component of the total knee prosthesis in a Korean population. Anat Cell Biol. 2010;43:252.
 22. Loures FB, de Araújo Góes RF, da Palma IM, Labronici PJ, Granjeiro JM, Olej B. Anthropometric 
study of the knee and its correlation with the size of three implants available for arthroplasty. Rev 
Bras Ortop. 2016;51:282–289.
 23. Lum ZC, Shieh AK, Dorr LD. Why total knees fail-a modern perspective review. World J Orthop. 
2018;9:60–64.
 24. Mahfouz M, Abdel Fatah EE, Bowers LS, Scuderi G. Three-dimensional morphology of the knee 
reveals ethnic differences. Clin Orthop Relat Res. 2012;470:172–185.
 25. Mahoney OM, Kinsey T. Overhang of the femoral component in total knee arthroplasty: risk fac-
tors and clinical consequences. J Bone Joint Surg Am. 2010;92:1115–1121.
 26. Marmor S, Renault E, Valluy J, Saffarini M. Over-voluming predicted by pre-operative planning in 
24% of total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2018;27(5):1544-1551.
 27. McCrory P. Campbell’s operative orthopaedics, 10th ed (4 vols). Br J Sports Med. 2004;38:367 LP – 
367.
 28. Mensch JS, Amstutz HC. Knee morphology as a guide to knee replacement. Clin Orthop Relat Res. 
1975;112:231–241.
 29. Merchant AC, Arendt EA, Dye SF, Fredericson M, Grelsamer RP, Leadbetter WB, Post WR, Teitge RA. 
The female knee: anatomic variations and the female-specific total knee design. Clin Orthop Relat 
Res. 2008;466:3059–3065.
 30. Mihalko W, Fishkin Z, Krakow K. Patellofemoral overstuff and its relationship to flexion after total 
knee arthroplasty. Clin Orthop Relat Res. 2006;449:283–287.
 31. Ritter MA, Faris PM, Keating EM, Meding JB. Postoperative alignment of total knee replacement. 
Its effect on survival. Clin Orthop Relat Res. 1994;299:153–156.
 32. Rojanasthien S, Okamoto R, Ozawa N, Koshino T. Tibial plateau-fibular head distance of normal 
Japanese knees measured in lateral view of roentgenogram. Nihon Seikeigeka Gakkai Zasshi. 
1989;63:1353–1357.
 33. Tamari K, Tinley P, Briffa K, Aoyagi K. Ethnic-, gender-, and age-related differences in femorotibial 
angle, femoral antetorsion, and tibiofibular torsion: cross-sectional study among healthy Japa-
nese and Australian Caucasians. Clin Anat. 2005;19:59–67.
 34. Thienpont E, Becker R. Anthropometric measurements of the knee: time to make it fit. Knee Surg 
Sports Traumatol Arthrosc. 2014;22:2889–2890.
 35. Trickett RW, Hodgson P, Forster MC, Robertson A. The reliability and accuracy of digital templat-
ing in total knee replacement. J Bone Joint Surg Br. 2009;91-B:903–906.
 36. Urabe K, Miura H, Kuwano T, Matsuda S, Nagamine R, Sakai S, Masuda K, Iwamoto Y. Comparison 
between the shape of resected femoral sections and femoral prostheses used in total knee 
39
Anthropometric measurement of Indonesian versus Dutch patients
Ch
at
er
 2
arthroplasty in Japanese patients: simulation using three-dimensional computed tomography. J 
Knee Surg. 2003;16:27–33.
 37. Vaidya S V, Ranawat CS, Aroojis A, Laud NS. Anthropometric measurements to design total knee 
prostheses for the Indian population. J Arthroplasty. 2000;15:79–85.
 38. van Hamersveld KT, Marang-van de Mheen PJ, Nelissen RGHH. The effect of coronal alignment on 
tibial component migration following total knee arthroplasty. J Bone Joint Surg. 2019;101:1203–
1212.
 39. Westrich GH, Agulnick MA, Laskin RS, Haas SB, Sculco TP. Current analysis of tibial coverage in 
total knee arthroplasty. Knee. 1997;4:87–91.
 40. Yang B, Song C, Yu J, Yang Y, Gong X, Chen L, Wang Y, Wang J. Intraoperative anthropometric 
measurements of tibial morphology: comparisons with the dimensions of current tibial implants. 
Knee Surg Sports Traumatol Arthrosc. 2014;22:2924–293.
 41. Yue B, Varadarajan KM, Ai S, Tang T, Rubash HE, Li G. Differences of knee anthropometry between 
Chinese and white men and women. J Arthroplasty. 2011;26:124–130.

Chapter 3
A comparison of clinical and patient 
recorded outcomes of TKR in Asian 
versus North American patients
Budhiparama N.C.
Gaudiani M.A.
White P.B.
Satalich J.
Nelissen R.G..
Ranawat A.S.
Ranawat C.S.
Journal of Orthopaedic Surgery (2019);27(2):1–6
Chapter 3
42
ABSTRACT
Background. Cultural differences between continents may also affect the outcome on 
interventions. This study compared an Asian and North American cohort of total knee 
replacement (TKR) patients.
Questions/purposes. This study aims to compare the patient-reported outcome measures 
as well as a functional outcome after TKR between these two different patient popula-
tions with a different cultural societal background in two different countries.
Patients and Methods. A retrospective study on two cohorts of 76 Asian TKR patients and 
64 North American TKR patients were compared. Demographics, patient-reported out-
come measures (Knee Society Score (KSS), Patient-Administered Questionnaire (PAQ), 
and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)), knee 
range of motion (ROM), and radiographic component position were compared.
Results. The Asian cohort had more females compared to the North American and sig-
nificantly worse preoperative ROM, and worse KSS function score and PAQ pain scores. 
The preoperative KSS knee score and WOMAC scores were comparable between the two 
groups. Postoperatively, the differences in WOMAC and KSS knee scores were significant, 
while KSS function and PAQ were comparable between groups.
Conclusions. Even though Asian TKR patients had significantly worse preoperative 
scores, their postoperative outcomes were comparable to North Americans. The higher 
preoperative functional deficit and the higher pain levels in the Asian population might 
be due to cultural differences and/or socioeconomic reasons, which made Asian patients 
present with more severe conditions in the preoperative consultation for a possible sur-
gical treatment compared to North Americans. More research is needed to investigate 
the difference between these cultural impacts on TKR outcomes.
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INTRoduCTIoN
Osteoarthritis (OA) is a common cause of debilitating knee pain. Total knee replacement 
has emerged as an effective treatment for osteoarthritis of the knee. Clinical outcomes 
have been positive and total knee replacements are now performed worldwide.1-3 
Previous studies have examined the outcomes and compared the results across dif-
ferent Western countries, such as the Sweden, The Netherlands, United States, United 
Kingdom, and Australia.4-7 The variation of patients preoperatively has been thought to 
be a result of different health care systems and access. However, these populations are 
largely Caucasian, living in comparable societies with presumably similar stresses on 
their knees during daily living. There has not been a comparison of total knee clinical 
outcomes between a Western population and an Asian population who live in their 
continent with their specific societal surroundings, which will also have an impact on 
the lower extremity and more specifically, knee use.
Asian populations have different cultural practices than Western populations and have 
been found to have a higher prevalence of tibiofemoral OA when compared to Cauca-
sian subjects.8,9 Studies suggest that the cause is due to squatting, which is common 
among Asian populations. Squatting requires a high degree of knee flexion and five to 
six times more tibiofemoral contact forces than bodyweight. It has been found that the 
tibiofemoral reaction forces from posterior direction to anterior happens rapidly when 
squatting and those have significant long-term effects on the joint cartilage.10 These 
effects could result in variations between Western and Asian populations both at the 
preoperative and at the postoperative state.
There is also an average size difference between Asian and Caucasian populations. Mor-
phometric analyses have found that typically an Asian knee is smaller than a Caucasian 
knee.11–13 These factors could contribute to different clinical outcomes between an Asian 
and a Caucasian population in its relations with implant design14,15 and warrants more 
research.
In addition to the morphological differences, there are large socioeconomic differences 
between certain Asian and North American populations. For example, the World Bank 
classifies the United States as a “high income” country and Indonesia as “lower middle 
income”.16 Socioeconomic factors have been found to contribute to different preopera-
tive status in various ethnic groups.17
We aim to compare the clinical and patient-reported outcome measures (PROM) and 
postoperative radiographic measurements between the two patient cohorts. Our first 
objective was to assess the variation in clinical and PROM of TKR between these two 
populations. The second objective was to identify what factors influence the variation in 
clinical and PROM between the two populations.
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MATeRIAL ANd MeThodS
A retrospective analysis of two institutional review board approved registries of patients 
with TKRs at two institutions between 2007 and 2014. One institution was located in 
Indonesia and has a patient base that is primarily of Chinese, Malay, or Indian ethnic 
backgrounds, whereas the other location was located in the United States with a patient 
base majority of Caucasian. To prevent confounding data due to knee implant design, 
the same implant was studied between the Asian and Caucasian cohorts. The inclu-
sion criteria were patients with OA who underwent primary TKR using the PFC Sigma 
rotating platform with high flexion posterior stabilized design (DePuy Synthes, Warsaw, 
Indiana, USA). The exclusion criteria were patients with revision TKR and patients with 
periprosthetic joint infection. Thus, 76 TKRs from the Indonesia Institution and 64 from 
the United States Institution could be included. None of the patients were lost to follow-
up. The follow-up averaged between 4.27 years and 4.40 years for the Asian and North 
American cohorts, respectively.
Two fellowship trained, high-volume, arthroplasty specialists performed all TKRs, using 
similar gap-balancing techniques. Both surgeons used similar pain protocols, which 
included an intraarticular injection, and both cohorts of patients went home with the 
same rehabilitation protocols after surgery. All patients were matched for age and body 
mass index (BMI).
All patients had clinical findings recorded preoperatively and at their latest annual 
follow-up. Clinical findings included range of motion (ROM) as measured by a goniom-
eter by one of the two senior authors. Flexion values, as well as the presence of flexion 
contractures, were measured at each follow-up appointment. Full ROM was defined 
as flexion values minus the degree of the flexion contracture. Pain and function were 
assessed preoperatively and at the last follow-up using both the knee society pain and 
function scores (KSS, a higher score indicates better function), as well as the Western On-
tario and McMaster Universities Osteoarthritis Index (WOMAC, a lower score indicates 
better function). Additionally, a patient administered questionnaire (PAQ) was utilized 
to assess patient satisfaction, pain, and difficulty performing flexion-based activities, 
including kneeling, negotiating stairs, squatting, and sitting on heels.18 The pain domain 
portion of the PAQ was reported separately (a higher score indicates more pain).
Anteroposterior (AP) and lateral knee radiographs were collected at the last follow-up at 
both institutions. AP femoral flexion, AP tibial angles, lateral femoral flexion, and lateral 
tibial angles were calculated with the same technique to assess component position-
ing and alignment in the coronal and sagittal planes. This technique was previously 
described in Gromov et al.19
Statistics were primarily descriptive with means and standard deviations calculated 
for continuous variables; frequencies and percentages were calculated for discrete 
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variables. Comparison between cases and controls was made using independent t-test. 
Significance was set at a p-value <0.05. Analyses were performed using SPSS version 25.
ReSuLTS
Preoperative patient demographics are found in Table 1. No significant difference in de-
mographic data between Asian and North American patients were seen. The mean age 
for Asian and North American were 68.85 ± 3.90 years and 70.02 ± 5.29 years respectively 
with no significant difference (p=0.107). The mean BMI for Asian and North American 
was 27.46 ± 3.58 and 28.40 ± 4.41 respectively with no significant difference (p=0.276).
Preoperative clinical scores showed the Asian cohort had significantly lower scores than 
North American patients for both KSS function score (54.34 ± 12.00 vs. 61.79 ± 18.63; 
p=0.006) and knee ROM (103.88 ± 19.41 vs. 111.17 ± 13.11; p=0.016). Compared to the 
American cohort, the Asian patients also had significantly higher (i.e. more pain) preop-
erative PAQ pain scores (18.4 ± 4.3 vs. 16.1 ± 2.0; p=0.001) but better for total PAQ score 
(65.15 ± 10.58 vs. 74.01 ± 16.90; p=0.0001). No significant difference between Asian 
and North American for KSS Knee Score (53.40 ± 14.55 and 55.67 ± 14.10 respectively; 
p=0.266) and WOMAC Score (70.25 ± 7.55 and 68.56 ± 11.53 respectively; p=0.173).
Postoperatively, the Asian cohort had a slightly lower KSS Knee score (93.18 points ± 
4.72 vs. 96.50 points ± 4.64; p=0.0001) but better WOMAC scores (33.36 ± 10.11 vs. 37.90 
± 12.71; p=0.021) compared to North American TKR patients. The postoperative range 
of motion of the knee (p=0.661), KSS function score (p=0.441), and total PAQ score 
(p=0.335) were comparable between the two cohorts (Table 2).
The postoperative mean femorotibial angle was 184.9° ± 1.09 for the Asian TKR patients 
and 184.2° ± 2.82 for the North American TKR (p=0.133). Position of the TKR as measured 
at radiographs, showed that the mean AP femoral component angle of the TKR in the 
Asian cohort was 95.6° ± 1.19 and the North American 94.4° ± 2.28° (p<0.0001). The 
mean AP tibial angle in Asian knees was 89.3° ± 1.1° and the North Americans TKR 89.8° 
± 2.1° (p=0.051). On the lateral radiographs, TKR positions were different as well, the 
Asian cohort had less lateral femoral flexion position than the North American TKRs 
(8.3° ± 3.02° vs. 14.9° ± 3.74°; p<0.0001); the lateral tibial slope angle was slightly higher 
in the Asian TKRs compared to the North American TKRs (86.0° ± 2.12° vs. 90.8° ± 3.2°; 
p<0.0001).
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Table 1. Preoperative patient characteristics
Asian North American p-value
Mean Std Mean Std  
Age (years) 68.85 3.90 70.02 5.29 0.107
BMI 27.46 3.58 28.40 4.41 0.2763
Follow up 4.27 1.29 4.40 0.63 0.763
SD: standard deviation; BMI: body mass index
Table 2. Clinical and patient recorded outcome scores comparing Asian with North American patients.
Pre-op Post-op
Asian
North
American   Asian
North
American  
Mean Std Mean Std P-value Mean Std Mean Std P-value
Range of Motion (°) 103.88 19.41 111.17 13.11 0.016 123.94 11.35 124.42 10.55 0.661
Knee Society Knee scorea 53.40 14.55 55.67 14.10 0.266 93.18 4.72 96.50 4.64 0.000
Knee Society Function scorea 54.34 12.00 61.79 18.63 0.006 97.23 3.50 93.75 11.81 0.441
WOMACb 70.25 7.55 68.56 11.53 0.173 33.36 10.11 37.90 12.71 0.021
PAQb 65.15 10.58 74.01 16.90 0.000 20.05 14.04 26.89 22.95 0.335
PAQ Pain Scoreb 18.4 4.3 16.1 4.3 0.0009 11.3 2.0 11.7 2.7 0.2936
SD: standard deviation; WOMAC: Western Ontario and McMaster Universities Osteoarthritis Index; PAQ: 
Patient-Administered Questionnaire
a higher scores are better
b lower scores are better
Table 3. Comparison of post-operative TKR position at AP and Lateral Radiographs in the two cohorts
Degree Asian TKR position North American TKR P-value
AP Femoral component Anglea 95.6 ± 1.2° 94.4 ± 2.3° <0.000
AP Tibial component Anglea 89.3 ± 1.1° 89.8 ± 2.1° 0.06
AP Femorotibial Angleb 184.9 ± 1.2° 184.1 ± 3.4° 0.04
Lateral radiograph Femoral component positionc 8.3 ± 3.0° 14.9 ± 3.7° <0.0001
Lateral radiograph Tibial sloped 86.0 ± 2.1° 90.8 ± 3.2° <0.0001
TKR: total knee replacement; AP: anteroposterior
a>90° are in valgus, <90° are in varus
b>180° is valgus
cLarger value indicates more component flexion versus extension
d<90° more posterior slope
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dISCuSSIoN
Both the Asian and North American cohort had an improvement in postoperative range 
of motion, function and pain scores. Interestingly, despite a lower preoperative range of 
motion of the knees in the Asian patients, postoperatively, there was no significant dif-
ference between the two patient populations. This is interesting because preoperative 
range of motion is found in multiple studies to be an important determinant of post-
operative range of motion, which is again associated with overall patient satisfaction 
and functional level.20-25 Asian patients with the same TKR design as the North Ameri-
can population had a larger improvement of postoperative range of motion of knees 
despite a worse ROM preoperatively. This is caused by either implant position and/or 
postoperative rehabilitation. The femoral component was in 7 degrees more flexion 
position in North American knees, while the tibial component was in about 4 degrees 
more posterior tilt, thus these component positions seemed not to be a major cause 
for the better postoperative ROM improvement in Asian TKR. With respect to rehabilita-
tion, both hospitals started with a protocol of immediate postoperative ROM exercises 
and ambulation. A possible difference in the Asian and the Caucasian patients is that 
the former needs hyperflexion for daily life, either for squatting or for praying position 
(i.e. Moslem). These cultural differences in knee use are most probably related to the 
better functional recovery of the knees in Asian patients. The significant improvement 
in postoperative KSS pain score, KSS functional score, and WOMAC score were found 
in Asian cohort especially in WOMAC pain night in bed, pain sitting, pain standing, AM 
and PM stiffness, rising from sitting, standing, bending WOMAC, and on/off WOMAC. 
The most important is KSS functional and WOMAC pain sitting and standing, and AM 
and PM stiffness, since we know that Asian people have many cultural and religious 
activities that require improvement of those functions. Although other factors such as 
obesity also influence postoperative range of motion, the BMI was comparable between 
both cohorts.
Our results are in contrast with another study using the same mobile bearing high 
flexion design (Sigma RPF) which concluded that preoperative flexion and the design 
of the knee prosthesis were the predominant factors of postoperative flexion.26 But 
that study was most likely done in Caucasians. Another previous study also found that 
preoperative flexion played a significant role in the postoperative gain in flexion and 
not the type of prosthesis.27 These results have been found for more than two decades 
by others.17,25-28 Furthermore, our results also indicate that for North American and Asian 
patients, despite the various differences in knee morphology, preoperative deformity, 
and postoperative use in daily life, the implant provides comparable postoperative 
outcomes in both patient cohorts.
In our study, we found a slightly worse, preoperative WOMAC score for Asian compared 
to North American, and a higher PAQ pain scores (i.e. more pain). The latter might reflect 
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cultural and social differences between these countries. In Asian cohort, it is possible that 
socioeconomic status is associated with delayed healthcare, with a subsequent worse 
osteoarthritis stage at presentation for treatment. Although this research was done 
in a private hospital in Indonesia, the insurance coverage, both from national health 
care and private do not fully cover the surgery expenses. This economic shortcoming 
causes patients to delay getting their surgeries. Despite this, the postoperative patient 
reported scores were comparable between these two groups and even slightly better 
(i.e. KSS knee, WOMAC, overall PAQ) for the Asian patients. The overall PAQ (i.e. patient 
satisfaction, flexion-based activities including kneeling, negotiating stairs, squatting 
and sitting on heels) was 30% better in Asians (20 vs. 27 points in North Americans), but 
did not reach significance.
A study from Singapore among different ethnicities, did also found no statistical differ-
ence in outcome measures for TKR of different ethnic groups.24 The difference between 
that study and ours is most likely the result of the different patient ethnicities within 
different social settings (Indonesia and US) in contrast to different patient ethnicities 
(Malay, Chinese and Indian) within the same social setting (Singapore).
Preoperative PAQ Pain score in Asian cohort was significantly higher than in North 
American. Based on a previous study by Mengelson et al,29 pain is a major determinant 
for outcome of TKA among women, and different perceptions of pain are noted in vari-
ous ethnic groups, thus ethnicity should be considered as a covariate in evaluating TKA 
outcomes. Nevertheless, Asian patients had higher postoperative KSS knee score and 
WOMAC outcome scores.
Preoperative clinical score comparison between these two cohorts showed slightly but 
significantly worse scores (i.e. in ROM, KSS function score and PAQ pain score) in Asian 
cohort compared to the North American. These results supported a previous study 
conducted across Europe, Canada, the United States, UK, and Australia for outcome 
of total knee replacement, which showed a wide range of preoperative scores across 
these countries.4,5 The authors attributed the worse WOMAC scores and knee function 
to the long waiting times in the UK compared to other countries as well as to cultural 
differences. Gossec et al comparing almost 2000 patients, found high preoperative pain 
levels mainly in Canada, with lower pain levels in most European countries.5 For that 
matter, the severity of the preoperative pain level is considered by most surgeons to 
be the major determinant to indicate a total knee replacement, in presence of at least 
moderate radiological osteoarthritis and old age.7
It has been reported that ethnic minorities in the US are less likely to consider TKR, due 
to limited health care access, cultural and socio-economic factors such as familiarity, 
and cost.17 Such social differences are seldom mentioned in articles but are a major 
driver when indicating and performing elective arthroplasty surgery. For that matter, 
comparing results between countries can be severely biased, health care access differ-
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ences are present in the Netherlands, which has a solidarity system of private health 
insurance.6 Reliance on natural remedies, religious beliefs, and fear of surgery are also 
additional factors, which have been found to influence the decision to engage in TKR. 
We presume a variety of these reasons cause a delay in presentation in Asian patients, 
which explained why Asian patients had lower function score, worse ROM, and higher 
patient pain scores preoperatively.
Postoperative outcome scores were clinically comparable even after controlling for 
confounding variables. Our results mirror other studies in finding that geographic lo-
cation alone does not dictate outcome scores,1 despite differences in socio-economic 
environment.6 However, in a study examining outcomes in the United States, the United 
Kingdom, and Australia, patients in the United Kingdom had lower postoperative func-
tional scores even after controlling for confounding variables.4 They were not able to de-
termine an exact cause, but noted that WOMAC pain scores were similar for all countries. 
While there is little data comparing an Asian country versus a North American one, we 
believe our results agree with other studies and show that location is not a factor in TKR 
outcomes, despite perceived differences with respect to daily use of the lower extremity 
in Asian and Caucasian patients.
As for component position, AP femoral and tibial component measurements were sta-
tistically different between the two groups. On the lateral view, the Asian patients had 
less femoral flexion and more posterior tibial slope in comparison to the North American 
patients, despite the use of similar intraoperative guiding systems. These differences in 
sagittal plane alignment between countries are interesting and potentially indicative 
of the previously described morphological differences between Asian and non-Asian 
patients. However, post-operative, and change in range of motion values were not sig-
nificant between the two cohorts. More research is needed to explain these differences.
This study has certain limitations. First, all surgeries were performed by two special-
ized knee surgeons in specialized arthroplasty centers. Therefore, the postoperative 
outcome scores can be partially overestimated when extrapolated to the general TKR 
population. Secondly, only patients with the Sigma RPF knee were used to eliminate 
prosthesis difference on the outcome between these two cohorts. Thirdly, the North 
American population had a wide variety of ethnic groups and both cohorts did not 
have detailed ethnic and socioeconomic demographic data. We assume both cohorts 
are similar demographically to the city and country they reside in, the North American 
cohort was based in a major American metropolitan city and the Asian came from a 
major Indonesian metropolitan city. The North American demographic data shows the 
majority to be Caucasian. Finally, although preoperative outcome score data and range 
of motion data were collected prospectively, this is a retrospective study and as such 
unknown confounders could not be corrected for.
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CoNCLuSIoNS
Asian patients had significantly worse preoperative outcome scores, both on the pain 
score, function score, and knee range of motion but post-operative outcome results 
were slightly better for the Asian patients compared to the North American counterpart. 
Cultural and societal differences (i.e. health care access) may be drivers in both the pre-
operative presentation as well as the postoperative perception of outcome (i.e. patient 
reported outcome) as well as function (i.e. the need for a knee to high flex during social 
activities). Both aspects, cultural and social should be taken into account when compar-
ing outcome of elective arthroplasties between different countries.
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ABSTRACT
Background. Anterior knee pain, which has a prevalence of 4% to 49% after TKA, may 
be a cause of patient dis- satisfaction after TKA. To limit the occurrence of anterior knee 
pain, patellar denervation with electrocautery has been proposed. However, studies 
have disagreed as to the efficacy of this procedure.
Questions/purposes. We evaluated patients undergoing bilateral simultaneous TKA 
procedures without patellar resurfacing to ask: (1) Does circumferential patellar cau-
terization decrease anterior knee pain (Kujala score) postoperatively compared with 
non-cauterization of the patella? (2) Does circumferential patellar cauterization result in 
better functional outcomes based on patient report (VAS score, Oxford knee score, and 
Knee Injury and Osteoarthritis Outcome Score) than non-cauterization of the patella? (3) 
Is there any difference in the complication rate (infection, patellar maltracking, fracture, 
venous thromboembolism, or reoperation rate) between cauterized patellae and non-
cauterized patellae?
Methods. Seventy-eight patients (156 knees) were included in this prospective, quasi-
randomized study, with each patient serving as his or her own control. Patellar cauteriza-
tion was always performed on the right knee during simultaneous, bilateral TKA. Five 
patients (6%) were lost to follow-up before the 2-year minimum follow-up interval. A 
single surgeon performed all TKAs using the same type of implant, and osteophyte exci-
sion was performed in all patellae, which were left unresurfaced. Patellar cauterization 
was performed at 2 mm to 3 mm deep and approximately 5 mm circumferentially away 
from the patellar rim. The preoperative femorotibial angle and degree of osteoarthritis 
(according to the Kellgren-Lawrence grading system) were measured. Restoration of the 
patellofemoral joint was assessed using the anterior condylar ratio. Clinical outcomes, 
consisting of clinician-reported outcomes (ROM and Kujala score) and patient-reported 
outcomes (VAS pain score, Oxford knee score, and Knee Injury and Osteoarthritis Out-
come Score), were evaluated preoperatively and at 1 month and 2 years postoperatively.
Results. At the 2-year follow-up interval, no difference was observed in the mean Ku-
jala score (82 ± 2.9 and 83 ± 2.6 for cauterized and non-cauterized knees, respectively; 
mean difference 0.3; 95% confidence interval, -0.599 to 1.202; p = 0.509). The mean VAS 
pain score was 3 ± 0.9 in the cauterized knee and 3 ± 0.7 in the non-cauterized knee 
(p = 0.920). The mean ROM was 123° ± 10.8° in the cauterized knee and 123° ± 10.2° in 
the non-cauterized knee (p = 0.783). There was no difference between cauterized and 
non-cauterized patellae in the mean Knee Injury and Osteoarthritis Outcome Score for 
symptoms (86 ± 4.5 versus 86 ± 3.9; p = 0.884), pain (86 ± 3.8 versus 86 ± 3.6; p = 0.905), 
activities (83 ± 3.2 versus 83 ± 2.8; p = 0.967), sports (42 ± 11.3 versus 43 ± 11.4; p = 
0.942), and quality of life (83 ± 4.9 versus 83 ± 4.7; p = 0.916), as well as in the Oxford 
knee score (40 ± 2.1 versus 41 ± 1.9; p = 0.771). Complications were uncommon and 
there were no differences between the groups (one deep venous thromboembolism in 
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the cauterized group and two in the control group; odds ratio 0.49, 95% CI, 0.04-5.56; p 
= 0.57).
Conclusions. Patellar cauterization results in no difference in anterior knee pain, func-
tional outcomes, and complication rates compared with non-cauterization of the patella 
in patients who undergo non-resurfaced, simultaneous, bilateral, primary TKA with a 
minimum of 2 years of follow-up. We do not recommend circumferential patellar cauter-
ization in non-resurfaced patellae in patients who undergo TKA.
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INTRoduCTIoN
Anterior knee pain is a common patient complaint not only before TKA, but also after 
TKA. It was found in 4% to 49% of patients after TKA, resulting in dissatisfaction, morbid-
ity, and potential revision surgery.3,4,6,7,11,16,26,27,34,47 Several studies have investigated the 
possible sources of anterior knee pain after TKA, including patellofemoral degenerative 
changes, patellar maltracking, overstuffing, prosthesis design, and preoperative gait 
patterns, but a single cause or mechanism has not been determined.19,28,30,33,36,40
The patella is innervated by a network of superficial sensory nerves including the 
anterior femoral cutaneous nerve, lateral and medial femoral cutaneous nerves, and 
lateral and medial retinacular nerves.23 Dye13 revealed that the peripatellar soft tissue, 
which is rich in substance P nerve fibers, was a possible source of anterior knee pain. 
Theoretically, if these nerve fibers are cauterized with electrocautery, denervation of the 
anterior knee region and relief of patellofemoral pain might be achieved, and a number 
of studies have tested this premise.19,21,23–27
Rationale
Although some studies have indicated that patellar denervation may decrease the 
incidence of anterior knee pain2,10,37, others have found that patellar denervation had no 
substantial effect during follow-up.3,29,38,45 Several meta-analyses have been performed 
to compare cauterized and non-cauterized patellae. Nevertheless, controversy still ex-
ists, which is partly related to provided evidence. One meta-analysis did not provide a 
quality assessment of analyzed articles15, while another showed a moderate risk of bias22 
and others showed a low risk of bias.9,44,46 Zhang et al.46 showed there was a decrease 
in the incidence of anterior knee pain but no difference in patellar scores. Cheng et al.9 
combined randomized and non-randomized controlled trials in their meta-analysis, 
which may have caused bias, and also showed no clinical difference between cauter-
ized and non-cauterized patellae. Furthermore, their meta- analysis had heterogenous 
implants and surgical techniques (for example, different implants and techniques of 
cauterization and limited data on the depth of cauterization). This will cause bias in com-
paring results. Additionally, most studies were performed in unilateral TKA, introducing 
a difference in pain perception between patients, which is known to be large. Only two 
studies compared cauterized and non-cauterized unresurfaced patellae in patients 
undergoing simultaneous, bilateral TKA. One of these two studies did not evaluate 
scoring of anterior knee pain and used a mid-vastus approach2, and both studies had 
small samples and short follow-up periods.2,45 To the best of our knowledge, no study 
has evaluated the effect of patellar denervation on the presence of anterior knee pain in 
unresurfaced patellae undergoing simultaneous, bilateral TKA with mid-term follow-up. 
We hypothesized that patellar circumferential cauterization will not result in less pain, 
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a better outcome, or difference in complication rate in patients who undergo TKA with 
non-resurfaced patellae.
Research Questions
We evaluated patients undergoing bilateral, simultaneous TKA procedures without pa-
tellar resurfacing to ask: (1) Does circumferential patellar cauterization decrease anterior 
knee pain (Kujala score) postoperatively compared with non-cauterization of the pa-
tella? (2) Does circumferential patellar cauterization result in better functional outcomes 
based on patient report (VAS score, Oxford knee score, and Knee Injury and Osteoarthritis 
Outcome Score) than non-cauterization of the patella? (3) Is there any difference in the 
complication rate (infection, patellar maltracking, fracture, venous thromboembolism, 
or reoperation rate) between cauterized patellae and non-cauterized patellae?
PATIeNTS ANd MeThodS
Study Design and Setting
This was a prospective study of 78 consecutive patients who underwent simultaneous, 
bilateral primary TKA between February 2015 and October 2016 at Medistra Hospital, Ja-
karta. During simultaneous, bilateral TKA, cauterization of the patella was performed on 
all right knees. Thus, a quasi-randomized study design was used in which each patient 
served as his or her own control, with the right leg in each patient receiving circumfer-
ential denervation. The research study was approved by our institutional review board. 
All patients gave informed consent for participation in the study.
Participants
The inclusion criteria were patients with primary, bilateral patellofemoral knee osteo-
arthritis (minimum Kellgren-Lawrence Grade 3) who underwent simultaneous, bilateral 
TKA. Patients with rheumatoid arthritis, infected or septic arthritis, other inflammatory 
arthritis, secondary or traumatic osteoarthritis, preexisting or congenital bony defor-
mities, severe knee deformities (a varus or valgus deformity) greater than 15°, flexion 
contracture greater than 10°, patellar dislocation, or preexisting comorbidities (such as 
diabetes mellitus or chronic heart disease) were excluded. Patients were followed for a 
minimum of 2 years (mean 30 ± 5.9 months; range 24-45 months).
Study Flow
A total of 78 patients (156 knees) were included in this study, based on the inclusion and 
exclusion criteria. However, 6% (five of 78) were lost to follow-up (Fig. 1). Sixty-seven 
women and six men with a mean age of 66 years (range 45-83 years) and a mean BMI of 
28 kg/m2 (range 22–38.1 kg/m2) participated in this study.
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Study Flow  
A total of 78 patients (156 knees) were included in this study, based on the inclusion and 
exclusion criteria. However, 6% (five of 78) were lost to follow-up (Fig. 1). Sixty-seven women 
and six men with a mean age of 66 years (range 45-83 years) and a mean BMI of 28 kg/m2 
(range 22–38.1 kg/m2) participated in this study.  
 
 
Fig. 1 This figure shows a flowchart of patients selected for inclusion in the study. 
 
Variables, Clinical Outcome Measures, Data Sources, and Bias  
Anterior knee pain was evaluated using the Kujala score20, which has been shown to have high 
internal consistency (0.83-0.91)18. Functional outcome was evaluated using ROM, VAS score 
for pain while walking, Knee Injury and Osteoarthritis Outcome Score, and Oxford knee score. 
Clinical outcomes were evaluated preoperatively and at 1 month and 2 years postoperatively 
by a single orthopaedic surgeon (KN), who was not a part of the main surgical team. Patients 
were blinded about which side underwent patellar denervation. The evaluator was not involved 
in providing the interventions and was blinded to group allocation until the end of the study.  
There were no differences in preoperative clinical out- come assessments (ROM, VAS, Knee 
Injury and Osteoarthritis Outcome Score, Oxford knee score, and Kujala score), femoral 
anterior condylar ratio, mechanical femorotibial angle, and radiologic severity (determined with 
fig. 1 This figure shows a flowc art of patients selected for inclusion in the study.
Variables, Clinical Outcome Measures, D ta Sources, and Bias
Anterior knee pain was evaluated using the Kujala score20, which has been shown to 
have high internal consistency (0.83-0.91)18. Functional outcome was evaluated using 
ROM, VAS score for pain while walking, Knee Injury and Osteoarthritis Outcome Score, 
and Oxford knee score. Clinical outcomes were evaluated preoperatively and at 1 month 
and 2 years postoperatively by a single orthopae ic surgeon (KN), who was no  a par  
of the main surgical team. Patients ere blinded about which side underwent patellar 
denervation. The evaluator was not involved in providing the interventions and was 
blinded to group allocation until the end of the study.
There were no differences in preoperative clinical out- come assessments (ROM, VAS, 
Knee Injury and Osteoarthritis Outcome Score, Oxford knee score, and Kujala score), 
femoral anterior condylar ratio, mechanical femorotibial angle, and radiologic severity 
(determined with the Kellgren-Lawrence grading system) between knees with circum-
ferential electrocauterization of the patellar rim and those without (Table 1). There were 
no differences in the anterior condylar ratio (0.3 ± 0.1 versus 0.2 ± 0.1; p = 0.192) or in 
the mechanical femorotibial angle (177° ± 3° versus 178° ± 2°; p = 0.751) between the 
two groups postoperatively.
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Radiographic Assessment
Bilateral knee and long-leg standing radiographs were taken before surgery, and an-
other radiograph was taken 24 hours after surgery. The mechanical femorotibial angle 
of both knees was measured using the long-leg standing radiograph. True lateral-knee 
radiographs were used to analyze the femoral anterior condylar ratio using digital im-
age viewer software (General Electric Centricity Digital Imaging and Communications in 
Medicine Viewer 3.1.4., Chicago, IL, USA). The anterior condylar ratio was used to assess 
restoration of the patellofemoral joint and evaluate overstuffing of the patellofemoral 
joint. Overstuffing of the patellofemoral joint occurs when there is an increase in the 
thickness of the patellofemoral joint. It has been reported to lead to maltracking and 
wear, stretching of the medial patellofemoral ligament, anterior knee pain, and limited 
ROM of the knee5. Overstuffing might change the patella-to-femur distance, leading 
to change in the moment arm of the quadriceps, which might be evaluated using the 
anterior condylar ratio. The femoral anterior condylar ratio is the ratio between the 
femoral anterior condyle’s height and the femoral shaft’s diameter, as measured 5 cm 
above the superior pole of the patella (Fig. 2). An independent radiologist (SI) performed 
all radiographic evaluations.
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Table 1. Patient demographic and clinical scores 
 
 
 
Fig. 2 This figure shows a lateral knee radiograph for measurement of the anterior condylar ratio, which was 
obtained by dividing the peak anterior condyle’s height by the diameter of the femur (A) preoperatively and (B) 
postoperatively. 
 
 
fig. 2 This figure shows  ateral knee radiograph f  easurement of the ant rior condylar ratio, which was 
obtained by dividing the peak anterior condyle’s height by the diameter of the femur (A) preoperatively 
and (B) postoperatively.
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Table 1. Patient demographics and clinical outcome scores
Characteristics
Patellar 
Denervation
Left knee
p value
mean ± SD mean ± SD
Age (years) 66 ± 7 66 ± 7  
BMI (kg/m2) 28.3 ± 4 28.3 ± 4  
Gender, n (%)      
Women 67 ± 92 67 ± 92  
Men 6 ± 8 6 ± 8  
Preoperative KOOS for symptoms 45 ± 12 44 ± 12 0.787
Preoperative KOOS for pain 46 ± 12 46 ± 12 0.918
Preoperative KOOS for activities of daily living 46 ± 14 45 ± 14 0.841
Preoperative KOOS for sports and recreation 13 ± 8 13 ± 8 0.879
Preoperative KOOS for quality of life 25 ± 9 25 ± 9 0.730
Preoperative Oxford knee score 23 ± 3 24 ± 3 0.712
Kujala preoperative 40 ± 9 41 ± 9 0.707
Preoperative VAS 8 ± 1 8 ± 1 0.410
Preoperative ROM (°) 101 ± 19 100 ± 20 0.662
Preoperative femorotibial angle (°) 189 ± 5 191 ± 6 0.051
Postoperative femorotibial angle (°) 177 ± 3 178 ± 2 0.751
Preoperative anterior condylar ratio 0.3 ± 0.1 0.3 ± 0.1 0.744
Delta anterior condylar ratio (difference between 
preoperative and post anterior condylar ratio)
0.05 ± 0.1 0.06 ± 0.1 0.548
Postoperative anterior condylar ratio 0.3 ± 0.1 0.2 ± 0.1 0.192
Kellgren-Lawrence grade, n (%)     0.606
3 25 ± 34.2 28 ± 38.4  
4 48 ± 65.8 45 ± 61.6  
KOOS = Knee Injury and Osteoarthritis Outcome Score
Description of Surgical Procedure
A single experienced surgeon (NCB) performed all surgeries. The implanted prosthesis 
was the ATTUNE cruciate-retaining prosthesis (DePuy Synthes, Warsaw, IN, USA) with a 
fixed-bearing insert. All patients were intravenously administered 8 mg of dexametha-
sone 1 hour before surgery to reduce postoperative pain and nausea, as well as 750 mg 
of tranexamic acid 1 hour before and 6 hours after the procedure to reduce bleeding. A 
tourniquet was used during the procedure. The operation was always performed first on 
the right side, regardless of the severity of arthritis, through a standard medial parapa-
tellar approach. A tibial cut was made perpendicular to the mechanical axis using an 
extramedullary alignment guide with the slope set at 7°. A distal femoral cut was made 
in 6° of valgus using an intramedullary femoral alignment guide, and the extension gap 
was measured using spacer blocks. Femoral rotation and the posterior femoral condyle 
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cut were determined using a hybrid method, a combination of the measured resection 
technique and gap-balancing technique. The flexion gap was measured using spacer 
blocks. The posterior femoral osteophytes were excised; subsequently, trial implants 
were inserted to assess the joint space; varus and valgus stability, patellar tracking, and 
ROM were measured; and the pull-out lift-off test32 was performed. Osteophytes of the 
patella were excised, and no patellae in any knee were resurfaced.
Circumferential electrocautery denervation was always performed on the right patellar 
rim, regardless of the severity of patellar arthritis, but electrocautery was not performed 
in the left patella (Fig. 3). Electrocautery was performed using a Valleylab electrocautery 
unit (Valleylab Inc., Boulder, CO, USA) with monopolar coagulation diathermy of 50 W 
at a depth of 2 mm to 3 mm and approximately 5 mm circumferentially away from the 
patellar rim. Patellar tracking was assessed using a “no-thumb test” with the tourniquet 
deflated and the medial capsule left open. If the knee was stable with no tightness in 
flexion and extension and no patellar maltracking, based on a tibial and femoral trial 
evaluation, then the tibial and femoral components were implanted. No patellar mal-
tracking or ligament imbalance was found during the intraoperative evaluation. The 
wound was closed, and a vacuum drain was used. The same technique was used in the 
contralateral knee, without circumferential patellar cauterization. The patients were 
blinded to the cauterized and non-cauterized sides.
 Outcome of patellar denervation in simultaneous bilateral TKA  
  55  
ambulation using a walker were performed on the second day. Antithrombotic prophylaxis 
using an oral direct-factor Xa inhibitor (rivaroxaban) was administered to all patients for 14 
days postoperatively. The postoperative care and rehabilitation were identical for both knees.  
 
 
Fig. 3 This figure shows the patella after (A) circumferential cauterization and peripatellar soft-tissue excision and 
(B) peripatellar soft-tissue excision only in patients undergoing non-resurfaced, simultaneous, bilateral TKA. 
 
Statistical Analysis  
The statistical analysis was performed using IBM Statistical Package for the Social Sciences 
version 21.0 (SPSS Inc., Chicago, IL, USA). Paired t-tests were used to compare preoperative 
and postoperative values. Independent t-tests were used to compare the results of knees with 
circumferential cauterization of the patellar rim and the results of those without. Tests of the 
correlation between the anterior condylar ratio and VAS score, Kujala score, and Knee Injury 
and Osteoarthritis Outcome Score for pain were performed to observe any meaningful 
correlation that could confound the results of the groups. A p value of 0.05 was considered 
statistically significant. Based on previous studies, the effect size of the Kujala patellofemoral 
scale ranges from 0.34 to 0.54. Using an ? of 0.05, ? of 20%, and power of 80%, the total 
sample size was 115 knees, or 58 knees in each group.  
 
Results  
Does Circumferential Patellar Cauterization Decrease Anterior Knee Pain?  
There were no differences in the mean Kujala score between the cauterized and non-
cauterized groups at 2 years of follow-up (82 ± 2.9 versus 83 ± 2.6; mean difference 0.3; 95% 
confidence interval, -0.6 to 1.2; p = 0.509) (Table 2). The mean difference between 
preoperative and 2-year post-operative scores was 42.1 ± 7.5 (95% CI, -43.9 to -40.3; p < 
0.001) and 41.7 ± 7.7 (95% CI, -43.5 to -39.9; p < 0.001) for the cauterized and non-cauterized 
groups, respectively. The postoperative Kujala scores of both knees improved at 1 month and 
fig. 3 This figure shows the patella after (A) circumferenti l cauterization and erip tellar soft-tissue exci-
sion and (B) peripatellar soft-tissue excisio  only in patie ts unde going non-resurfaced, simultaneous, 
bilateral TKA.
Postoperative Care and Rehabilitation
Physiotherapy and exercises were performed as soon as the patient returned to the 
ward. The vacuum drain was removed at  maximum of 24 hours after surgery. ROM 
and raight-leg raising ex rcises were performed continuously during the first day in 
the ward. A continuous passive motion device was also used while performing ROM ex-
ercises twice per day from the first day. An isometric quadriceps strengthening exercise 
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and assisted weightbearing ambulation using a walker were performed on the second 
day. Antithrombotic prophylaxis using an oral direct-factor Xa inhibitor (rivaroxaban) 
was administered to all patients for 14 days postoperatively. The postoperative care and 
rehabilitation were identical for both knees.
Statistical Analysis
The statistical analysis was performed using IBM Statistical Package for the Social Sci-
ences version 21.0 (SPSS Inc., Chicago, IL, USA). Paired t-tests were used to compare 
preoperative and postoperative values. Independent t-tests were used to compare the 
results of knees with circumferential cauterization of the patellar rim and the results of 
those without. Tests of the correlation between the anterior condylar ratio and VAS score, 
Kujala score, and Knee Injury and Osteoarthritis Outcome Score for pain were performed 
to observe any meaningful correlation that could confound the results of the groups. A p 
value of 0.05 was considered statistically significant. Based on previous studies, the effect 
size of the Kujala patellofemoral scale ranges from 0.34 to 0.54. Using an α of 0.05, β of 
20%, and power of 80%, the total sample size was 115 knees, or 58 knees in each group.
ReSuLTS
does Circumferential Patellar Cauterization decrease Anterior Knee Pain?
There were no differences in the mean Kujala score between the cauterized and non-
cauterized groups at 2 years of follow-up (82 ± 2.9 versus 83 ± 2.6; mean difference 
0.3; 95% confidence interval, -0.6 to 1.2; p = 0.509) (Table 2). The mean difference 
between preoperative and 2-year post-operative scores was 42.1 ± 7.5 (95% CI, -43.9 
to -40.3; p < 0.001) and 41.7 ± 7.7 (95% CI, -43.5 to -39.9; p < 0.001) for the cauterized 
and non-cauterized groups, respectively. The postoperative Kujala scores of both knees 
improved at 1 month and 6 months postoperatively but not at 2 years of follow-up (Fig. 
4). Moreover, no association was observed between the femoral anterior condylar ratio 
and anterior knee pain as represented by the VAS score, Kujala score, and Knee Injury 
and Osteoarthritis Outcome Score (Table 3).
Table 2. Comparison of delta (difference) between baseline (preoperative) and postoperative Kujala scores
Timepoint
Kujala score
Patellar
denervation
Control
Mean difference
between groups (95% CI)
p value
(between groups)
1 month 36.5 ± 8.0 36.2 ± 8.3 -0.3 (-0.3 to 2.3) 0.808
2 years 42.1 ± 7.5 41.7 ± 7.7 -0.3 (-2.8 to 2.2) 0.803
There were no baseline differences between the groups. Data are presented as mean difference from the 
baseline to 1 month and 2 years
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6 months postoperatively but not at 2 years of follow-up (Fig. 4). Moreover, no association was 
observed between the femoral anterior condylar ratio and anterior knee pain as represented 
by the VAS score, Kujala score, and Knee Injury and Osteoarthritis Outcome Score (Table 3).  
 
Table 2. Comparison of delta (difference) between baseline (preoperative) and postoperative Kujala scores 
 
 
 
Fig. 4 This figure shows the postoperative Kujala score of both knees over time. 
 
Table 3. Correlation of the delta femoral anterior condylar ratio with the Knee Injury and Osteoarthritis Outcome 
Score, pain score, Kujala score for anterior knee pain, and VAS scores for the left and right knees  
 
 
  
fig. 4 This figure shows the postoperative Kujala score of both knees over time.
Table 3. Correlation of the delta femoral anterior condylar ratio with Knee Injury and Osteoarthritis Out-
come Score, pain score, Kujala score for anterior knee pain, and VAS scores  left and right knee
Parameter Patellar denervation Control
Anterior condylar ratio correlation
Correlation 
coefficient
p 
value
Correlation 
coefficient
p 
value
Knee Injury and Osteoarthritis Outcome Score 
for pain
-0.093 0.432 -0.057 0.630
Kujala score -0.040 0.737 -0.067 0.576
VAS score -0.027 0.818 -0.016 0.893
Delta is mean difference from the baseline to 2 years postoperatively
does Circumferential Patellar Cauterization Result in Better functional 
outcomes Scores?
No differences were found in the mean VAS score between the cauterized and non-
cauterized knees (3 ± 0.9 versus 3 ± 0.7; p = 0.920) (Table 4). The mean difference in the 
preoperative and 2-year postoperative scores was 5.1 ± 0.8 (95% CI, 4.9-5.3; p < 0.001) 
for the cauterized group and 5.0 ± 1.0 (95% CI, 4.8-5.3; p < 0.001) for the non-cauterized 
group (Table 4). The postoperative VAS score of both knees decreased at 1 month and 6 
months postoperatively but not at 2 years of follow-up (Fig. 5). There were no differences 
in ROM between cauterized and non-cauterized knees postoperatively (123° ± 10.8° ver-
sus 123° ± 10.2°; mean difference -0.4; 95% CI, -3.9 to 2.9; p = 0.783) at 2 years of follow-
up (Table 4). The mean difference in ROM preoperatively and 2 years postoperatively 
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was 21.8° ± 16.2° (95% CI, -25.6 to -18.0; p < 0.001) in the cauterized group and 23.2° ± 
16.9° (95% CI, -27.1 to -19.3; p < 0.001) in the non-cauterized group. There was also no 
difference in the Oxford knee score (40 ± 2.1 and 41 ± 1.9; p = 0.771) between cauterized 
and non-cauterized patellae, respectively, at 2 years postoperatively (Table 4). The mean 
difference in the Oxford knee score between preoperatively and 2 years postoperatively 
was 17.0 ± 2.9 (95% CI, -17.7 to -16.3; p < 0.001) and 16.9 ± 3.0 (95% CI, -17.7 to -16.3; p 
< 0.001) in the cauterized and non-cauterized groups, respectively.
There were no differences in all parameters of the Knee Injury and Osteoarthritis Out-
come Score between the two groups (p > 0.05) (Table 2). There were no differences in 
the mean Knee Injury and Osteoarthritis Outcome Scores for symptoms (86 ± 4.5 versus 
86 ± 3.9; mean difference -0.101; 95% CI, -1.478 to 1.275; p = 0.884), pain (86 ± 3.8 versus 
86 ± 3.6; mean difference -0.074; 95% CI, -1.291 to 1.144; p = 0.905), activities of daily 
living (83 ± 3.2 versus 83 ± 2.8; mean difference 0.021; 95% CI, -0.965 to 1.006; p = 0.967), 
sports and recreation (42 ± 11.3 versus 43 ± 11.4; mean difference 0.137; 95% CI, -3.577 to 
3.851; p = 0.942), and quality of life (83 ± 4.9 versus 83 ± 4.7; mean difference -0.085; 95% 
CI, -1.673 to 1.503; p = 0.916) for cauterized and non-cauterized patellae. Postoperative 
ROM, Oxford knee scores, and Knee Injury and Osteoarthritis Outcome Score improved 
in both knees at 1 month postoperatively but not at 2 years of follow-up (Table 4) (Fig. 6).
Is There Any Difference in the Complication Rate of Cauterized Patella?
No complications were associated with infections; patellar fracture, dislocation, sublux-
ation, or maltracking; or extensor mechanism disruption. No revision or reoperation was 
required for any reason in either group. However, late deep venous thromboembolism 
was observed in two patients (one knee in the cauterized group and two in the control 
group) (odds ratio 0.49; 95% CI, 0.04-5.56; p = 0.57). These were observed at 6 months 
postoperatively and were treated successfully. No difference in the complication rate 
was found between the cauterized and non-cauterized groups.
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Table 4. Comparison of delta (difference) between baseline (preoperative) and postoperative clinical outcomes  
 
 
 
Fig. 5 This figure shows the postoperative VAS pain score of both knees over time. 
 
fig. 5 This figure shows the postoperative VAS pain score of both knees over time. Outcome of patellar den rvation in simultaneous bilateral TKA  
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Fig. 6 This figure shows the postoperative clinical outcome assessment of both knees over time. 
 
Is There Any Difference in the Complication Rate of Cauterized Patella?  
No complications were associated with infections; patellar fracture, dislocation, subluxation, or 
maltracking; or extensor mechanism disruption. No revision or reoperation was required for 
any reason in either group. However, late deep venous thromboembolism was observed in two 
patients (one knee in the cauterized group and two in the control group) (odds ratio 0.49; 95% 
CI, 0.04-5.56; p = 0.57). These were observed at 6 months postoperatively and were treated 
successfully. No difference in the complication rate was found between the cauterized and 
non-cauterized groups.  
 
Discussion  
Persistent anterior knee pain after TKA is likely caused by multiple factors that are not always 
easily identifiable; hence, its management remains difficult.11 Patellar resurfacing, leaving the 
patella unresurfaced, and patellar circumferential denervation (or not) are advocated as 
management options for anterior knee pain in patients who undergo TKA.12,31 Patellar 
resurfacing is not routinely performed in Southeast Asian patients. This is because Asian 
people have a smaller stature and thinner patellae than other individuals do, and the 
resurfacing procedure tends to cause patellar fracture and associated complications. Second, 
patellar resurfacing results in additional costs to the patient because of limited national or 
private healthcare insurance.1,8 In this study, we sought to answer the question of whether 
fig. 6 This figure hows the postopera ive clinical outcome ass ssm nt of both knees over time.
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dISCuSSIoN
Persistent anterior knee pain after TKA is likely caused by multiple factors that are not 
always easily identifiable; hence, its management remains difficult.11 Patellar resurfac-
ing, leaving the patella unresurfaced, and patellar circumferential denervation (or not) 
are advocated as management options for anterior knee pain in patients who undergo 
TKA.12,31 Patellar resurfacing is not routinely performed in Southeast Asian patients. This 
is because Asian people have a smaller stature and thinner patellae than other individu-
als do, and the resurfacing procedure tends to cause patellar fracture and associated 
complications. Second, patellar resurfacing results in additional costs to the patient 
because of limited national or private healthcare insurance.1,8 In this study, we sought 
to answer the question of whether circumferential patellar denervation in unresurfaced 
patellae would result in decreased anterior knee pain, improved function, and different 
complication rates in Southeast Asian patients who undergo simultaneous, bilateral TKA 
and found it offered no benefit.
Limitations
Our study has several limitations: First, our study was quasi-randomized rather than 
formally randomized; that is, all patients had the intervention (patellar denervation) in 
the right knee, while the left knee served as a control. Between-limb differences such as 
right-sided limb dominance, which is more common39, could have favored the treatment 
group. Despite this, there were no between-group differences. A possible explanation is 
that these patients were all Asian, and in Asia, a floor-based lifestyle is culturally norma-
tive. Because these people squat, kneel, and hyperflex with both knees, it is possible that 
limb dominance is not as strong a factor in this population as it is in other populations 
(such as people from the United States and Europe). To minimize evaluation bias, we 
blinded patients as to which knee was cauterized, and we assigned a different assessor 
who was blinded to group allocation and not involved in the intervention or surgical 
team to evaluate the results. Because the patient was unaware which side underwent 
patellar denervation, the patient-reported outcome scores were not biased. We rea-
soned that because the patient’s perception of pain was the dominant outcome, the 
major advantage of this study is that we included only bilateral knees, compared with 
studies including unilateral knees in a randomized design. Second, a small sample size 
increases the risk that we will falsely accept the null hypothesis that anterior knee pain 
between treatment groups was not different (Type II error). The minimal clinically impor-
tant difference for the Kujala score is 3, which is higher than our delta mean values. Cir-
cumferential cauterization did not improve anterior knee pain clinically. Third, we used 
a cauterization depth of 2 mm to 3 mm. No meta-analysis or even comparative study 
has compared the cauterization depth. However, one study14 showed the effectiveness 
of performing cauterization at a depth of 1 mm to 3 mm in reducing anterior knee pain 
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in patients undergoing TKA. Fourth, a single independent radiologist interpreted the 
radiograph results, with no intraobserver reliability. This also might cause bias (intrinsic 
errors) in radiograph interpretation regarding the femorotibial angle, anterior condyle 
ratio, and radiographic osteoarthritis. However, because radiologic measurements were 
performed using digital software with precise landmarks, the possibility of intrinsic 
errors could be minimized. Generally, bilateral TKAs are performed less often than uni-
lateral TKAs are, and studies comparing the outcome of circumferential cauterization 
of the patella in patients undergoing simultaneous, bilateral, non-resurfaced TKA are 
limited. Comparing clinical outcomes with those of the contralateral knees in the same 
individual undergoing simultaneous, bilateral TKA may eliminate confounders such as 
differences in pain and subjective perceptions between individuals.
does Circumferential Patellar Cauterization decrease Anterior Knee Pain?
Our study found no difference in anterior knee pain between circumferential patellar 
cauterization and non-cauterization of non-resurfaced patellae in our population at 1 
month, 6 months, 1 year, or 2 years after surgery. Similarly, two studies on electrocau-
terization of the patella compared with non-cauterization had similar results in terms 
of relief of anterior knee pain after TKA.3,29 A prospective randomized controlled trial21 
compared electrocautery with non-electrocautery and found no substantial differences 
in pain at 3 months, 6 months, or 5 years of follow-up in patients undergoing non-resur-
faced TKA, and similar results were also observed in several other studies.2,3,29,45 However, 
different outcomes were shown by van Jonbergen et al.37; there were improvements in 
postoperative WOMAC total and function scores in the cautery group compared with 
the scores of patients in the non-cautery group, but improvements in postoperative 
WOMAC pain scores were not seen at 1 year of follow-up. However, these differences 
were not observed at the 3.7-year follow-up interval.38 The differences in early functional 
outcome in that study, compared with our result, may be because of differing implant 
designs. We used a fixed-bearing cruciate-retaining implant, while van Jonbergen et al. 
used a fixed-bearing, posterior-stabilized implant. At least one study has shown that 
fixed-bearing, cruciate-retaining designs have better clinical outcomes and lower revi-
sion rates than fixed-bearing, posterior-stabilized designs.43 The differences in the depth 
of cauterization (1 mm versus 2 mm to 3 mm) may also play a role in the early result. 
A meta- analysis14 has revealed that circumferential patellar cauterization could result 
in improved knee function scores but did not decrease anterior knee pain. However, 
even this study showed there was functional improvement; there was no improvement 
clinically based on the minimal clinically important difference. Two additional meta-
analyses44,46 revealed that patellar cauterization did not decrease anterior knee pain or 
improve clinical outcomes at 12 months of follow-up. Despite this, Xie et al.44 recom-
mended circumferential cauterization because of its good safety profile. However, Li et 
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al.22 and Zhang et al.46 showed there was improvement, but did not clearly recommend 
cauterization (Table 5). Other meta-analyses9,15 showed no improvement and did not 
recommend patellar cauterization in patients undergoing TKA. However, these meta-
analyses had relatively short follow-up intervals and used different patellar cauteriza-
tion depths, types of implants, and operative techniques, and some of these studies 
compared cauterization with non-cauterization in resurfaced patellae.
does Circumferential Patellar Cauterization Result in Better functional 
outcomes Scores?
In our study, there was no difference in functional outcome scores at 1 month, 6 
months, 1 year, or 2 years after surgery between circumferential patellar cauterization 
and non-cauterization of non-resurfaced patella in patients undergoing simultaneous, 
bilateral TKA. A study comparing patelloplasty only and patelloplasty combined with 
circumferential cautery found no major differences in pain and functional outcomes 3 
years after surgery.17 Spencer et al.35 compared resurfaced patellae without denervation 
with unresurfaced patellae with denervation and found no substantial differences in 
pain and functional scores after 2 years of follow-up. Consistent with these studies, the 
reason for our findings are as follows: first, we used “patella-friendly” components in 
this study. The patella-friendly implant has an extended anterior flange with a deeper 
and wider trochlear groove. TKA implants with a patella-friendly design might lower the 
reoperation rate because of patellofemoral problems and postoperative anterior knee 
pain.25,42 Second, there is no consensus regarding the standard circumferential patellar 
cauterization technique. In our study, patellar cauterization was performed at 2 mm 
to 3 mm deep and approximately 5 mm circumferentially away from the patellar rim, 
without damaging the cartilage. Fan et al.14 recommended patellar electrocauterization 
of the synovial soft-tissue layer within 1 cm of the circumference of the patella and at 
a depth of not greater than 1 mm to 3 mm, with 50 W of monopolar diathermy. Third, 
we excised the peripatellar soft tissues such as the synovium and infrapatellar fat pad in 
both groups. Peripatellar soft tissue, according to some studies, contains pain-sensitive 
nerve-end fibers responsible for postoperative anterior knee pain.14,23,27,36,37,41,44 Finally, 
many other factors contribute to anterior knee pain, and some patients experience 
anterior knee pain after TKA regardless of their preoperative condition.1,8,27
Is There Any difference in the Complication Rate of Cauterized Patella?
Similar to other previous studies, our study did not reveal a difference in complications 
between the two groups.17,21,36,45,46 Specifically, no complications were associated with 
patellar fracture, dislocation, subluxation, and maltracking, or an extensor mecha-
nism injury. Revision surgery for pain or a patellofemoral problem was not required. 
Although not seen in our study, several complications after non-resurfaced patellar cau-
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terization have been described: chondrolysis because of progression of osteoarthritis 
or mechanical factors27; proprioceptive disturbance after electrocauterization, causing 
patellar degeneration owing to gait or altered joint loading that could not be detected 
because of diminished proprioception17; thermal injury to the patellar tendon, which is 
an entry point of the patellar vessel that supplies the patella and could lead to osteone-
crosis and damage to the extensor mechanism; and direct cartilage damage.24,36
CoNCLuSIoNS
We found no difference in anterior knee pain, functional outcomes, and complication 
rates up to 2 years postoperatively between circumferential cauterization and non-
cauterization of the patella in patients who underwent non-resurfaced, simultaneous, 
bilateral TKA. We therefore do not recommend circumferential patellar cauterization in 
patients undergoing non-resurfaced TKA.
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ABSTRACT
Background. Accelerometer-based navigation is a handheld navigation tool that was 
introduced to offer a simpler technique compared with more-cumbersome computer-
assisted surgery (CAS). Considering the increasing number of adopters, it seems 
important to evaluate the potential clinical benefits of this technology compared with 
conventional TKA.
Questions/purposes. In this systematic review, we asked: (1) Is accelerometer-based navi-
gation more accurate than conventional TKA? (2) Does accelerometer-based navigation 
provide better functional outcome than conventional TKA? (3) Does accelerometer-
based navigation increase surgical time or decrease the risk of complications or reopera-
tions compared with conventional TKA?
Methods. This systematic review included all comparative prospective and retrospec-
tive studies published in the MEDLINE/PubMed and Cochrane libraries over the last 10 
years. Inclusion criteria were all studies in English that compared accelerometer-based 
navigation with conventional TKA. Eleven studies met these criteria with 621 knees in 
accelerometer-based navigation group and 677 knees in conventional TKA group. Results 
related to alignment, objective and subjective functional scores, duration of surgery, 
complications and reoperations were extracted and compared between accelerometer-
based-navigation and conventional TKA. Methodological quality was assessed using 
Methodological Index for Nonrandomized Studies (MINORS) tool (for nonrandomized 
control trials) and Cochrane Risk of Bias (for randomized control trials (RCTs). All stud-
ies with fair or better quality were included. Four RCTs and six nonrandomized studies 
comparing accelerometer-based navigation to conventional TKA were found.
Results. Inconsistent evidence on mechanical axis alignment was found, with five of 
nine studies slightly favoring the accelerometer-based navigation group, and the other 
four showing no differences between the groups. Only two of eight studies favored 
accelerometer-based navigation in terms of tibial component alignment in the coronal 
plane; the other six found no between-group differences. Similarly, mixed results were 
found regarding other metrics related to component alignment; a minority of studies 
favored accelerometer-based navigation by a small margin, and most studies found no 
between-group differences. Only three studies evaluated functional outcome and none 
of them showed a difference in range of motion or patient-reported outcomes. Most 
studies, six of seven, found no between-group differences concerning surgical time; 
one study demonstrated a slight increase in time with accelerometer-based naviga-
tion. There were no between-group differences in terms of the risk of complications, 
which generally were uncommon in both groups, and no reoperations or revisions were 
reported in either group.
Conclusions. We found conflicting evidence about whether accelerometer-based 
navigation reduces the number of coronal-plane outliers or improves alignment to a 
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clinically important degree, and we found no evidence that it improves patient-reported 
outcomes or reduces the risk of complications or reoperations. Accelerometer-based 
navigation may increase surgical time. The overall quality of the evidence was low, 
which suggested that any observed benefits were overestimated. Given the absence 
of higher-quality evidence demonstrating compelling benefits of this accelerometer-
based navigation technology, it should not be widely adopted.
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INTRoduCTIoN
Total knee arthroplasty is an effective procedure to treat knee osteoarthritis7,21,39, and in 
so doing, to restore knee alignment and ligament balance.7,16,18,21,23 Proper component 
alignment is important to improve the likelihood of functional restoration, patient 
satisfaction, and TKA survivorship.7,16 Data from national implant registries with more 
than 95% completeness (National Joint Registry, Sweden, Australia, Netherlands) 
showed that wear and loosening— the risks of which are influenced by component 
alignment—account for 22% to 30% of revisions, comparable to the risks of instability 
and infection.33,60 Despite emerging new concepts concerning the ideal alignment in 
TKA, standard mechanical alignment remains the most widely used approach.8,22,36,51–53,64
However, using conventional mechanical alignment guides in TKA might lead to 
component alignment error exceeding 3° on the tibia.38 In one previous study, the 
recommended alignment in the coronal plane (within 3° of a neutral mechanical axis) 
was achieved in only 70% to 80% of patients undergoing conventional TKA using extra 
and intramedullary guides.41 Computer-assisted surgery systems were developed to 
improve the accuracy of component positioning; there is some evidence that navigation 
reduces the risk of revision and implant loosening and early migration11,61, but other 
studies found no improvement in patient-reported outcomes or ROM18,30,35,40,47 with no 
difference in the risk of tibial component migration compared with conventional TKA.50
Accelerometer-based navigation is a portable surgical navigation system that does not 
use a large computer console for TKA. After early validation studies, Nam et al44 first 
studied accelerometer-based navigation in 2011 in a cadaveric study. Accelerometer-
based navigation is a handheld, single-use, sterile device used within the operative 
field to determine the hip center of rotation and the femoral mechanical axis, which 
are used to determine the resection planes of the distal femur and the proximal tibia.27 
These systems are wireless and imageless, and they capture data during the procedure, 
and display those data directly on pods, which are attached to the femoral and tibial 
resection guides within the surgical field. The systems guide resection angles in the 
coronal and sagittal planes, and confirm alignment accuracy of the femoral and tibial 
components after resection.54 As appealing as this sounds, studies have disagreed about 
the advantages and disadvantages of these systems in TKA, in terms of TKA alignment, 
surgical time, and a variety of clinical and functional outcomes.17,18,27,32,45
In light of these controversies, we sought to perform a systematic review of accelerome-
ter-based navigation in TKA, and we asked the following questions: (1) Is accelerometer-
based navigation more accurate than conventional TKA? (2) Does accelerometer-based 
navigation provide better functional outcome than conventional TKA? (3) Does acceler-
ometer-based navigation increase surgical time or decrease the risk of complications or 
reoperations compared with conventional TKA?
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MATeRIALS ANd MeThodS
We performed a systematic review using the MEDLINE/PubMed and Cochrane Library 
databases to identify relevant studies published between January 2008 and May 2018 
that met the eligibility criteria to compare the efficacy of accelerometer-based naviga-
tion and conventional TKA.
Medical subject headings (MeSH) and key terms were used with the search criteria: 
limited to humans and published in English; with keywords: ((((Total knee arthroplasty) 
OR Total Knee Replacement) AND Accelerometer-based navigation) OR Handheld 
navigation) OR KneeAlign2) OR IASSIST) AND Conventional arthroplasty))) was done. 
Two authors (NCB, ILG) separately reviewed all abstracts for eligibility. An initial search 
yielded 39 references; after using the selection criteria 28 studies were excluded due 
to the following reasons: irrelevant topic (nonTKA), still an ongoing clinical study (ab-
stract only), not a comparative study, and duplicate paper. After exclusions, 11 studies 
remained after evaluation by the two authors. We hand-searched study bibliographies 
to ensure there were no other eligible trials; there were none.
Using the Methodological Index for Non-Randomized Studies (MINORS) tool, we re-
viewed these articles for methodological quality; one paper was excluded because of 
high risk of bias (MINORS score of 12; Fig. 1) done by Vanniar et al.62 We assessed all 
articles for methodological quality using the MINORS tools for nonrandomized studies 
(Table 1), which consists of 12 points: 8 points for a noncomparative study and addi-
tional 4 points for a comparative study54. The points for a noncomparative study are: (1) 
stated aim of study; (2) inclusion criteria; (3) collection data; (4) endpoint of study; (5) 
unbiased evaluation; (6) follow-up period; (7) loss of follow-up; (8) prospective calcula-
tion of sample size. The additional points for a comparative study are: (1) gold standard 
for control group; (2) contemporary groups; (3) baseline equivalence; (4) statistical 
analyses. These items are scored 0 (not reported), 1 (reported but not adequately), or 2 
(reported and adequately). A score ≤12 is considered to be of low quality (high risk of 
bias), whereas a study with MINORS score > 12 is thought to be of high quality. We used 
the Cochrane Risk of Bias tools for randomized control trials (Table 2). The Cochrane 
Risk of Bias tools10 consist of 7 points: (1) random sequence generation; (2) allocation 
concealment; (3) selective reporting; (4) other bias; (5) blinding of participants and 
personnel; (6) blinding of outcomes assessment; (7) incomplete outcomes data. These 
items are assessed for high, low, or unclear and each study is interpreted with good, fair, 
or poor quality based on the criteria.
From these studies, six studies were assessed with MINORS and four studies with Co-
chrane Risk of Bias tools. In all, 10 studies were included. All studies adequately reported 
a clear study aim and outcome measures (Table 3). In light of the small number of RCTs 
and the overall study quality (which was only fair), we did not perform a meta-analysis.
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figure 1. Flow chart shows the numbers of articles initially identified and exclusion and inclusion steps
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Table 1. Quality scoring of included studies based on the Methodological Items for Non-Randomized Stud-
ies (MINORS) criteria*
Study MINoRS items MINoRS score
1 2 3 4 5 6 7 8 9 10 11 12
Liow et al35 2 1 2 2 0 2 2 2 2 2 2 2 21
Moo et al41 2 2 2 2 0 1 2 0 2 2 2 2 19
Goh et al17 2 2 2 2 2 2 2 2 2 2 1 2 23
Kawaguchi et al27 2 2 2 2 2 2 2 2 2 2 1 2 23
Ueyama et al 201760 2 0 2 2 0 1 2 2 2 2 1 2 18
Ueyama et al 201861 2 2 2 2 2 1 2 2 2 2 2 2 23
Vanniar et al 201862 2 0 0 0 0 0 2 1 1 2 1 1 10
* Eleven included studies, seven of which were retrospective trials analyzed with the MINORS criteria.31
MINORS tools consist of 12 points, with 8 points for non-comparative study and additional 4 points for 
comparative study. Points for non-comparative study are: (1) consist of stated aim of study; (2) inclusion; (3) 
collection data; (4) endpoint of study; (5) unbiased evaluation; (6) follow up period; (7) loss of follow up; (8)
prospective calculation of sample size. Additional for comparative study are: (1) gold standard for control 
group; (2) contemporary groups; (3) baseline equivalence; (4) statistical analyses. These items are sored 0 
(not reported), 1 (reported but not adequately), or 2 (reported and adequately). Score ≤12 is considered to 
be of low quality (high risk of bias), where as a study with MINORS score >12 is thought to be of high quality. 
The bold is excluded due to high risk of bias (MINORS score ≥12)
In each article, we reviewed alignment, including (1) hip-knee-ankle angle (HKA) or 
mechanical axis (MA); (2) placement of the femoral component through the coronal 
femoral alignment (CFA), sagittal femoral alignment (SFA), and axial femoral plane 
(AFP); (3) placement of the tibial component, which involves coronal tibial alignment 
(CTA), sagittal tibial alignment (STA) and axial tibial plane (ATP); (4) outliers, defined as 
deviation > 3° of neutral alignment for HKA or MA, deviation > 3° from 90° for CFA, SFA, 
and CTA, and also > 3° deviation from 87° for STA, patient-reported outcomes, range of 
motion, operative time, complications, or reoperations between accelerometer-based 
navigation and conventional TKA. For alignment, we used full limb on standing position. 
A minimum of 2 weeks postoperative follow-up was required to include data about 
patient-reported outcomes.
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Table 2. Cochrane risk of bias tools for randomized controlled trials (RCT)
Cochrane risk Nam et al42 Gharaibeh et al16 Ikawa et al23 Kinney et al30
Random sequence generation Low risk Low risk Low risk Low risk
Allocation concealment Low risk Low risk Low risk Low risk
Selective reporting Low risk Low risk Low risk Low risk
Other bias High risk Low risk Unclear risk Unclear risk
Blinding of participants and personal Low risk Unclear risk Low risk Low risk
Blinding of outcome assessment Low risk Low risk Low risk Low risk
Incomplete outcome data Low risk Low risk Low risk Low risk
Conclusion fair quality fair quality fair quality fair quality
Cochrane Risk of Bias tools consist of 7 points10:(1) random sequence generation; (2) allocation conceal-
ment; (3) selective reporting; (4) other bias; (5) blinding of participants and personnel; (6) blinding of out-
come assessment; (7) incomplete outcome data. These items are assessed for high, low, or unclear and each 
study is interpreted with good, fair, or poor quality based on the criteria.
ReSuLTS
Accuracy
We observed small, inconsistent differences in MA and HKA; five of nine studies favored 
accelerometer-based navigation17,18,24,28,37, while four of nine found no differences 
between the study groups.31,42,43,58 In terms of coronal-axis alignment of the femoral 
component, seven of nine studies favored accelerometer-based navigation17,18,24,28,37,58,59, 
but the effect size generally was small. Only three studies compared the sagittal place-
ment of femoral component and none of those studies showed a difference between 
accelerometer-based navigation and the conventional TKA group.17,58,59 Only one study 
evaluated the axial placement of the femoral component61; it found no differences 
between the study groups (Table 3).
Of the nine studies that evaluated tibial component coronal plane alignment, only two 
favored accelerometer-based navigation, and the differences were small28,37; the other 
seven studies found no differences between the groups.17,18,31,42,43,58,59 None of the five 
studies that evaluated sagittal alignment of the tibial component found differences 
between the study groups.17,42,43,58,59 The one study that evaluated axial placement of the 
tibial component59 found no between-group differences.
Only two of six studies that evaluated the proportion of patients with outliner align-
ments supported accelerometer-based navigation28,37; the other four found no differ-
ences in this important endpoint.17,18,42,43
A minority of studies (four of nine) that evaluated CFA outliers favored accelerom-
eter-based navigation18,24,58,59; the remainder did not.17,28,31,42,43 Only one study58 of 
five17,28,42,58,59 that evaluated SFA outliers supported accelerometer-based navigation 
over conventional alignment techniques. Regarding axial placement of femoral com-
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ponent outliers, only one study by Ueyama et al59 evaluated this endpoint; the authors 
observed no differences between the study groups.
Only one study of seven found accelerometer-based navigation superior to conven-
tional TKA in reducing the proportion of knees that were outliers with regard to CTA44; 
the other six found no between-group differences.17,18,31,42,58,59 Likewise, only one of 
five studies saw a reduced likelihood of CTA outliers43, with the other four arriving at 
a no-difference conclusion.17,42,58,59 Only one study compared the proportion of outli-
ers in axial placement of the tibial component; it showed no difference between the 
accelerometer-based navigation and the conventional TKA group.59
functional outcome
None of the three studies that evaluated ROM found a difference between accelerome-
ter-based navigation and conventional approaches to TKA alignment18,58,59; none of the 
four studies that evaluated the Knee Society Score found a benefit to accelerometer-
based navigation18,28,37,58, and neither of the two that evaluated the Oxford Knee Score 
(OKS), SF36 physical component score (PCS), and SF-36 mental component score (MCS) 
found between-group differences, either.18,37
Surgical Time, Complications, and Reoperations
In one of seven studies, surgical time was increased in the accelerometer-based naviga-
tion group compared with conventional TKA (83.9 ± 21.8 minutes versus 72.5 ± 14.6, p < 
0.001)37; the other six did not show an increase.17,18,28,43,58,59
Concerning complications, there were no differences between accelerometer-based 
navigation and conventional TKA using either an intramedullary, extramedullary, or a 
combined technique in the three studies that reported on this endpoint.18,28,37 No reop-
erations or revisions were reported in any study, but one study reported asymptomatic 
DVT and asymptomatic PE in the accelerometer-based navigation group (17% and 8%, 
respectively) and conventional group (19% and 11%, respectively).59
dISCuSSIoN
The importance of better alignment in TKA derives from the apparently higher revision 
risk from wear and loosening that are associated with malalignment.12,49 Computer-
assisted surgery systems (CAS) have been shown to be helpful in some studies in terms 
of achieving neutral alignment in the coronal plane compared with conventional 
TKA.2,4,5,6,13,15,19,29,34,39,43,58,64 However, improved component and overall limb alignment 
accuracy does not guarantee improved clinical and functional outcomes.4,9,20,40 Conven-
tional CAS systems with large console computers are criticized because they seem to 
increase operative time and cost, are associated with a long learning curve14,16, have 
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sensitive optical instruments6, and do not demonstrate an improvement in implant sur-
vival. Accelerometer-based navigation was introduced as a simpler and potentially less 
expensive alternative; it was originally used for the tibial component, but more recently 
it had also been used to guide the distal femoral cut.43 Although previous studies have 
disagreed about its efficacy17,18,24,28,31,37,42,43,58,59, accelerometer-based navigation is seeing 
wider use.24,28 Thus, an evaluation of the potential clinical benefits and complications 
of this technology compared with conventional TKA seems important. We therefore 
performed a systematic review to ask: (1) Is accelerometer-based navigation more ac-
curate than conventional TKA? (2) Does accelerometer-based navigation provide better 
functional outcomes than conventional TKA? (3) Does accelerometer-based navigation 
result in increased surgical time, decreased complications and fewer reoperations 
compared with conventional TKA? We found very inconsistent (and generally small) 
benefits in favor of accelerometer-based navigation in terms of alignment, but no ben-
efits regarding the functional outcomes or the risk of complications or reoperations. 
Until or unless more compelling evidence in favor of the new technology emerges, we 
recommend against its widespread adoption.
Several limitations of this study must be noted. First, only four RCT studies were included, 
and the study quality of these was only fair. Because studies with high bias risk will tend 
to overestimate the benefits of the new treatment, the already-small advantages in 
some endpoints in this review that favored accelerometer-based navigation should be 
considered inflated. The accelerometer-based navigation systems used were not identi-
cal, although the principles were the same, and this might influence results, however, it 
is difficult to say how. In some studies, accelerometer-based navigation was used only 
for one component (either femoral or tibial)24,28,43. This probably unfairly advantaged 
accelerometer-based navigation, resulting in that technology looking better than it 
probably would if it had been used alone. This should further caution the reader that 
this technology seems to offer little advantage. Secondly, this is not a meta-analysis; the 
small number of published RCTs concerning accelerometer-based navigation precluded 
the statistical pooling of results (meta-analysis). Another limitation was the absence of 
long-term assessments of revision risk; although it is possible that over the longer term a 
benefit favoring accelerometer-based navigation may emerge in terms of this endpoint, 
the small and inconsistently observed alignment benefits of this approach make this 
seem unlikely.
Accelerometer-based navigation attempts to combine the accuracy of CAS with the fa-
miliarity of conventional TKA.17 Our systematic review showed that using accelerometer-
based navigation improved alignment in some but not in most studies. In light of the 
high risk of bias, which likely inflated the apparent benefits of accelerometer-based 
navigation in terms of these parameters, we cannot recommend its wide adoption. One 
possible application that we believe deserves further study is in the knees of some Asian 
97
Accelerometer-based navigation in TKA
Ch
ap
te
r 5
patients, where femoral bowing is a problem. One study found that accelerometer-based 
navigation decreased the proportion of knees with outliers in terms of hip-knee-ankle 
alignment of more than 3° from neutral (as well as malalignments of both the femoral 
and tibial components)58, although we caution against drawing firm inferences from one 
study, and that study did not demonstrate improvements in functional outcomes.
Several studies evaluated the clinical and functional outcomes of accelerometer-based 
navigation and conventional TKA, but none found accelerometer-based navigation to 
be superior to conventional TKA.18,28,37 Prior studies have suggested that improved align-
ment may be associated with superior patient-reported outcomes26,56; however, this has 
not consistently been found to be the case.47 In our systematic review, we determined 
that accelerometer-based navigation improved alignment but not patient-reported 
outcomes or ROM; the absence of differences favouring that technology over conven-
tional TKA regarding outcome scores further confirms that any such benefits are of little 
importance to patients.
We found no benefit with accelerometer-based navigation concerning complications 
or reoperations, and one study found it increased surgical time.37 A study by Parratte 
et al48 showed no improvement in survival rates when the alignment reached the neu-
tral mechanical axis ± 3° when compared with the outlier group. This was a subject of 
controversy since previous studies had shown that neutral mechanical axis of 0° ± 3° 
would improve implant durability.39,47 But many factors contribute to long-term TKA 
survivorship1,25,57; a new concept of constitutional varus was introduced because 30% 
of individuals have constitutional varus, which may contribute to functional and long-
term durability3. We found no difference in emboli, asymptomatic DVT and PE, infection, 
perioperative mortality, fracture, or revision.18,24,28,31,36,59
We saw no consistent benefit with accelerometer-based navigation over conventional 
TKA in terms of alignment, and no benefit at all regarding patient-reported outcomes, 
ROM, complications or reoperations. The new technique may or may not add surgical 
time to the operation. Additionally, we note that study quality was highly variable, with 
most studies exhibiting a high risk of bias; this would be expected to cause an increase 
in the apparent benefit of the novel treatment, and so this further reinforces our conclu-
sion that there is not enough evidence to recommend accelerometer-based navigation. 
Given the absence of high-quality evidence demonstrating compelling benefits of this 
accelerometer-based-navigation technology for patient outcomes, we recommend 
against wide adoption of accelerometer-based navigation in TKA.
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ABSTRACT
Venous thromboembolism (VTE) has been identified as an immediate threat to patients 
undergoing major orthopaedic procedures such as total hip arthroplasty (THA) and 
total knee arthroplasty (TKA). Given the known dangers of VTE, arthroplasty surgeons 
are sensitive to the need for VTE thromboprophylaxis. However, the modalities of 
thromboprophylaxis used to minimize the risks to patients have been variable. Clinical 
practice guidelines have been published by several professional organizations, while 
some hospitals have established their own protocols. The 2 most popular guidelines 
are those published by the Academy of Orthopaedic Surgeons (AAOS) and American 
College of Chest Physicians (ACCP), both from North America. Prior to 2012, these rec-
ommendations varied depending on underlying definitions, methodology, and goals of 
the 2 groups. For the first time, both groups have similar recommendations that focus 
on minimizing symptomatic VTE and bleeding complications. The key to determining 
the appropriate chemoprophylaxis for patients is to balance efficacy of a prophylactic 
agent, while being safe in regard to bleeding complications. However, a multimodal 
approach that focuses on early postoperative mobilization and the use of mechanical 
prophylaxis, in addition to chemoprophylaxis, is essential.
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INTRoduCTIoN
As the number of total joint arthroplasties performed worldwide continues to grow, a 
commensurate increase in the number of venous thromboembolism (VTE) events can 
be anticipated. Although the incidences of symptomatic deep vein thrombosis (DVT) 
and pulmonary embolism (PE) are low, the incidence of asymptomatic DVTs has been 
estimated to be 20%–40% of inpatients undergoing total hip arthroplasty (THA) and 
total knee arthroplasty (TKA).1 Unfortunately, the risk of symptomatic VTE has remained 
stable over the past 2 decades. Therefore, the use of effective and safe chemoprophylaxis 
agents is crucial for minimizing the risk of VTE events in these patients. Despite several 
decades of experience and hundreds of clinical studies, there is still no consensus on the 
ideal method of thromboprophylaxis for patients undergoing THA and TKA. This incon-
sistency has raised the concern that many patients are at risk for insufficient prophylaxis 
or excessive bleeding risks. In a retrospective study involving 3497 patients who had 
THAs or TKAs between April 1, 2004 and December 31, 2006, Selby et al found that only 
40% of patients received the 8th edition American College of Chest Physicians (ACCP) 
recommended thromboprophylaxis.2 Out of the patients receiving non-ACCP recom-
mended prophylaxis, 81 % received shorter than the minimum 10 days recommended, 
making them twice as likely to experience a DVT (3.76% vs 2.01%, P=0.003) and more 
than 8 times more likely to experience a PE (1.19% vs 0.14%, P=0.001).
In the past 2 years, there have been remarkable changes to the clinical guidelines for 
VTE prophylaxis, mostly pertaining to changes in the ACCP guidelines. This review 
will describe the new guidelines published by the American Academy of Orthopaedic 
Surgeons (AAOS) and ACCP, their influences on how surgeons prescribe thrombopro-
phylactic agents, and the currently available chemoprophylactic options.
ACCP and AAoS Guidelines
A number of concerns have been identified with the previous ACCP clinical guidelines. 
Until the eighth conference in 2008, prior methodologies emphasized multicenter, 
randomized clinical trials with venographically proven DVTs as the endpoint. The United 
States (US) Food and Drug Administration (FDA) recognizes venographically proven 
DVTs as a valid endpoint for the efficacy of VTE prophylactic drugs. This method is very 
expensive and often weighted toward studies utilizing aggressive pharmaceutical 
chemoprophylaxis. However, the vast majority of DVTs are asymptomatic. In addition, 
venography has been largely replaced by ultrasound (US) techniques in most major 
medical centers and hospitals. Moreover, the clinical significance of asymptomatic DVTs 
has been extensively debated. In a recent study, Parvizi et al3 found a very low corre-
lation between the presence of DVTs and PEs, and, therefore, questioned the clinical 
significance of an asymptomatic DVT.
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In essence, the ACCP guidelines were more focused on efficacy, often under emphasizing 
the risk of bleeding, which is associated with serious complications including hematoma, 
infection, and reoperation. Moreover, the ACCP described a major bleeding episode as 
overt bleeding associated with at least 1 of the following: death or life threatening clini-
cal event; bleeding confirmed as retroperitoneal, intracranial or intraocular; transfusion 
of more than 2 packed units of blood cells or whole blood; or decrease of haemoglobin 
more than 2 g/dL compared with relevant postoperative level4. These criteria generally 
do not apply to THA and TKA patients. Galat et al5 reported that patients with wound 
complications requiring reoperation within 30 days of TKA were 10 times more likely to 
have subsequent major surgery and associated morbidities than those without. How-
ever, failure to meet the ACCPs strict criteria of major bleeding event resulted in under 
reporting of bleeding complications in many studies. Investigations by both Keeney 
et al6 and Novicoff et al7 revealed a dramatic increase in bleeding after adopting the 
ACCP protocols. Finally, not only did the orthopaedic surgeons experience an increase 
in bleeding, but they were also prohibited from using less aggressive and less expensive 
options such as aspirin with mechanical compression devices, even in young patients 
with a very low VTE risk.8–10
Another major concern with the ACCP guidelines was that numerous potential financial 
conflicts of interest were found with many authors. As a result, the Institute of Medicine 
issued recommendations regarding guideline development that discouraged any finan-
cial conflict of interest among its authors of clinical guidelines.11
Due to the many concerns raised regarding the ACCP guidelines, the AAOS formed 
its DVT/PE workgroup in 2007 and issued its own recommendations by reviewing the 
available literature on VTE with symptomatic DVT, PE, and mortality as endpoints.12 The 
goal was to achieve more balance between minimizing risk and maximizing efficacy, 
while minimizing conflicts of interest during the guideline development. Patients were 
classified based on their medical history to identify their risk of VTE and bleeding. The 
AAOS guidelines were in conflict with the ACCP guidelines until the ninth edition of the 
ACCP recommendations, which was published in 2012.13
In 2012 edition, the ACCP addressed almost all the concerns found in their previous clinical 
guidelines. Their methodology was changed dramatically to focus on more symptomatic 
and significant outcomes like bleeding and wound drainage. While the AAOS was unable 
to recommend a specific modality of prophylaxis nor the optimal duration of treatment, 
the ACCP recommended several choices. The conflicts of interest issue were addressed 
with more than half their authors declaring no potential financial conflict of interests. They 
also recommend a mobile intermittent pneumatic compression device (IPCD) that has a 
compliance monitoring chip as supported in a study by Colwell et al.14 Importantly, neither 
guideline could identify any literature that supported the use of IVC filters to prevent PE. 
Moreover, both guidelines recommended against routine US screening.
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Chemoprophylaxis
VTE prophylaxis for THA and TKA patients are available in chemical and/or mechanical 
forms. In recent years, there has been significant progress towards developing more 
effective and practical thromboprophylaxis agents to include either injectable low 
molecular weight heparin (LMWH)15 or the latest oral anticoagulant agents (factor X in-
hibitors and direct thrombin inhibitors).16,17 Chemical prophylaxis agents included in the 
clinical guidelines were aspirin, warfarin, LMWH, fondaparinux, dabigatran, rivaroxaban, 
and apixaban. All are approved for use in United States except dabigatran and apixaban. 
This review will concentrate on studies that were influential to the formation of AAOS 
and ACCP recommendations. The following paragraphs will also describe briefly the 
current chemical prophylaxis suggested by ACCP guidelines and the recent available 
research papers.
Aspirin
Aspirin has been a popular chemoprophylaxis agent for the last three decades. It is still 
widely used in North America, although it is considered less available in Europe.18 The 
ACCP guidelines4 recommended aspirin as a chemoprophylaxis agent, rather than no 
prophylaxis at all (Grade 1B). This is due to the Pulmonary Embolism Prevention (PEP) 
trial,19 which concluded that low-dose aspirin, when taken for thirty-five days, would 
result in 7x less symptomatic DVT cases, but in three bleeding cases and two non-fatal 
myocardial infarctions per 1000 patients. On the other hand, AAOS guidelines recom-
mend the use of pharmacologic agents and/or mechanical compressive devices for 
prevention of VTE but is inconclusive on which strategy is optimal.12
In a study by Vulcano et al, the rate of VTE between aspirin was compared to warfarin in 
adjunct to multimodal prophylaxis (i.e. early mobilization post operatively, pneumatic 
compression devices, and regional anaesthesia).20 The results showed a lower rate of 
VTE, PE, proximal DVT and distal DVT for the aspirin group. However, the findings may 
be biased since aspirin was given to low-risk patients and warfarin was given to high-risk 
patients.
Unfractionated Heparin (UFH)
Heparin is one of the oldest thromboprophylaxis agents for VTE following major surgery. 
However, due to the inconvenient method of administration (subcutaneous injection 
2-3 times a day) and an increased frequency of complications such as heparin-induced 
thrombocytopenia (HIT), the use of this agent has decreased in popularity. In fact, UFH 
is very rarely included as a studied agent in recent publications.21
Leyvraz et al22 studied 349 patients undergoing THA in 28 European orthopaedic de-
partments. All patients had venograms completed 10 days after the surgery. The results 
showed DVT events in 16% of UFH patients and 12.6% of LMWH patients, (p = 0.45) and 
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the incidence of proximal DVT was much lower in LMWH group (2.9% and 13.1%, re-
spectively; p < 0.001). Bleeding events were low and comparable between both groups.
Low Molecular Weight Heparin
Low molecular weight heparin is generated from unfractionated heparin either through 
physical, chemical, or enzymatic depolarization.4 Some of the available LMWHs are 
enoxaparin, dalteparin, and tinzaparin. Among these three, only two (enoxaparin and 
dalteparin) are indicated in major orthopaedic surgery.23
A meta-analysis study involving16 randomized controlled trials (RCTs) compared enoxa-
parin with the newer anticoagulants (rivaroxaban, dabigatran, apixaban).24 The study 
concluded that newer anticoagulants are higher in efficacy, but also have higher risk 
of bleeding. The risk of symptomatic VTE was lower with rivaroxaban (relative risk [RR] 
0.48, 95% confidence interval [CI] of 0.31 to 0.75), and similar with dabigatran (RR = 0.71, 
CI 0.23 to 2.12) and apixaban (RR = 0.82, CI of 0.41 to 1.64). In terms of safety outcome, 
rivaroxaban was associated with a significant increase in the risk of clinically relevant 
bleeding (RR= 1.25, CI of 1.05 to 1.48; p = 0.01). Dabigatran did not show a significant 
increase compared to enoxaparin (RR = 1.12, CI of 0.94 to 1.35; p = 0.21), regardless the 
dosage used (150 mg or 220 mg). However, this study found that apixaban was associ-
ated with a significant reduction in risk of bleeding (RR = 0.82, CI of 0.69 to 0.98; p = 
0.03). On the same paper, after balancing efficacy and safety (symptomatic DVT or PE 
with clinically relevant bleeding events), no significant difference was found between 
LMWH and newer anticoagulant agents. However, it is important to note that all papers 
reviewed in this meta-analysis were sponsored by pharmaceutical companies.
Another review tried to compare indirectly between dalteparin and enoxaparin as 
prophylaxis in patients following THA.25 From nine RCTs that were studied (all compared 
to placebo), results demonstrated comparable safety and efficacy between these two 
LMWHs. Both have 50% risk reduction of VTE compared to placebo (RR = 0.50, p < 0.001) 
and no increase in major bleeding (RR = 1.19, p = 0.76), heparin induced thrombocyto-
penia (RR = 1.13, p = 0.83) or death (RR 0.72, p 0.59). Although this study showed similar 
efficacy and safety between enoxaparin and dalteparin, more RCTs comparing these 
two agents are needed to actually see the difference.
One of the older reviews26 compared the cost-effectiveness between enoxaparin and 
warfarin for DVT prophylaxis following THA. The study showed that the occurrence of 
DVT was lower in the enoxaparin group (13.6%) compared to warfarin group (20.6%). 
In ACCP guidelines4, the single most suggested thromboprophylactic agent was LMWH, 
unless patients had a high risk for bleeding or were uncooperative with injections.
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Warfarin
Warfarin is a vitamin K antagonist and has been widely used in United States as an 
anticoagulant agent since 1954 for various indications.27 It derived its name because 
it was discovered at the University of Wisconsin (WARF = Wisconsin Alumni Research 
Foundation). It was the first oral anticoagulant. However, the usage is restricted by the 
bleeding risk, potential drug interaction, and requirement for constant monitoring (INR).
Warfarin has been compared to low molecular weight heparin (LMWH) as prophylaxis 
for TKA in several multicenter clinical trials.28-32 To summarize, all studies showed that 
LMWH was a more effective agent to prevent DVT formation (p < 0.05), but no difference 
to warfarin in preventing symptomatic events including PE, in part since most of studies 
measured primary outcome as asymptomatic DVT. Moreover, LMWH resulted in more 
bleeding episodes compared to warfarin, although the difference is not significant (p 
> 0.05).
Factor Xa Inhibitor (fondaparinux, rivaroxaban, apixaban)
There are two types of factor Xa inhibitors, the indirect and direct. Fondaparinux and 
idraparinux are examples of indirect factor Xa inhibitors. They are synthetic, highly selec-
tive factor Xa inhibitors that work in a pentasaccharide form. However, the development 
of idraparinux was terminated due to prolonged elimination half-life and increased risk 
of bleeding longer than six months. On the other hand, direct factor Xa inhibitors work 
by binding to the active site of factor Xa, thus blocking the interaction with its sub-
strate.33-35 Examples of oral direct factor Xa inhibitors are rivaroxaban, apixaban, edoxa-
ban and betrixaban.35 Rivaroxaban and apixaban are recommended by the ACCP in the 
same manner as the fondaparinux.4 However, the increase in efficacy is accompanied 
by an increased bleeding risks, which is why LMWH remains the most recommended 
chemoprophylaxis.13
A multicenter RCT from Japan studied the effect of fondaparinux compared to placebo 
and the dose-response effect (0.75 mg, 1.5 mg, 2.5 mg and 3.0 mg) in patients with 
TKA or THA (two separate sub-studies).34 In the TKA sub-study, the incidence of VTE was 
34.2%, 21.3%, 16.2%, and 9.5% in groups receiving fondaparinux 0.75mg, 1.5mg, 2.5mg 
and 3.0mg respectively, compared to the placebo group (65.3%). In THA sub-study, the 
incidence of VTE was 24.2%, 4.6%, 7.4%, and 14.4%, compared to the placebo group 
(33.8%). In both sub studies, each group receiving fondaparinux showed significant 
reduction in asymptomatic VTE events compared to placebo (p < 0.001), while no major 
or minor bleeding difference was found between the fondaparinux and placebo groups.
Turpie at al36 completed a meta-analysis on VTE prevention between fondaparinux 
and enoxaparin in patients undergoing elective major orthopaedic surgery (THA, 
TKA, and ORIF of hip fractures). The result showed greater reduction of VTE events in 
the fondaparinux groups (6.8%) compared to enoxaparin (13.7%), and the result was 
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consistent in all studies reviewed. Despite more major bleeding events that occurred 
in the fondaparinux group (p = 0.008), clinically relevant bleeding that led to death or 
occurred in critical organs did not differ between the two groups. According to ACCP 
recommendation4, fondaparinux is suggested as chemoprophylaxis agent in patients 
undergoing THA or TKA, but its use needs thorough judgment based on the patients’ 
bleeding risks and is positioned with a lower recommendation than LMWHs. Therefore, 
due to bleeding concerns, the use of fondaparinux in North America is not as popular as 
other VTE prophylaxis for arthroplasty.37
Rivaroxaban
Rivaroxaban is an FDA approved oral direct factor Xa inhibitor that also requires no 
monitoring. There have been four Phase III randomized trials38-41 to assess the efficacy 
of rivaroxaban as a VTE prophylaxis agent in total joint arthroplasty patients. Lassen et 
al38 showed that 10 mg of rivaroxaban taken once daily was more effective than 40 mg 
of enoxaparin administered once daily in reducing overall VTE for TKA patients (RR = 
9.2%, p < 0.001). There was no difference in major bleeding between rivaroxaban and 
enoxaparin groups (0.6% vs. 0.5%; p >
0.05). In a different study comparing 10 mg of rivaroxaban once a day with 30 mg enoxa-
parin every twelve hours in TKA patients, Turpie et al39 found the rivaroxaban group 
yielded a lower overall VTE incidence and mortality rate compared to enoxaparin group 
(absolute risk reduction 3.19%, 95% CI 0.71-5.67; p = 0.0118). No difference in major 
bleeding events between both group (0.7% vs 0.3%; p = 0.109). In the latest retrospec-
tive review, Jensen et al42 associated rivaroxaban with more re-operations than LMWH 
after TKA (3.94% vs. 1.8%; p = 0.046).
In a study comparing 10 mg of rivaroxaban taken six hours post-operatively against 
40 mg enoxaparin administered the evening pre-operatively as prophylaxis for THA, 
Eriksson et al found rivaroxaban to be significantly more effective than enoxaparin in 
preventing total VTE (1.1% vs. 3.7%, RR of 2.6%, p < 0.001) but not in symptomatic events 
(96.8% vs 97.0%; p > 0.05). No difference in occurrence of major bleeding (p = 0.18).40 
In another study comparing usage of ribaroxaban with extended duration of thirty-five 
days against administration of enoxaparin for ten to fourteen days, Kakkar et al found 
rivarovaban to be significantly more effective than enoxaparin in limiting total VTE and 
symptomatic episodes (RR = 7.3%, CI of 5.2 - 9.4; p < 0.0001). No significant difference 
on any bleeding during treatment (p = 0.25).41 The current controversy for rivaroxaban is 
the timing of first dosage. In the above-mentioned four studies, rivaroxaban was admin-
istered six to eight hours postoperatively, but it may be safer to start the first dosage the 
next day especially if the drug does have any effect on the development of symptomatic 
events.
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Studies to date may not have found significant differences in adverse event between 
direct factor Xa inhibitors and LMWH, but direct factor Xa inhibitors do have a bleeding 
risk that is still higher than LMWH. Lassen et al43 conducted an analysis from four phase 
III clinical trials (i.e. RECORD 1-4 [Regulation of Coagulation in Orthopaedic Surgery 
to prevent deep venous thrombosis and pulmonary embolism]). These trials involved 
12,383 patients undergoing THA or TKA which then randomized to receive either oral 
rivaroxaban 10 mg once daily or subcutaneous enoxaparin 40 mg once daily (RECORD 
1-3) or enoxaparin 30 mg twice daily (RECORD 4). The adverse event was observed 
only during the active treatment period. These studies showed that patients who un-
derwent TKA have more complications compared to THA patients despite the types of 
prophylaxis given. Moreover, although the number of bleeding events were higher in 
rivaroxaban treatment groups, the difference was not significant. This can be one of the 
reasons rivaroxaban has been approved in more than 115 countries worldwide for the 
prevention of VTE after TKA or THA.
Apixaban
Apixaban is a direct oral factor Xa inhibitor that has not been approved by FDA in 
United States. Lassen et al44-46 conducted a series of studies comparing apixaban against 
different doses of enoxaparin as prophylaxis for total joint arthroplasty patients. For 
TKA patients, when 2.5 mg of apixaban taken twice daily was assessed against 30 mg 
of enoxaparin administered twice daily, both groups showed extremely low overall 
VTE rates, but apixaban resulted in significantly less bleeding risk.44 In another study 
where 2.5 mg of apixaban taken twice daily was compared against 40 mg of enoxaparin 
administered once daily, Lassen et al found the overall VTE and mortality rate to be 
significantly lower in the apixaban group.45 There was no significant difference found 
between the two groups in terms of non-major bleeding risks. For THA VTE prophylaxis, 
when 2.5 mg of apixaban was taken twice a day had been compared to 40 mg enoxa-
parin taken once daily by Lassen et al, results showed that apixaban was more effective 
in lowering overall VTE events and mortality rate.46 The same study showed that with 
every 147 patients, apixaban prevented one VTE event without any additional bleeding 
risk. These three studies suggested that 2.5 mg of apixaban taken once daily is the more 
effective prophylactic agent when compared to 40 mg of enoxaparin administered once 
daily but showed the same efficacy when comparing 30 mg of enoxaparin administered 
twice daily. A meta-analysis performed by Russell et al to investigate the efficacy of 
2.5 mg of apixaban or 10 mg rivaroxaban against enoxaparin as prophylaxis after total 
hip and knee arthroplasty summarized that oral factor Xa inhibitors were superior to 
enoxaparin in preventing DVT, but there was no difference in the rate of PE, mortality, or 
post-operative wound infections.47
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Direct Thrombin Inhibitor (dabigatran)
Direct thrombin inhibitors (DTIs) work by binding specifically to the active center of 
thrombin and inactivate free and fibrin-bound thrombin. This process is reversible leav-
ing small amount of free and active thrombin to control hemostasis.35
Dabigatran is the first oral DTI approved for the chemoprophylaxis following major or-
thopaedic procedures. It was first approved by Health Canada and European Medicines 
Agency in 2008 and is now available in more than 75 countries. It has the benefit of 
oral administration, being highly specific, a reversible effect, not require monitoring, 
and having a slow onset. Thus, the haemostatic process may take place after procedures 
and before the effect of anticoagulant commences.48 In the US, dabigatran etexilate is 
an FDA approved oral direct thrombin inhibitor for prevention of atrial fibrillation and 
stroke, but not for VTE prophylaxis after THA and TKA.
A trial by Eriksson et al49 compared dabigatran against enoxaparin (oral dabigatran 220 
mg, oral dabigatran 150 mg, subcutaneous enoxaparin 40 mg; all once daily). Efficacy 
outcomes measured were symptomatic DVT, venographic DVT, and/or symptomatic 
PE. The safety outcome measured was bleeding events during the course of study. The 
result showed efficacy outcome (total VTE and death) of 37.7%, 36.4%, and 40.5% for 
enoxaparin, 220 mg dabigatran, and 150 mg dabigatran, respectively. The major bleed-
ing occurrence also did not differ significantly among three groups (1.3% vs. 1.5% vs 
1.3% respectively; p > 0.05).
Ginsberg et al50 also found both doses of dabigatran to be comparable to 30 mg of 
enoxaparin taken twice daily in terms of bleeding episodes for total knee arthroplasty 
patients. Based on the above trials, ACCP concluded that dabigatran was comparable to 
enoxaparin/LMWH in terms of efficacy and bleeding risks.
Mechanical Prophylaxis
Mechanical prophylaxis is any compressive device applied to an affected limb. It can 
be a compressive stocking, IPCD, or similar working devices. A single center study con-
ducted in Stockholm reported no significant difference in VTE incidence in 5,310 THA 
and TKA patients after discontinuing the use of postoperative compression stockings. 
The incidence was 2.7% and 2.3% (p = 0.4) before and after the cessation, respectively.51
ACCP guidelines suggest the use of IPCD be at least 18 hours a day as an adjunct to 
chemoprophylaxis, or in patient with high risk of bleeding.13 The AAOS guidelines 
recommend use of mechanical compressive devices in patients with known bleeding 
disorders, such as haemophilia or active liver disease or as with chemoprophylaxis in 
patient with previous VTE.12
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Intermittent pneumatic compression devices
Some studies have found that mechanical prophylaxis such as IPCDs are quite effective 
in reducing the risk of DVT and PE in arthroplasty patients by more than 50% without 
any risk for bleeding. However, in the past, patients’ treatment ceased upon discharge 
from hospital and adherence to routine application became a challenge. Therefore, 
the introduction of portable, battery-powered devices allows patients to utilize these 
devices in the hospital or at home. Moreover, a monitoring chip implanted in the device 
helps monitor a patient’s compliance. Colwell et al14 showed in a multicenter random-
ized controlled trial comparing IPCD against enoxaparin that IPCD was just as effective 
as enoxaparin in preventing proximal and distal DVT and PE events, but resulted in a 
much lower bleeding risk (1.3% IPCD vs 4.3% LMWH). There was no difference in mortal-
ity rate. As a side note, this paper disclosed that one or more of its authors or immediate 
family received benefits from the commercial party.
Combined Modalities
Combined prophylactic modalities have been shown to improve the efficacy.52,53 How-
ever, it is still unclear whether this advantage also applies to total joint arthroplasty, 
whether the combined modalities are indeed better than either chemoprophylaxis or 
mechanical compression device alone, or whether they can prevent pulmonary emboli. 
In a systematic review and meta-analysis of 1399 patients, Kakkos et al54 found that in 
TKA, the rate of DVT was reduced from 18.7% with anticoagulant alone to 3.7% with 
combined modalities (RR = 0.27; p = 0.03). For THA, the rate of DVT was reduced from 
9.7% with anticoagulant alone to
0.9% with additional intermittent mechanical leg compression (RR = 0.17; p < 0.001). 
However, when anticoagulant was added to compression compared to compression 
alone, the rate of DVT was insignificantly reduced from 8.7% to 7.2% for THAs, but no 
data was available for the TKA group. Further research with a larger population on the 
role of combined modalities of thromboprophylaxis in total joint replacement and in 
other high-risk orthopaedic surgeries is needed.
duration
The ACCP guidelines recommend a minimum of 10 to 14 days of prophylaxis in patients 
undergoing THA or TKA. However, it suggests extending the thromboprophylaxis to 35 
days in the outpatient period (Grade 2B).13
Conflicts of Interest
With so many choices of thromboprophylaxis currently available on the market, ortho-
paedic surgeons have to be cautious when deciding the most suitable prophylaxis for 
their patients. The AAOS and ACCP guidelines, current literature, and individual needs of 
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each patient must be taken into consideration. Moreover, when reviewing study results 
for each modality, one has to be aware of any potential financial conflicts of interest. 
A recent evidence-based review by Lee et al revealed that out of seventy-one eligible 
studies identified, fifty-two were industry funded, fourteen were not and the remaining 
five did not disclose the source of funding.55 Most of these industry-sponsored studies 
were performed in Western countries. The review further showed a significant correla-
tion between the funding source and qualitative conclusions. Only 3.8% of the fifty-
two industry-sponsored studies had unfavourable conclusions, whereas 21.4% of the 
fourteen non-industry-sponsored studies indicated that the modality examined were 
neither effective nor safe. Since more studies are sponsored by industry than not, one 
will find more favourable conclusions to the use of the sponsored prophylactic agents 
or recommendations for extended use. The limitation to the review by Lee et al is that 
the number of non-industry-sponsored studies were small, and therefore the authors’ 
analysis was sensitive to the conclusions of those studies. In another study to evaluate 
thromboembolic complications after fast-track THA and TKA, Husted et al found that 
if patients were mobilized within 4 hours after surgery and given prophylaxis for one 
to four days duration, no DVT, PE, or mortality was found in the study.56 The authors 
also questioned whether extended prophylaxis was actually needed when patients 
were mobilized early since the majority of studies on extended prophylaxis were partly 
sponsored by pharmaceutical companies.
Asian Perspective
There are large variations in reported cases of postoperative DVT after THA and TKA 
in Asian populations, even within the same country. The general consensus is that the 
rates are lower in Asia as compared to Western countries.57-61 However, due to lack of 
reported data which leads to substantial under-estimation of VTE incidence, this con-
sensus is debatable.62,63 However, several multicenter study such as the SMART (Surgical 
Multinational Asian Registry in Thrombosis), AIDA (Assessment of the Incidence of Deep 
Vein Thrombosis in Asia), and Asia Pacific Thrombosis Advisory Board stated that the 
incidence rates of DVT in Asian populations are similar compared to the Western.64,65,66 
The paucity and variation in available data regarding the incidence of DVT in arthro-
plasty patients makes it difficult to prepare guidelines and protocols for thrombopro-
phylaxis.64,65 The variations in data can be due different methods of detection, different 
designs of studies, lack of patients incidence data, and different lifestyles and dietary 
content. Despite declaration of minimal incidence of DVTs, developed Asian countries 
such as Korea, Japan, and China have established their own guidelines. This shows some 
consensus that clinical protocols and guidelines are necessary for each country regard-
less of the actual incidences reported. In addition, these guidelines can differ due to 
poor understanding of risk factors like ethnicity and genetic susceptibility.
115
VTE prophylaxis in arthroplasty: changing trends
Ch
ap
te
r 6
CoNCLuSIoNS
The number of arthroplasties performed worldwide continues to increase annually. VTE 
remains a clinical concern due to the risk of symptomatic VTE and fatal PE. For the first 
time in history, the AAOS and ACCP are mostly in alignment in their latest recommen-
dations. Both guidelines now focus on symptomatic events and bleeding risks. There 
should be a balance between efficacy and safety because inappropriate anticoagulation 
results in excessive bleeding. There are still limitations in the published guidelines that 
represent the limitations in the current literature. Further research is needed to identify 
patients at risk of VTE and bleeding. The final decision on ideal thromboprophylaxis 
remains with the treating physician who is most familiar with each patient’s unique 
medical history. The current clinical guidelines provide an orthopaedic surgeon with 
more latitude, and choices of VTE prophylaxis without emphasis on aggressive chemical, 
and often unneeded, prophylaxis. Modern arthroplasty advocates early postoperative 
mobilization and use of mechanical prophylaxis in combination with chemoprophylaxis. 
The key to determining the appropriate chemical prophylaxis for patients is to balance 
safety and efficacy while minimizing bleeding.
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Total knee arthroplasty is a common surgery done by orthopaedic surgeon in symptom-
atic end-stage knee osteoarthritis, which debilitates patients in their functionality. TKA 
procedures have been more increasingly performed worldwide, especially in develop-
ing Asian country such as Indonesia. Despite numerous innovative methodological and 
sophisticated technological advancements in TKA, approximately 20-25% of all patients 
undergoing particular surgery reported dissatisfaction. Several reasons can be account-
able for this, such as implant design, surgical technique, patient selection, as well as 
patients perception (cultural background, expectations on outcome). Focus areas for 
improvement which are addressed can be distinguished in improvement of surgical 
skills, and decision making on which patient needs surgery, what should be considered 
in TKA. More specifically is whether there are any differences in outcome based on the 
background of patients, especially in Asian patients living in Asia.
Patients satisfaction on outcome after TKA is influenced by patient factors, surgical fac-
tors, and postoperative complications. Pre-operative planning, surgical technique, and 
implant choice play an important role in patient satisfaction. Having a good implant-
bone fit and avoid overhang will increase implant survival and patient satisfaction. 
Every knee is unique: the shape, contour, and size. Characteristics of individual knee are 
different between races which, in turn, could influence the compatibility between the 
bone and implant in terms of TKA procedure. For that matter, anthropometry of the knee 
in relation to implant size is important. A retrospective study was done to evaluate dif-
ferences in anthropometric dimensions between Indonesian Asian and Dutch Caucasian 
TKA patients with respect to sizes of nine TKA systems (Vanguard, Genesis II, Persona 
-standard and narrow-, GK Sphere, Gemini, Attune -standard and narrow-, and Sigma 
PFC) (chapter 2). Radiographic anthropometric data on distal femur, proximal tibia, 
and patellar dimension were measured in 67 Caucasian and 67 Asian patients matched 
for age and gender. In anterior-posterior dimension (AP) and medial-lateral dimension 
(ML), the Caucasian femur and tibia are larger than the Asian, but the aspect ratio (ML/
AP) is larger in Asian patients compared to Caucasian patients (both tibia and femur). 
The Asian patients have a relative patella baja compared to the Caucasians. Overall, the 
smallest sizes in the Asian patients could not be matched with any of the nine knee 
systems. To achieve an optimal fit knee-implant, the knee systems should be available in 
a wider range of sizes (i.e. more smaller sizes). With respect to the fit of the implant to the 
natural knee, total knee arthroplasty remains a compromise to nature. Implant overhang 
may cause over-voluming and popliteus tendon impingement and these might result 
in persistent postoperative pain, which leads to deteriorating patient’s satisfaction. 
Therefore, pre-operative planning (implant sizing and implant type) should be done in 
TKA. Implant sizing preoperative and intraoperatively is a must to avoid overhang and 
to achieve implant-bone fit.
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Although patient’s perception and expectation of TKA is subjective, it is very important 
to address and to optimize when a TKA is indicated. Cultural background of patients 
may be of influence on perception and expectation on outcome of TKA. Cultural dif-
ferences between continents, may also affect differences in outcome on interventions. 
For that matter we performed a comparison study between Asian and North American 
population (chapter 3). A retrospective study compared an Asian (76 patients) and 
North American (64 patients) cohort of total knee replacement (TKR) patients. Demo-
graphics, patient recorded outcomes scores (KSS, PAQ, WOMAC), knee range of motion 
(ROM), and radiographic component position were compared. The Asian cohort had 
significantly worse preoperative range of motion, worse KSS function score, and worse 
PAQ pain scores compared to the North American but preoperative KSS knee score and 
WOMAC scores were comparable between the two groups. Postoperatively, WOMAC 
and KSS knee score were better in Asian compared to North American while KSS func-
tion and PAQ were comparable between groups. Even though Asian TKR patients had 
significantly worse preoperative scores, their postoperative outcomes were comparable 
to North Americans. The higher preoperative functional deficit and the higher pain lev-
els in the Asian population might be due to cultural differences and/or socio-economic 
reasons. The latter is probably the reason why Asian patients present with more severe 
conditions in the preoperative consultation for a possible surgical treatment compared 
to North Americans. More research is needed to investigate the difference between 
these cultural impacts, which also exist within the same country, even more between 
different continents, on TKA outcomes.
Beside those patient-associated factors, surgical technique is similarly important. All 
surgeons are urged to improve their surgical technique. Classical surgical techniques 
(gap balancing technique and measured resection technique) have been developed. 
Another technique, hybrid technique, combining the gap balancing and measured re-
section technique was also generally used. But none of those technique is superior than 
the others and still in debate. Another consideration is resurfacing or not resurfacing 
the patella. Anterior knee pain (AKP) after TKA may be an important reason for patient 
dissatisfaction. Both advocates and opponents arise regarding resurfacing or not resur-
facing the patella. The advocates found that AKP will decrease with resurfacing patella, 
but opponents proved that the incidence of AKP was similar with or without patellar 
resurfacing. Some surgeons prefer to do secondary patellar resurfacing in unresurfaced 
patella of TKA to treat AKP postoperatively without considering the actual cause of 
AKP itself. Another technique to reduce AKP is with thermal lesion to the peripatellar 
soft tissue. Patellar electro-cauterization is believed to denervate patellar so it might 
reduce efferent pain signals. Theoretically it should decrease AKP. But this theory should 
be proven clinically. We performed a prospective study to investigate whether there 
is any difference in knee pain relief, functional outcomes, and complications between 
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intraoperative circumferential cauterized and non-cauterized patella on unresurfaced 
simultaneous bilateral TKA (chapter 4). Seventy-three patients (146 knees) were in-
cluded in this study with TKA performed by a single experienced surgeon using cruciate 
retaining prosthesis and fixed bearing insert. Circumferential patellar cauterization was 
performed on the right knee regardless of severity of the arthritis while the left patella 
was treated with debridement and osteophytes excision without cauterization. Evalua-
tions were done with minimum of 2-years follow up by assessing ROM, VAS, KOOS score, 
OKS, Kujala Anterior Knee Pain score, and complications. No differences were found in 
demographic and clinical preoperative characteristics and radiologic severity (Kellgren-
Lawrence grading) between the groups. Mean ROM, VAS, KOOS, OKS, and Kujala knee 
score were improved after surgery in both groups. However, no differences in knee pain, 
functional outcomes, and complications were found between circumferential cauter-
ized and non-cauterized patella in unresurfaced simultaneous bilateral TKA at minimum 
of 2 years follows up. Our study here is an important piece of evidence that patellar 
denervation did not provide any significant benefit in reducing the AKP after TKA.
Alignment in TKA and its effect on outcome is also in debate. Two methods of align-
ment are used in TKA to achieve neutral alignment of the knee: anatomical alignment 
and mechanical alignment. Neither is superior but the majority of surgeons believe 
that mechanical alignment is superior. Both studies proved no difference in functional 
outcome exist between anatomical and mechanical alignment. However, it has recently 
been demonstrated with RSA (micro movements of the knee prosthesis in the bone) 
that a varus state (also with constitutional preop varus) causes more knee prosthesis 
migration. The latest alignment method introduced is kinematic alignment. Kinematic 
alignment aims to restore native pre-arthritic alignment as well as good ligament bal-
ancing which is highly dependent on inter-individual. The normal native knee has a 
constitutional alignment, being either varus or valgus, within 3 degrees of error. Using 
kinematic alignment claimed that it is more likely to achieve this native joint alignment 
even in constitutional varus or valgus aligned knees.
The importance of prosthetic alignment is also influenced by the precision of the 
bone resection, with either alignment technique. To improve this knee alignment goal 
and thus prosthetic alignment, intraoperative instruments are developed. Computer-
assisted surgical (CAS) navigation was developed to accommodate this, but studies 
found several shortcomings (bulky, expensive devices) and no difference in functional 
outcome compared with conventional TKA. Therefore, patient-specific instrumentation 
(PSI) was introduced but also yielded no different functional outcome compared with 
conventional TKA. To answer the shortcomings of CAS and PSI, accelerometer-based 
navigation was introduced. It is a handheld navigation, single-use, sterile device used 
within the operative field to determine the hip center of rotation and the femoral 
mechanical axis. It guides the resection at the appropriate coronal and sagittal planes 
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and validates the alignment accuracy and confirms placement of the femoral and tibial 
component. A systematic review to compare the accelerometer-based navigation with 
conventional TKA was done (chapter 5). Four randomized control trials with fair to bet-
ter quality were included and six non-randomized studies also with fair and better qual-
ity were included. Conflicting evidence of accelerometer-based navigation in reducing 
implant and alignment outliers, with no improvement in patient-reported outcomes or 
reduction of complication were found. We recommend not to widely adopt the use of 
accelerometer-based navigation until proven otherwise. Even with the newest surgical 
technique, no significant functional improvement was found compared with conven-
tional TKA. But the big question arises regarding the best alignment in TKA. Which is the 
best alignment, anatomical alignment, mechanical or kinematic alignment? How many 
degrees of alignment deviation is acceptable and how to evaluate soft tissue balancing 
in TKA?
Finally, we addressed one of the major postoperative complications in TKA. Many factors 
influence the incidence of complications. Body mass Index (BMI), age, and bilateral pro-
cedures increase the incidence of complications. A BMI ≥30.0 kg/m2, age ≥80 years, and 
bilateral procedure were significant risk factors for systemic complications, whereas a 
BMI ≥30.0 kg/m2 is a risk factor for post-operative DVT. Venous thromboembolism (VTE), 
i.e. deep vein thrombosis (DVT) or pulmonary embolism (PE), is the third most com-
mon cardiovascular disease and occurs in 1-2 per 1000 person per year in the general 
population. Of all patients with VTE, around two thirds are diagnosed with DVT and one 
third with PE. In order to minimize this risk, VTE prophylaxis becomes a must in TKA, 
although we do not exactly know which patient is in need for (prolonged) prophylaxis. 
A multimodal approach, using chemical and mechanical prophylaxis with early post-
operative mobilization, are essential in VTE prophylaxis (chapter 6). Chemoprophylaxis 
agents used in VTE prophylaxis are aspirin, warfarin, LMWH, fondaparinux, dabigatran, 
rivaroxaban, and apixaban. The key to determine appropriate chemoprophylaxis agents 
is to balance its efficacy with its risk of bleeding complication and to combine it with 
mechanical prophylaxis in a patient specific mode.
Future research focuses on how to improve patient’s satisfaction by either optimizing 
patient factors, improve surgical factors (such as how to evaluate tissue balancing using 
intra-operative equipment, how to improve component alignment), or optimizing post-
operative care (such as how to reduce postoperative pain, improve rehabilitation, and 
minimize postoperative complication). These studies should be based on Indonesian 
population from an Implant Registry in Indonesia. In the end, “no surgical innovation 
without evaluation” is the only way to improve outcome for our patients.
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future Recommendation
More high-quality studies are needed to improve not only implant survival but also 
patient’s satisfaction and functionality. Furthermore, decreasing postoperative compli-
cations needs (inter)national collaboration and is a must in any medical field. For that 
matter, the IDEAL collaboration, no innovation without evaluation sets the standard. 
International guidelines, with national adaptations, will assist surgeons in better deci-
sion making for their patients. A new implant design that accommodates the anatomical 
features of Asian patients or even 3D printed implants might improve outcomes. But 
even for 3D printed implants, it holds that there is no innovation without evaluation.
Possible future research can focus on:
•	 Surgical	level
 o  Development of an implant registry for Indonesian Hip & Knee and interpreted 
by orthopaedic surgeons. This system can give feedback to the surgeons on the 
outcome of their surgery
 o  Training of surgeons, junior and senior alike when they use a new implant in skills 
labs thus reducing complications
•	 Patient	level
 o  Development of PROMs which are specific for Indonesian patients
 o  Patient’s expectation management
 o  Improved pain management
 o  Improved rehabilitation for OA
•	 Implant	level
 o  3D printed implant and feedback on the ligament balancing based on machine 
learning data or artificial intelligence can be used to give intraoperative feedback 
to the surgeon
 o  High-quality low-cost generic implants will become available, implants are be-
coming a commodity
Conclusions
Up to date, there are insufficient data to create evidence-based results for the TKA 
technique. Level 1 evidence-based studies are required to create recommendations 
and guidelines to increase health care in TKA. Besides, in choosing the best operative 
technique and implant, evidences are also needed (both basic science and clinical) and 
should not be market driven. As for all medical disciplines: no innovation without evalu-
ation, as patient’s safety and outcome are of paramount importance.

Chapter 8
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Totale knie arthroplastiek (TKA) is een veel voorkomende operatie uitgevoerd door 
orthopedisch chirurgen bij ernstige invaliderende klachten van een eindstadium van 
radiologische knie artrose. Ondanks het toenemende aantal TKA-patiënten zijn nog 
steeds 20-25% van de patiënten ontevreden na deze operatie. Hiervoor zijn verschil-
lende redenen verantwoordelijk zoals, implantaat ontwerp, chirurgische techniek, 
patiënt selectie, maar ook de perceptie van patiënten (culturele achtergrond, verwa-
chtingen) over de uitkomst na operatie. Aandachtsgebieden om de uitkomsten na 
TKA voor patiënten te verbeteren kunnen worden onderscheiden in type implantaat, 
methoden ter verbetering van chirurgische vaardigheden, besluitvorming over welke 
patiënt chirurgie of een conservatief beleid nodig heeft, en patiënt’s verwachtingen met 
betrekking de verwachte uitkomst van een behandeling. Specifieker is of er verschil-
len in uitkomst zijn op basis van de achtergrond van patiënten, vooral bij Aziatische 
patiënten die in Azië wonen.
De tevredenheid van patiënten over de uitkomst na TKA wordt beïnvloed door patiënt 
factoren, chirurgische factoren (techniek en implantaat) en postoperatieve complicaties. 
Technische aspecten zoals preoperatieve planning, chirurgische techniek en implantaat 
keuze zijn de klassieke onderwerpen die een belangrijke rol spelen bij de uitkomst na 
een TKA en dus ook de patiënt tevredenheid. Het hebben van een goede implantaat-
gewricht pasvorm, zonder dat het uitsteekt buiten tibia of femur of dat de componenten 
te klein zijn, verminderd niet alleen de klachten bij patiënten, maar verminderd ook de 
kans op loslating. In dat kader, is het belangrijk of de op westerse mensen ontworpen 
knieprothese ook een optimale passing heeft bij Aziaten in Indonesië. Hiervoor werd 
een retrospectief onderzoek gedaan om verschillen in de antropometrische dimensies 
te evalueren tussen de Indonesische Aziaten en Nederlandse westerse TKA-patiënten 
met de dimensies van negen TKA-systemen (Vanguard, Genesis II, Persona-standard 
en Persona-narrow, GK Sphere, Gemini, Attune-standard en Attune-narrow en Sigma 
PFC) (hoofdstuk 2). Radiologische metingen van het distale femur, proximale tibia 
en de patella werden gemeten in 67 Aziatische patiënten, die gematched waren qua 
leeftijd en geslacht met 67 westerse Nederlandse patiënten. In anterieure-posterieure 
dimensie (AP) en mediale-laterale grootte (ML) is het distale femuren de tibia groter bij 
Nederlandse patiënten groter dan bij de Indonesische Aziaten, echter de verhouding 
tussen beide (ML/AP), de dimensie is groter bij de Aziatische, zowel tibia als femur. De 
Aziatische patiënten hebben een relatieve patella baja in vergelijking met de westerse. 
Over het algemeen konden de kleinste maten bij de Aziatische patiënten niet worden 
geëvenaard met een van de negen knie systemen. Gezien de kleinere dimensies die bij 
patiënten aanwezig kunnen zijn, (evenals extreem grote dimensies) zullen kniesyste-
men die uiterste maten meenemen in hun productlijn, zorgen dat er een optimalere 
passing ontstaat van het implantaat. Patiënt specifieke plaatsing zal leiden tot een 
betere uitkomst. Uiteindelijk blijft het verrichten van een totale knie arthroplastiek altijd 
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een compromis met de natuur, niet alleen qua vorm maar vooral met betrekking tot de 
biomechanica.
Hoewel de perceptie en de verwachting van TKA subjectief zijn, is het zeer belangrijk 
om deze te optimaliseren wanneer een TKA wordt aangegeven. De culturele achter-
grond van patiënten kan van invloed zijn op deze perceptie en verwachting van de 
uitkomst na TKA. Culturele verschillen tussen verschillende continenten kunnen ook 
invloed hebben op verschillen in de uitkomst van interventies. Daarom hebben we 
een vergelijking studie uitgevoerd tussen een Aziatische en een Noord-Amerikaanse 
TKA patiënten groep (hoofdstuk 3). Het betrof een retrospectieve studie waarbij een 
Aziatische (76 patiënten) en een Noord-Amerikaanse (64 patiënten) patiëntengroep 
een TKA kreeg van hetzelfde type. Demografische gegevens, patiënt uitkomst scoren, 
zogenaamde PRO (patient reported outcome) waren hetzelfde in beide groepen. De 
scoren die gebruikt werden zijn gewrichten specifiek en betreffen pijn en functie (KSS, 
PAQ, WOMAC), knie beweging (range of motion) en radiologie (i.e. stand postoperatief 
van de prothese). Het Aziatische cohort had een aanzienlijk slechtere preoperatieve 
kniefunctie, KSS-functie Score, en een hogere PAQ pijn (meer pijn) scores in vergelijking 
met de Noord-Amerikaanse patiënten. De preoperatieve KSS knie Score en WOMAC 
scores waren vergelijkbaar tussen de twee groepen. Postoperatief, waren de WOMAC en 
KSS knie Score beter (dus meer functie) in de Aziatische in vergelijking met de Noord-
Amerikaanse patiënten, terwijl de KSS-functie en PAQ pijn vergelijkbaar waren tussen 
groepen. Hoewel Aziatische TKA-patiënten een significant slechtere preoperatieve score 
hadden, waren hun postoperatieve uitkomsten vergelijkbaar met Noord-Amerikanen. 
De slechtere preoperatieve functie en de hogere pijn score in de Aziatische populatie 
kunnen te wijten zijn aan culturele verschillen en/of sociaaleconomische redenen. Dit 
laatste is waarschijnlijk een reden waarom Aziatische patiënten laat vooreen preopera-
tieve consultatie voor een mogelijke chirurgische behandeling komen in vergelijking 
met Noord-Amerikanen. Er is meer onderzoek nodig om het verschil te onderzoeken van 
deze mogelijke culturele en sociale oorzaken. Deze kunnen ook binnen een zelfde land 
bestaan, afhankelijk van zorg systemen, maar ook tussen verschillende continenten.
Naast deze patiënten factoren is de chirurgische techniek belangrijk. Alle chirurgen wor-
den aangespoord om hun chirurgische techniek te verbeteren. Klassieke chirurgische 
technieken (Gap Balancing techniek en gemeten resectie techniek) zijn ontwikkeld in de 
loop der jaren. Een andere techniek, hybride techniek, combineert de knie uitbalanceren 
en gemeten resectie techniek. Maar geen van deze technieken is bewezen superieur 
aan de ander, er bestaat nog steeds discussie. Een andere discussie bij TKA, is wat te 
doen met de patella: resurfacing of niet resurfacing. De aanwezigheid van anterieure 
kniepijn (AKP) na TKA kan een belangrijke reden zijn voor patiënt ontevredenheid. 
Zowel voorstanders als tegenstanders van patella resurfacing hebben nog geen over-
tuigende bewijzen laten zien, wanneer het een of het ander beter is met betrekking tot 
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het voorkomen van AKP, en bij welk type patiënt. Daarom hebben sommige chirurgen 
de voorkeur om een secundaire patellaire resurfacing te doen indien AKP postoperatief 
aanwezig is, echter zonder de eigenlijke oorzaak van AKP te overwegen. Een andere 
techniek om AKP te verminderen is met diathermie, waarbij een thermische laesie rond 
het peripatellaire zachte weefsel wordt aangebracht. Het idee van deze patellaire 
electrocauterisatieis een denervatie waardoor minder efferente pijn signalen worden 
waargenomen. We hebben een prospectieve studie uitgevoerd of er een verschil is in 
pijn gewaarwording, functionele, en complicaties uitkomsten tussen intra-operatieve 
patellaire diathermie en niet-diathermische cauterisatie bij niet geresurfacede patellae 
tijdens een gelijktijdige bilaterale TKA (hoofdstuk 4). 73 patiënten (146 knieën) werden 
opgenomen in deze studie. De TKA werd uitgevoerd door een enkele ervaren chirurg 
met behulp van kruisband sparende knieprothese met een vast lager. Circumferentiële 
patellaire cauterisatie en osteofyt verwijdering werd uitgevoerd van de rechterknie 
ongeacht de ernst van de artrose. De linker patella werd alleen behandeld met osteo-
phyten excisie zonder cauterisatie. Evaluaties werden gedaan gedurende minimaal 2 
jaar follow-up door het beoordelen van ROM, VAS, KOOS Score, Oxford knie Score (OKS), 
Kujala anterieure kniepijn score, en complicatie. Er werden geen verschillen gevonden 
in klinische preoperatieve kenmerken en radiologische ernst van de artrose (Kellgren-
Lawrence-beoordeling) tussen de groepen. Gemiddelde ROM, VAS, KOOS, OKS, en Ku-
jala knie Score waren postoperatief verbeterd in beide groepen. Echter, er waren geen 
verschillen in pijn gewaarwording, functionele, en complicaties tussen de patellaire 
cauterisatie en niet-cauterisatie groepen bij deze gelijktijdig uitgevoerde bilaterale TKA 
patiënten tijdens follow-up.
Een ander discussie punt bij knieprothese chirurgie betreft de chirurgische techniek om 
een TKA uit te lijnen en het effect daarvan op de uitkomst. Twee methoden van uitlijning 
worden gebruikt om een neutrale uitlijning van een knieprothese te krijgen: de anato-
mische en de mechanische knie uitlijning. Welke superieur is, is klinisch niet duidelijk, 
maar de meerderheid van de chirurgen gelooft dat de mechanische uitlijning superieur 
is. Er bestaan echter geen goede studies die bewijst dat de verschil in functionele uitkom-
sten bestaat tussen anatomische en mechanisch uitlijnen van de knie. Wel is er recent 
met RSA (microbewegingen van de knieprothese in het bot) aangetoond dat een varus 
staat (ook bij constitutionele preop varus) meer knieprothese migratie veroorzaakt. De 
meest recente uitlijningmethode is de kinematische uitlijning. Deze methodiek, claimt 
dat elke knie individueel uitgelijnd wordt gebaseerd op een pre-artrose situatie, waarbij 
ook een goede ligamentaire balanceren bereikt wordt. De normale native knie heeft een 
constitutionele uitlijning, ofwel lichte varus of valgus, binnen 3 graden foutmarges. Met 
behulp van de kinematische uitlijningsmethode wordt geclaimd dat deze oorspronkeli-
jke uitlijning van de native knie weer bereikt kan worden, zelfs in constitutionele varus 
of valgus knieën.
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Het belang van knieprothese uitlijning is ook van invloed op de precisie van de botre-
sectie dus positie van de knieprothese, die weer invloed heeft op de overleving van de 
prothese op lange termijn. Ter verbetering van knieprothese uitlijningzijn intraopera-
tieve instrumenten worden ontwikkeld. Computer-Assisted chirurgische (CAS) navigatie 
werd hiervoor ontwikkeld ,maar met verschillende tekortkomingen (grote, dure ap-
paraten), waarbij ook geen evident voordeel was in vergelijking met conventionele TKA. 
Hierna werd patiënt-specifieke instrumentatie (PSI) geïntroduceerd, met eveneens geen 
beter functioneel resultaat in vergelijking met conventionele TKA. Recent werd om de 
tekortkoming van CAS en PSI te beantwoorden, een op een accelerometer gebaseerde 
compacte navigatie geïntroduceerd. Het is een compact (past in hand) navigatie appa-
raat, voor eenmalig gebruik. Dit gesteriliseerde apparaat wordt gebruikt in het operatie , 
eerst wordt het rotatie centrum van de heup bepaald, waarna de mechanische femorale 
as wordt bepaald. Het apparaat begeleidt de botresectie in de juiste coronale en sagit-
tale vlakken en valideert de knie as uitlijning en bevestigt de plaatsing van de femorale 
en tibiale component. Er werd een systematische review van deze op een accelerometer 
gebaseerde navigatie uitgevoerd in vergelijk met een conventionele TKA (hoofdstuk 
5). Uiteindelijk werden vier gerandomiseerde studies geïncludeerd met redelijke tot 
goede kwaliteit en zes niet-gerandomiseerde studies. De studies lieten tegenstrijdige 
uitkomsten zien van op accelerometer gebaseerde navigatie in het verminderen van 
malalignement van implantaten bovendien was er geen verbetering van de door de 
patiënt gemelde uitkomsten en ook geen vermindering van complicaties. We raden aan 
om het gebruik van op accelerometer gebaseerde navigatie niet op grote schaal toe te 
passen voordat er voldoende bewezen voordelen zijn in goed uitgevoerde studies.
Uiteindelijk is er dus zelfs met de nieuwste chirurgische techniek geen evidente func-
tionele verbetering in vergelijk met conventionele TKA. Maar de belangrijkste vraag 
met betrekking tot uitlijning in TKA is: wat is de beste uitlijning, anatomische uitlijning, 
mechanische of kinematische uitlijning? Hoeveel mag de knie en dus been uitlijning 
afwijking van “neutraal” en wat is “neutraal” en wat is aanvaardbaar qua afwijking aan de 
weke delen rond de knie, voordat er klachten ontstaan?
Ten slotte werden belangrijke postoperatieve complicatie in TKA onderzocht. Veel 
factoren beïnvloeden het voorkomen van complicaties. Body Mass Index (BMI), leeftijd 
en een bilaterale knieprocedure in één chirurgische sessie verhogen de incidentie van 
complicaties. De betreffende afkapwaarden, waarboven meer kans op complicaties 
optreed zijn: BMI >30,0 kg/m2, leeftijd > 80 jaar, en bilaterale procedure in één sessie 
waren significante risicofactoren. Veneuze trombo-embolie, diepe veneuze trombose 
(DVT) en longembolie, behoort tot de op 3 van cardiovasculaire ziekten en treedt op 
bij 1-2 per 1000 personen in de algemene bevolking. Van deze patiënten heeft 2/3 
een DVT en 1/3 een longembolie. De mortaliteit is 12% in 1 jaar. Na een DVT ontwik-
kelt 50% van de patiënten een post trombotisch syndroom. Om dit risico op DVT te 
135
Dutch summary / Samenvatting
Ch
ap
te
r 8
minimaliseren, is trombose profylaxe belangrijk TKA chirurgie. Alleen hebben niet alle 
patiënten het nodig, maar onderzoek naar welke groep een hoog risico heeft en dus 
trombose profylaxe is niet bekend. Momenteel vindt risicostratificatie onderzoek plaats, 
om zodoende in de toekomst maatwerk, patiënt specifieke, profylaxe te kunnen geven. 
Een multimodale aanpak, met behulp van chemische en mechanische profylaxe met 
vroege postoperatieve mobilisatie, is essentieel bij VTE-profylaxe (hoofdstuk 6). Che-
moprofylaxis middelen die worden gebruikt bij VTE profylaxe zijn aspirine, warfarine, 
LMWH, fondaparinux, dabigatran, rivaroxaban en apixaban. De sleutel tot het bepalen 
van de juiste chemoprofylaxe medicamenten is een veilig evenwicht creëren tussen de 
werkzaamheid van trombose preventie en het vermijden van het risico op bloedingen 
complicaties. Dit eventueel in combinatie met mechanische onderbeen compressie 
profylaxe bij specifieke patiënten, kortom maatwerk bij hoog risico patiënten.
Toekomstig onderzoek naar uitkomsten van knieprothese chirurgie zal zich onder an-
dere richten op het preoperatief kunnen voorspellen welke patiënt veel nut zal hebben 
van een bepaald type interventie, zoals conservatief, osteotomie, unicondylaire, totale 
knieprothese. Omdat het uiteindelijke doel is tevredenheid van de patiënt bij deze 
electieve operaties. Hierbij moeten patiënt factoren (i.e. co morbiditeit, verwachting 
etc.), chirurgische factoren (i.e. knie as, stabiliteit, infectiekans etc.) en postoperatieve 
revalidatie (i.e. postoperatieve pijn minimaliseren, revalidatie verbeteren, complicaties) 
geoptimaliseerd worden.
Deze studies moeten gedaan worden op basis van de Indonesische bevolking, waarbij 
data uit een Implantaat Register in Indonesië, een belangrijke bijdrage kan leveren 
aan de kwaliteit van zorg verbetering voor de patiënt door de orthopedisch chirurg. 
Uiteindelijk is er geen chirurgische innovatie mogelijk zonder evaluatie, dit is de enige 
voorwaarde die zal leiden tot een verbeterde uitkomst voor onze patiënten.
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Pergantian sendi lutut total (total knee arthroplasty, TKA) adalah operasi yang sering 
dilakukan pada osteoarthritis (OA) lutut tahap lanjut yang menghambat fungsionalitas 
pasien. Meskipun jumlah TKA semakin meningkat, tingkat ketidakpuasan pasien masih 
sekitar 20-25%. Ada beberapa alasan yang dapat menyebabkan hal tersebut seperti 
desain implan, teknik operasi, pemilihan pasien, dan persepsi pasien (latar belakang 
budaya, ekspektasi terhadap hasil). Untuk meningkatkan kepuasan pasien, diperlukan 
peningkatan pada kemampuan operasi, pengambilan keputusan mengenai pasien 
mana yang membutuhkan operasi, dan hal-hal yang perlu dipertimbangkan di dalam 
TKA, khususnya pada perbedaan luaran pada pasien Asia.
Kepuasan pasien pasca TKA dipengaruhi oleh faktor pasien, teknik operasi, dan 
komplikasi pascaoperasi. Perencanaan praoperasi, teknik operasi, dan pemilihan 
implan juga berperan penting dalam kepuasan pasien. Implan yang sesuai dengan 
bentuk tulang dan tidak overhang akan meningkatkan kesintasan implan dan kepuasan 
pasien. Oleh karena itu, antropometri lutut dan hubungannya dengan ukuran implant 
sangatlah penting. Studi retrospektif dilakukan untuk menilai perbedaan ukuran 
antropometri antara pasien-pasien TKA Asia-Indonesia dan Kaukasoid-Belanda dan 
dibandingkan dengan ukuran sembilan sistem TKA yang berbeda (Vanguard, Genesis II, 
Persona – standard dan narrow, GK Sphere, Gemini, Attune – standard dan narrow, dan 
Sigma PFC) (Bab 2). Data antropometri radiografi pada femur distal, tibia proksimal, dan 
patela diperoleh dari 67 pasien Kaukasoid dan 67 pasien Asia yang disamakan usia dan 
jenis kelaminnya. Pada dimensi antero-posterior (AP) dan medio-lateral (ML), ukuran 
femur dan tibia pasien Kaukasoid lebih besar daripada Asia, tetapi aspek perbandingan 
(ML/AP) pasien Asia lebih besar daripada Kaukasoid baik pada tibia maupun femur. 
Pasien Asia relatif memiliki patella baja bila dibandingkan dengan Kaukasoid. Secara 
keseluruhan, ukuran terkecil pada pasien Asia tidak cocok dengan kesembilan sistem 
TKA. Untuk mencapai implan lutut yang optimal, harus disediakan ukuran implan lutut 
yang lebih beragam (yaitu ukuran yang lebih kecil). Selain itu, penyesuaian pun harus 
dilakukan pada TKA untuk mendapatkan implan yang sesuai dengan lutut alamiah. 
Overhang pada implan akan meningkatkan volume dan menekan tendon popliteus, 
yang akan menyebabkan nyeri menetap pascaoperasi dan menurunkan tingkat 
kepuasan pasien. Oleh karena itu, harus dilakukan perencanaan praoperasi (jenis dan 
ukuran implan) pada TKA. Pengukuran implan pra- dan intraoperatif wajib dilakukan 
untuk menghindari overhang dan menghasilkan implan yang sesuai dengan tulang.
Pada saat akan dilakukan TKA, persepsi dan ekspektasi pasien pascaoperasi perlu 
dikontrol dan dioptimalkan walaupun hal itu bersifat subjektif. Latar belakang budaya 
pasien dapat mempengaruhi persepsi dan ekspektasi terhadap hasil operasi TKA. 
Perbedaan budaya antar benua juga dapat memengaruhi perbedaan hasil intervensi. 
Untuk itu, kami melakukan sebuah studi perbandingan antara populasi Asia dan 
Amerika Utara (Bab 3). Studi kohort retrospektif dilakukan untuk membandingkan 
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76 pasien Asia dan 64 pasien Amerika Utara yang menjalani operasi pergantian sendi 
lutut total. Data demografis, skor luaran pasien (KSS, PAQ, WOMAC), rentang gerakan 
lutut (ROM), dan posisi komponen secara radiografi dibandingkan dalam studi ini. Grup 
pasien Asia memiliki ROM, skor fungsi KSS, dan nyeri PAQ praoperasi yang lebih buruk 
dibandingkan dengan grup Amerika Utara, tetapi skor KSS dan WOMAC praoperasi 
sebanding antara kedua grup. Pascaoperasi, skor KSS dan WOMAC pada grup Asia lebih 
baik bila dibandingkan dengan grup Amerika Utara, sedangkan skor PAQ dan fungsi KSS 
sebanding antara kedua grup. Meskipun pasien Asia memiliki skor praoperasi yang lebih 
buruk, hasil pascaoperasi sebanding dengan pasien Amerika Utara. Defisit fungsi dan 
tingkat nyeri praoperasi yang lebih tinggi pada populasi Asia dapat disebabkan oleh 
perbedaan budaya dan/atau faktor sosioekonomi. Alasan sosioekonomi inilah yang 
mungkin menjadi alasan mengapa pasien Asia memiliki kondisi yang lebih buruk pada 
saat datang untuk konsultasi praoperasi dibandingkan dengan pasien di Amerika Utara. 
Studi lebih lanjut diperlukan untuk meneliti dampak perbedaan budaya ini terhadap 
hasil akhir TKA, dimana bahkan dalam satu negara pun ditemukan perbedaan ini, 
terlebih lagi antar benua.
Selain faktor-faktor pasien, teknik operasi juga memegang peranan penting. Semua 
ahli bedah diharuskan untuk meningkatkan teknik bedah mereka. Teknik bedah klasik 
(teknik gap balancing dan measured resection) telah banyak digunakan. Teknik lain, 
yaitu teknik hybrid (kombinasi teknik gap balancing dan measured resection) juga sering 
digunakan. Namun, tidak ada satu teknik pun yang lebih unggul daripada teknik lain 
dan hal ini masih menjadi perdebatan. Perdebatan lain yang juga muncul adalah apakah 
perlu untuk meresurfasi patela atau tidak. Nyeri lutut anterior pasca TKA merupakan 
salah satu faktor penting penyebab ketidakpuasan pasien. Pro dan kontra pun muncul 
mengenai perlu atau tidaknya meresurfasi patela. Pendukung prosedur ini menyatakan 
bahwa nyeri lutut anterior akan berkurang dengan meresurfasi patela, tetapi penentang 
prosedur ini dapat menunjukkan tidak ada perbedaan insidensi nyeri lutut anterior 
dengan atau tanpa resurfasi patela. Beberapa ahli memilih untuk melakukan resurfasi 
patela sekunder, pada patela yang tidak diresurfasi untuk mengobati nyeri lutut anterior 
pascaoperasi tanpa mempertimbangkan penyebab nyeri lutut anterior itu sendiri. 
Teknik lain yang dapat dilakukan sebagai upaya mengurangi nyeri lutut anterior adalah 
denervasi patela, yaitu dengan memberikan lesi termal pada jaringan lunak peripatela. 
Kauterisasi peripatela tersebut dipercaya dapat mengurangi sinyal eferen dari jaringan 
peripatela, sehingga dapat mengurangi gejala nyeri lutut anterior. Secara teoretis, 
hal ini seharusnya mengurangi nyeri lutut anterior, tetapi teori ini harus dibuktikan 
secara klinis. Oleh karena itu, kami melakukan studi prospektif untuk menilai apakah 
ada perbedaan nyeri, fungsi, dan komplikasi antara patela yang dikauterisasi dan tidak 
pada TKA bilateral simultan tanpa resurfasi (Bab 4). Tujuh puluh tiga pasien (146 lutut) 
diikutsertakan dalam studi ini untuk menjalani TKA yang dilakukan oleh satu orang 
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ahli bedah berpengalaman, menggunakan prostesis cruciate retaining dan insert fixed 
bearing. Kauterisasi sirkumferensial hanya dilakukan pada lutut kanan dengan segala 
tingkat keparahan arthritis yang ada, sedangkan pada lutut kiri dilakukan debridement 
dan eksisi osteofit tanpa kauterisasi. Evaluasi dengan rentang waktu minimal 2 tahun 
dilakukan dengan menilai ROM, VAS, skor KOOS, skor lutut Oxford (OKS), skor nyeri 
lutut anterior Kujala, dan komplikasi. Dari studi ini, didapatkan tidak ada perbedaan 
karakteristik klinis praoperasi dan tingkat keparahan radiologis (skor Kellgren-Lawrence) 
antar kedua grup. Rerata ROM, VAS, KOOS, OKS, dan skor Kujala membaik pascaoperasi 
pada kedua grup. Namun, tidak ditemukan perbedaan nyeri lutut, fungsi, dan komplikasi 
antara patela yang dikauterisasi dan tidak dikauterisasi pada TKA bilateral simultan 
tanpa resurfasi selama evaluasi minimum 2 tahun.
Alignment pada TKA dan pengaruhnya terhadap hasil masih menjadi perdebatan. Dua 
metode yang digunakan dalam TKA untuk mencapai alignment yang netral adalah: 
alignment anatomis dan mekanis. Tidak ada yang lebih unggul antara satu sama lain, 
tetapi banyak ahli bedah yang meyakini bahwa alignment mekanis lebih unggul. 
Hasil studi menunjukkan tidak ada perbedaan fungsi antara alignment anatomis dan 
mekanis. Namun, penelitian dengan RSA (gerakan mikro dari prostesis lutut di tulang) 
menunjukkan bahwa kondisi lutut yang varus (dan juga varus konstitusional praoperasi) 
menyebabkan migrasi prostesis lutut yang lebih banyak. Metode alignment terkini 
yang dipergunakan adalah alignment kinematis. Alignment kinematis bertujuan untuk 
mengembalikan alignment alami seperti pra-artritis dan juga keseimbangan ligamen 
yang baik yang berbeda antar individu. Sendi lutut yang normal memiliki alignment 
konstitusional, baik varus ataupun valgus, sebanyak kurang lebih 3 derajat. Penggunaan 
alignment kinematis akan memungkinkan kita untuk mencapai alignment sendi yang 
alamiah, baik varus atau valgus konstitusional.
Alignment prostesis juga dipengaruhi oleh ketepatan reseksi tulang dalam teknik 
alignment manapun yang digunakan. Untuk memperbaiki alignment lutut dan 
prostesis, dikembangkanlah beberapa instrumen intraoperatif. Navigasi operasi 
berbasis komputer (computer-assisted surgery, CAS) dikembangkan untuk mencapai 
hal tersebut, tetapi studi menunjukkan beberapa kekurangan (alat yang besar dan 
mahal) dan tidak ada perbedaan pada fungsi pascaoperasi dibandingkan dengan TKA 
konvensional. Oleh karena itu, instrumentasi yang spesifik pada pasien (patient-specific 
implant, PSI) diperkenalkan. Akan tetapi PSI juga tidak memberikan perbedaan fungsi 
pascaoperasi dibandingkan dengan TKA konvensional. Untuk menjawab kekurangan 
CAS dan PSI inilah, kemudian diperkenalkan navigasi berbasis akselerometer. Alat ini 
berupa navigasi yang dapat digenggam, sekali pakai dan steril, yang digunakan pada 
lapangan operasi untuk menentukan pusat rotasi sendi panggul dan sumbu mekanis 
femur. Alat ini memandu reseksi tulang pada bidang sagital dan koronal sesuai yang 
diinginkan, serta memastikan ketepatan alignment dan kedudukan komponen 
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femur dan tibia. Kami melakukan kajian sistematis untuk membandingkan navigasi 
berbasis akselerometer dengan TKA konvensional (Bab 5). Kajian tersebut mencakup 
empat uji klinis terandomisasi dengan kualitas sedang dan baik, dan 6 studi tanpa 
randomisasi dengan kualitas sedang dan baik diikutsertakan dalam penelitian ini. 
Kami menemukan hasil yang bertentangan pada navigasi berbasis akselerometer 
dalam mengurangi outliers implan dan alignment, dan tidak ada perbedaan luaran 
pasien dan komplikasi dengan TKA konvensional. Kami merekomendasikan untuk tidak 
mengadopsi penggunaan navigasi berbasis akselerometer secara luas sampai terbukti 
sebaliknya. Bahkan dengan teknik bedah terbaru sekalipun, tidak ada perbedaan fungsi 
pascaoperasi antara navigasi berbasis akselerometer dengan TKA konvensional. Namun, 
yang menjadi sebuah pertanyaan besar adalah alignment manakah yang terbaik dalam 
TKA: alignment anatomis, mekanis, atau kinematis? Seberapa besar derajat deviasi yang 
masih dapat diterima dan bagaimana cara mengevaluasi keseimbangan jaringan lunak 
pada TKA?
Pada akhirnya, banyak faktor yang memengaruhi terjadinya komplikasi pasca TKA 
yang harus ditangani. Indeks massa tubuh (IMT), usia, dan prosedur bilateral dapat 
meningkatkan insidensi komplikasi. IMT ≥30.0 kg/m2, usia > 80 tahun, dan prosedur 
bilateral adalah faktor risiko yang signifikan untuk terjadinya komplikasi sistemik, 
sedangkan IMT ≥30.0 kg/m2 adalah faktor risiko untuk trombosis vena dalam (deep 
vein thrombosis, DVT) pascaoperasi. Tromboembolisme vena (venous thromboembilism, 
VTE), yaitu DVT atau emboli paru (pulmonary embolism, PE), merupakan penyakit 
kardiovaskular ketiga terbanyak dan terjadi pada 1-2 per 1000 orang per tahun dalam 
populasi umum. Dari semua pasien penderita VTE, sekitar duapertiga didiagnosis 
dengan DVT dan sepertiga dengan PE. Untuk meminimalkan risiko ini, profilaksis VTE 
merupakan suatu keharusan pada TKA, meskipun kita tidak mengetahui secara pasti 
pasien mana yang membutuhkan profilaksis jangka panjang. Pendekatan multimodal, 
menggunakan profilaksis kimiawi dan mekanis dengan mobilisasi segera pascaoperasi, 
sangatlah penting dalam mencegah VTE (Bab 6). Agen kemoprofilaksis yang digunakan 
untuk profilaksis VTE adalah aspirin, warfarin, LWMH, fondaparinux, dabigatran, 
rivaroxaban, dan apixaban. Kunci dalam menentukan agen kemoprofilaksis yang sesuai 
adalah mempertimbangkan keseimbangan antara efektivitas obat dengan resiko 
perdarahan dan mengkombinasikan dengan profilaksis mekanis pada setiap individu.
Penelitian ke depan harus berfokus pada bagaimana meningkatkan kepuasan pasien 
dengan cara mengoptimalkan faktor pasien, meningkatkan faktor bedah (bagaimana 
cara mengevaluasi keseimbangan jaringan menggunakan peralatan intraoperatif dan 
cara memperbaiki alignment komponen), atau mengoptimalkan perawatan pascaoperasi 
(meminimalkan nyeri pascaoperasi, memperbaiki rehabilitasi, dan meminimalkan 
komplikasi pascaoperasi). Studi-studi ini harus didasarkan pada populasi Indonesia dari 
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Registrasi Implan di Indonesia sendiri. Pada akhir kata, “tidak ada inovasi tanpa evaluasi” 
merupakan satu-satunya cara untuk meningkatkan luaran untuk pasien kita.
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CuRRICuLuM VITAe
Nicolaas Cyrillus Budhiparama was born in Medan, Indonesia on February 9th 1961.
He earned his medical doctor degree from University of North Sumatera in 1986. He 
began his training to be an orthopedic surgeon in Leiden in October 1987 under Prof. 
Dr. P. M. Rozing. Subsequently, he trained as a general surgeon in Westeinde ZH in Den 
Haag under the late Dr. Bob Koumans. In 1989, he returned to Leiden until he finished 
his training in 1993. After graduation, he worked as a full staff member and temporarily 
took the place of chef de clinique.
In 1994, he was asked to work in Indonesia and initiated the collaboration between 
University of Indonesia and University of Leiden in 1996. His interest in performing adult 
reconstructive surgery led to several fellowships in Europe and USA.
During his career, he has organized a lot of world class meetings, invited to speak at 
both National and International forums and appointed to be the board of directors and 
committees of several elite world organizations. He has founded several organizations, 
serves as Founding Godfather for Global Campaigns and Presidents for various orthope-
dic societies. Regarding his concern for promoting education and advancing research, 
he has founded Nicolaas Institute of Constructive Orthopedic Research and Education 
Foundation for Arthroplasty and Sports Medicine. His charitable foundation has funded 
the Paolo Aglietti Award and The Knee Travelling Fellowship at ISAKOS. He has multiple 
international research collaborations and publications to date.
In 2020, he will be the President of 3 Asia Pacific orthopaedic societies concurrently, 
namely Asia Pacific Arthroplasty Society (APAS), Asia Pacific Knee Society (APKS), and 
Arthroplsty Society in Asia (ASIA).
PoRTfoLIo
1. fellowships
•	 	Stanford	Fellowship	for	Arthroplasty,	Palo	Alto	(USA)	under	Prof.	William	J.	Maloney
•	 	Cotrel	Fellowship,	Paris	(France),	under	Prof.	Dubousset	and	Dr.	Chopin
•	 	AFOR	Fellowship,	Germany	and	Switzerland,	under	Prof.	Mittelmeier	and	Prof.	Trentz
•	 	St.	Vincent’s	Hospital,	Melbourne	(Australia),	under	Prof.	Peter	F.	Choong
2. Visiting fellowships
•	 	Harvard	Medical	School,	Boston,	(USA)	under	Prof.	Richard	Scott	and	Prof.	Thomas	S.	
Thornhill
•	 	Lennox	Hill	Hospital,	New	York	(USA),	under	Prof.	Chitranjan.	S.	Ranawat
•	 	Colorado	Joint	Replacement,	Denver	(USA),	under	Prof.	Douglas	A.	Dennis
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3. Current Positions
•	 	Founder	&	Chairman	of	Nicolaas	 Institute	of	Constructive	Orthopaedic	Research	&	
Education Foundation for Arthroplasty & Sports Medicine
•	 	1	of	18	Founding	Godfathers	of	ISAKOS	Global	Connection	Campaign
•	 	Founding	Chairman	and	Past	President	of	IHKS	(Indonesian	Hip	and	Knee	Society)
•	 	Founding	Chairman	and	Past	President	of	AAA	(ASEAN	Arthroplasty	Association)
•	 	President	for	APKS	(Asia	Pacific	Knee	Society)	2019	-	2021
•	 	President	for	ASIA	(Arthroplasty	Society	in	Asia)	2019	–	2020
•	 	President	Elect	for	APAS	(Asia	Pacific	Arthroplasty	Society)	2018	–	2020
•	 	Past	President	of	PEROSI	(Indonesian	Osteoporosis	Association)	2014	-	2017
•	 	Declarator	 of	 Beijing	Declaration	 at	 International	 Presidents’	 Forum	 to	 establish	 a	
World Orthopaedic Alliance (WOA)
•	 	Board	of	Directors	for	ISAKOS	(International	Society	of	Arthroscopy,	Knee	Surgery	&	
Orthopaedic Sports Medicine)
•	 	Consultant	for	Executive	Committee	for	ISAKOS
•	 	Deputy	Chair	of	Strategic	Planning	Committee	for	ISAKOS
•	 	Chairman	of	Development	Committee	for	ISAKOS
•	 	Board	of	Program	Committee	for	ISAKOS
•	 	Board	 of	 Scientific	 Committee	 for	WAIOT	 (World	 Association	 against	 Infection	 in	
Orthopaedics and Traumatology)
•	 	Board	of	Committee	of	APOA	(Asia	Pacific	Orthopaedic	Association)
•	 	Board	of	Committee	of	APKS	(Asia	Pacific	Knee	Society)
•	 	Board	of	Committee	of	APAS	(Asia	Pacific	Arthroplasty	Society)
•	 	Country	Representative	for	APHS	(Asia	Pacific	Hip	Society)
•	 	Expert	Council	for	IOA	(Indonesian	Orthopaedic	Association)
•	 	Expert	Council	for	PRSI	(Indonesian	Swimming	Federation)
•	 	Board	of	Congress	Program	Committee	for	APKASS	(Asia	Pacific	Knee,	Arthroscopy	&	
Sports Medicine Society)
•	 	Board	of	Committee	of	EFORT	Asia	(European	Federation	of	National	Associations	of	
Orthopaedic and Traumatology)
•	 	Global	Chair	for	ICJR	(International	Congress	for	Joint	Reconstruction)
•	 	Committee	member	of	ICHOM	(International	Consortium	for	Health	Outcomes	Mea-
surement) Hip & Knee Osteoarthritis Working Group
•	 	Regional	 representative	 at	 International	 Periprosthetic	 Joint	 Infection	 Consensus	
Meeting - 2018
•	 	Honorable	advisor	for	ASSA	(ASEAN	Society	for	Sports	Medicine	&	Arthroscopy)
•	 	Scientific	Committee	Director	of	Arthroplasty	Society	in	Asia	(ASIA)
•	 	Head	of	Department	of	Orthopaedic	Surgery	at	Medistra	Hospital,	Jakarta	–	Indone-
sia
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4. Academic Posts
•	 	Ass.	 Professor	 at	Department	of	Orthopaedic	 at	 Leiden	University	Medical	Center,	
The Netherlands
•	 	Visiting	Professor	at	Medical	School	of	Chinese	People’s	Liberation	Army,	Beijing	–	
China
•	 	Faculty	for	ICJR	(International	Congress	for	Joint	Reconstruction)
•	 	Global	Faculty	for	AO	Reconstruction
•	 	Senior	Lecturer	for	School	of	Medicine	of	University	of	Gajah	Mada,	Jogjakarta	–	In-
donesia
•	 	Senior	Lecturer	for	School	of	Medicine	of	University	of	Airlangga,	Surabaya	-	Indone-
sia
•	 	Senior	Lecturer	for	School	of	Medicine	of	University	of	Pelita	Harapan,	Jakarta	-	Indo-
nesia
•	 	Chairman	of	Committee	for	National	&	Foreign	Affairs	for	 Indonesian	Collegium	of	
Orthopaedic & Traumatology
•	 	Chairman/PIC	 for	 Collaboration	 between	 Indonesia	 Collegium	 of	 Orthopaedic	 &	
Traumatology and Australian Orthopaedic Association
•	 	Examiner	 for	 Indonesian	National	Orthopaedic	Board	Exams	 for	 Indonesian	Colle-
gium of Orthopaedic & Traumatology
•	 	Fellowship	Committee	and	Instructor	for	Indonesian	Hip	&	Knee	Society	Fellowship	
Program
5. editorial Posts
•	 	Associate	Editor	in	Chief	for	Arthroplasty	–	official	journal	for	ASIA
•	 	Associate	Editor	for	AJO	(The	American	Journal	of	Orthopedics)
•	 	Editorial	Board	Representative	for	OJSM	(Orthopaedic	Journal	of	Sports	Medicine)	–	
open access journal by AOSSM (American Orthopaedic Society for Sports Medicine)
•	 	Editorial	Board	for	International	Journal	of	Musculoskeletal	Infection
•	 	Editorial	Board	for	CIOS	(Clinics	In	Orthopaedic	Surgery)
•	 	Corresponding	Editor	for	JOS	(Journal	for	Orthopaedic	Surgery)
•	 	Editorial	Board	for	Arthropaedia
•	 	Reviewer	for	CORR	(Clinical	Orthopaedic	and	Related	Research)
•	 	Reviewer	for	JOA	(Journal	of	Arthroplasty)
•	 	Reviewer	for	AJSM	(American	Journal	of	Sports	Medicine)
•	 	Reviewer	 for	 KSSTA	 (Knee	 Surgery,	 Sports	 Traumatology	 &	 Arthroscopy)	 –	 official	
journal for ESSKA (European Society of Sports Traumatology Knee Surgery and 
Arthroscopy)
•	 	Reviewer	for	JISAKOS	(Journal	of	ISAKOS)
•	 	Reviewer	for	Knee	journal
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•	 	Member	of	ASBMR	(American	Society	of	Bone	Mineral	&	Research)	International	Task	
Force to address “Systems Approaches to Osteoporotic Fracture Secondary Preven-
tion”
•	 	Editor	of	ASEAN	Arthroplasty	Association	(AAA)	Comprehensive	Hip	&	Knee	Textbook	
1st Edition
6. Presentations
2019
Keynote Speaker and moderator
o Launch of Arthroplasty Journal. The 12th Congress of Chinese Association of Ortho-
paedic Surgeons (CAOS), Beijing, China
o Knee Arthroplasty. The 7th ICJR, Dubai, United Arab Emirates
o Return to Sports Post Injury for World Class Athletes. The 67th COE of IOA, Solo, Indo-
nesia
o The 12th Congress of Chinese Association of Orthopaedic Surgeons, Beijing, China
	 •	 	New	Technology:	Is	the	Latest	Always	The	Greatest?
	 •	 	Periprosthetic	Fractures	of	the	Lower	Extremities:	Global	Trends	&	Challenges
o Total Knee Arthroplasty at 11th JOSKAS Congress in Sapporo, Japan
o Total Knee Arthroplasty in Principles of Total Hip & Knee Arthroplasty at AO Recon 
course, in Jakarta, Indonesia
o Combined 6th IHKS – 11th APKS - APIS Meeting in Yogyakarta, Indonesia
	 •	 	New	Technology	in	TKR:	Is	The	Latest	Always	The	Greatest?
	 •	 	Management	of	Acute	PJI,	DAIR	or	Not?
	 •	 	How	Does	The	Modern	Knee	Design	Improve	Patient	Outcomes?
	 •	 	Controversial	Issues	Discussions	on	Arthroplasty
	 •	 	PJI	Session
	 •	 	Meet	The	Experts	in	Arthroplasty
o Primary TKA: Why do They Go Wrong? 20th APAS Meeting in Xiamen, China
o New Technology in TKR: Is The Latest Always The Greatest. The 41st Australian Knee 
Society Meeting, Canberra, Australia
o New Technology in TKR: Is The Latest Always The Greatest? The 7th ASIA Meeting & AO 
Recon Seminar, South Korea
Invited speaker
o Comparing the Outcome of Circumferential Patellar Denervation in Unresurfaced Si-
multaneous Bilateral Total Knee Arthroplasty. The 7th European Knee Society Closed 
Meeting, Megeve, France
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o The 7th ICJR ME Dubai, United Arab Emirates
	 •	 	Comparing	the	Outcome	of	Circumferential	Patellar	Denervation	in	Unresurfaced	
Simultaneous Bilateral TKA
	 •	 	The	Real	Value	of	DAIR:	What	does	the	2018	consensus	say?
o The 12th ISAKOS Congress, Cancun, Mexico
	 •	 	Target	for	Appropriate	Alignment
	 •	 	The	Role	of	New	Technologies
	 •	 	DAIR:	What	does	the	2018	consensus	say?
	 •	 	Extensor	Mechanism	Rupture?
o Limb Alignment & Kinematics. AO Recon course, Jakarta, Indonesia
o Return to Sports After Knee Injury for World Class Athlete. University of Sumatra 
Utara 67th Anniversary, Medan, Indonesia
o The 20th APAS Meeting, Xiamen, China
	 •	 	Comparing	the	Outcome	of	Circumferential	Patella	Denervation	in	Unresurfaced	
Simultaneous Bilateral TKA
	 •	 	Does	 Accelerometer-Based	 Navigation	 have	 any	 Clinical	 Benefit	 compared	 to	
Conventional TKA?
o The 79th AOA ASM Meeting, Canberra, Australia
	 •	 	New	Technology	in	TKR:	Is	The	Latest	Always	The	Greatest
	 •	 	He	Who	DAIRS	Wins
o Comparing the Outcome of Circumferential Patella Denervation in Unresurfaced 
Simultaneous Bilateral TKA. The 41st Australian Knee Society Meeting, Canberra, 
Australia
o Navigated Assisted TKA: The Specific Indications. The 20th ASIA Meeting & AO Recon 
Seminar, South Korea
Instructor
o IHKS Fellowship Training, Surabaya, Indonesia
	 •	 	Basic	Total	Knee	Arthroplasty
	 •	 	Tribological	and	Implant	Design
o Total Hip & Knee Arthroplasty. Principles of Total Hip and Knee Arthroplasty. AO 
Recon, Jakarta, Indonesia.
Panelist
o Challenging Case – Total Knee Arthroplasty. The 7th ICJR, Dubai, United Arab Emirates
o Hip Panel Discussion: Meeting The Experts. The 20th APAS, Xiamen, China
o VOC on Robotics by DePuy J&J, Singapore
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2018
Course chairman/director
o The 20th Asia Pacific Orthopedic Association Congress, Antalya, Turkey
Keynote Speaker and moderator
o Hip Arthroplasty. The 6th ICJR ME, Dubai, United Arab Emirates
o Hip Arthroplasty. The 2nd World Arthroplasty Congress, Rome, Italy
o Revision and Complications of Knee Replacement. The 78th AOA & APKASS Meeting, 
Sydney, Australia
Invited speaker
o The 6th ICJR ME, Dubai, United Arab Emirates
	 •	 	Early	Revision	of	PJI:	What	is	The	Real	Value	of	DAIR?
	 •	 	Periprosthetic	Fracture	around	the	Knee:	Is	Arthroplasty	an	Option?
	 •	 	Effective	Methods	to	Prevent	Hip	Dislocation
o The 20th Asia Pacific Orthopedic Association Congress, Antalya, Turkey
	 •	 	Periprosthetic	Fractures	around	Tibial	Component	of	TKR
	 •	 	The	Real	Value	or	Early	Revision:	DAIR	–	Indications	and	Limitations
	 •	 	Measured	Resection	&	Manual	Release
o Current Updates in Computer Navigation for TKA. The 2nd World Arthroplasty Con-
gress, Rome, Italy
o The 6th Annual Meeting of Emirates International Orthopedic Congress, Dubai, UAE
	 •	 	Gap	Balance	vs	Measured	Resection	Technique
	 •	 	The	Real	Value	of	Early	Revision:	DAIR	–	Indications	&	Limitations
o The 78th AOA & APKASS Meeting 2018 in Sydney, Australia
	 •	 	Should	we	resurface	the	patella	in	TKR?
	 •	 	Management	of	periprosthetic	infection:	the	role	of	DAIR
o AO Recon, Singapore
	 •	 	Extensor	Mechanism	failure	and	patellofemoral	complications
	 •	 	Periprosthetic	fractures	around	the	knee
o The 2nd Consensus Meeting 2018 on PJI, Philadelphia, USA
	 •	 	Is	Undergoing	a	colonoscopy	or	upper	GI	endoscopy	after	Total	Joint	Arthroplasty	
associated with an increased risk of SSI/PJI? If yes, does antibiotic prophylaxis 
prior to a colonoscopy or upper GI endoscopy after Total Joint Arthroplasty re-
duce the risk of SSI/PJI?
	 •	 	Can	Debridement,	Antibiotics,	 and	 Implant	Retention	 (DAIR)	be	Utilized	 in	 the	
Treatment of Acute PJI with a Megaprosthesis?
	 •	 	What	is	the	Definition	of	PJI	of	the	Knee	and	the	Hip?	Can	the	Same	Criteria	Be	
Used for Both Joints?
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o The 19th APAS, Bangkok, Thailand
	 •	 	Early	Revision	of	PJI	Revision:	What	is	the	Real	Value	or	DAIR?
	 •	 	Does	New	Technology	in	TKA	Improve	Patient’s	Outcome?
o The 18th Journées Lyonnaises de Chirurgie du Genou, Lyon, France
	 •	 	Revision	for	Periprosthetic	Fracture:	Specific	management	of	periprosthetic	tibial	
fractures
	 •	 	Revision	 due	 to	 Infection:	 What	 decision	 to	 make	 for	 which	 infection?	 DAIR:	
Debridement antibiotic and implant retention
o How to Make Perfect Femoral Rotation. The 10th APKS Meeting, Gwangju, South 
Korea
o The 6th Annual Meeting of Arthroplasty Society in Asia, Shanghai, China
	 •	 	Solution	for	Periprosthetic	Fracture
	 •	 	Solution	for	Infected	TJA
o The 10th PEROSI-ISCD Bone Densitometry & Body Composition Course, Jakarta
	 •	 	Clinical	Management	Part	1:	Non-Pharmacologic,	Estrogen	&	SERM	Treatment
	 •	 	Clinical	Management	Part	2:	Pharmacologic	Treatment	Continued
	 •	 	Clinical	Management	Part	3:	Further	Pharmacologic	Treatment	Considerations
Panelist
o Arthroplasty/Osteoarthritis Forum. The 78th AOA & APKASS Meeting, Sydney, Austra-
lia
o The 19th APAS Meeting, Bangkok, Thailand
	 •	 	Early	Revision	of	PJI	Revision:	What	is	the	Real	Value	or	DAIR?
	 •	 	Does	New	Technology	in	TKA	Improve	Patient’s	Outcome?
2017
Course chairman/director
o Infection Section. The 20th APOA Trauma & Infection Meeting, Kuala Lumpur, Malay-
sia
o ICJR Symposium. Combined 5th IHKS - ICJR Symposium, Jakarta, Indonesia
o Early Intervention for OA: A World Perspective Round Table Discussion. Combined 5th 
IHKS - ICJR Symposium, Jakarta, Indonesia
o Principles of Total Hip & Knee Arthroplasty. AO Recon Course, Jakarta, Indonesia
Keynote speaker and moderator
o Surgical Demonstration: Tibia First Balanced Femur Total Knee Arthroplasty. The 11th 
ISAKOS Congress, Shanghai, China
o Combined 5th IHKS - ICJR Symposium, Jakarta, Indonesia
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	 •	 	The	Great	Knee	Debate:	Should	We	Progress	to	Kinematic	Alignment	Rather	Than	
Mechanical Alignment
	 •	 	The	Great	Knee	Debate:	Cementless	TKA	vs	All	Poly	Tibial	Tray
	 •	 	World	Perspective	Discussion:	THA	for	Young	Adult:	Bearing	Surface
	 •	 	Knee	Arthroscopy
o The 1st THKS/AAA Master Course, Chiang Rai, Thailand
	 •	 	Revision	THA	Module	2:	Moderate	to	severe	Femoral	Bone	Loss
	 •	 	Revision	THA	Module	4:	Periprosthetic	Joint	Infection
o AO Recon Course, Jakarta, Indonesia
	 •	 	Performing	Total	Hip	Arthroplasty
	 •	 	Optimizing	Expectations	&	Outcomes
o The 7th PEROSI National Congress, Medan, Indonesia
	 •	 	Surgical	Management	of	Osteoporotic	Fracture
	 •	 	Zoledronic	Acid:	An	Effective	Once	Yearly	Infusion	for	Osteoporosis	Treatment
Invited speaker
o How I Treat Infected Arthroplasty? The 20th APOA Trauma & Infection Meeting, Kuala 
Lumpur, Malaysia
o How to Best Achieve Your Target? CAS. The 7th European Knee Society Closed Meet-
ing, London, UK
o Measured Resection vs Gap Balancing Technique in TKR: With Specific Reference to 
Patients’ Reported Outcome Measures. APKASS 2017 Meeting, Seoul, South Korea
o Case Study Review. The 1st ISCD Vertebral Fracture Assessment Course, Jakarta, Indo-
nesia
o The 11th ISAKOS Congress, Shanghai, China
	 •	 	Extensor	Mechanism	Rupture
	 •	 	Early	Revision:	What	is	The	Real	Value?	(DAIR	–	Indications	&	Limitations)
	 •	 	What	is	the	Target	for	Femoral	Component	from	a	Clinical	Standpoint?
o The 19th THKS Meeting, Hua Hin, Thailand
	 •	 	Extensor	Mechanism	Rupture	in	2017
	 •	 	Early	Revision:	What	is	The	Real	Value?	(DAIR	–	Indications	&	Limitations)
	 •	 	How	I	Treated	Infected	Arthroplasty?
o Periprosthetic Fracture in Lower Extremities in 2017: Global Trends & Challenges. 
Combined 5th IHKS - ICJR Symposium, Jakarta, Indonesia
o The 1st THKS/AAA Master Course, Chiang Rai, Thailand
	 •	 	Revision	THA	Module	3:	Instability	After	THA	-	Effective	Methods	to	Prevent	Hip	
Dislocation
	 •	 	Revision	TKA	Module	3:	Painful	Unstable	TKA	-	Identify	Etiology	&	Types	of	Insta-
bility After TKA
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o The 7th ISCD Course, Jakarta, Indonesia
	 •	 	Clinical	Management	Part	1:	Non-Pharmacologic,	Estrogen	&	SERM	Treatment
	 •	 	Clinical	Management	Part	2:	Pharmacologic	Treatment	Continued
	 •	 	Clinical	Management	Part	3:	Further	Pharmacologic	Treatment	Considerations
o AO Recon Course, Jakarta, Indonesia
	 •	 	Patellofemoral	Resurfacing	and	Tracking
	 •	 	Diagnosis	and	Treatment	of	Infection	in	TKA
o Penatalaksanaan Terkini OA Lutut & Panggul (Current Management of Hip & Knee 
Osteoarthritis). IOA Seminar, Aceh, Indonesia
Instructor
o DePuy J&J: Attune. Combined 5th IHKS - ICJR Symposium, Jakarta, Indonesia
2016
Keynote speaker and moderator
o TKR and New Technology. The 19th APOA Congress, Melbourne, Australia
o Patella Resurfacing in all TKAs is a Must. The 17th APAS Meeting, Penang, Malaysia
o Symposium: Management factors for Success in Primary TKA. The 8th APKS Meeting, 
Yokohama, Japan
o The Benefits of Viscosupplementation Injections for Treatment of OA. Meet The 
Expert, Jakarta, Indonesia
Invited speaker
o Periprosthetic Tibial Fracture. The 19th APOA Congress, Melbourne, Australia
o The 2nd Basic Orthopaedic Skill Course, Surabaya, Indonesia
	 •	 	How	I	Do	My	TKR?	Step	by	Step	Techniques
	 •	 	Managing	Intraoperative	Issues	and	Postoperative	Rehabilitation
o The 3rd ICJR Pan Pacific, Kona, Hawai
	 •	 	Measured	Resection	vs	Gap	Balancing	Technique	for	TKR	with	specific	reference	
to patient reported outcome
	 •	 	Is	The	Definition	of	High	Flexion	TKA	The	Same	for	Asian	&	Western	Patients?
o The 18th APAS Meeting, Penang, Malaysia
	 •	 	Periprosthetic	Tibial	Fracture
	 •	 	Measured	Resection	vs	Gap	Balancing	Technique	for	TKR	with	specific	reference	
to patient reported outcome
o A Comparison of Clinical and Patient Recorded Outcomes of TKR in Asian versus 
Western Patients. The 2nd Combined European Knee Society & American Knee Soci-
ety Closed Meeting, Paris, France
o SOA/AO Recon Course, Singapore
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	 •	 	Periprosthetic	Fractures	of	the	Lower	Extremities:	Global	Trends	&	Challenges
	 •	 	How	Do	I	Manage	Insitu	Hardware	When	Converting	to	a	TKA?
	 •	 	Measured	Resection	vs	Gap	Balancing	Technique	for	TKR	with	specific	reference	
to patient reported outcome
o Measured Resection vs Gap Balancing Technique in TKR: With Specific Reference to 
Patients’ Reported Outcome Measures. The 8th APKS Meeting, Yokohama, Japan
Instructor
o Workshop TKA by DePuy Synthes. Basic Orthopaedic Skill Course, Surabaya, Indone-
sia
Panelist
o How Do We Minimize Infection? The 3rd ICJR Pan Pacific, Kona, Hawai
o Panel Discussion. The 8th APKS Meeting, Yokohama, Japan
2015
Course chairman/director
o Controversial Issues in Arthroplasty & Worst Case. The 4th IHKS Meeting, Surabaya, 
Indonesia
o Knee Symposium. APAS Meeting, Delhi, India
Keynote speaker and moderator
o The 10th ISAKOS Meeting, Lyon, France
	 •	 	Knee:	Replacement
	 •	 	Total	Knee	Replacement
o ASEAN Forum. Combined 7th APKS - 17th THKS - 8th AAA Meeting, Bangkok, Thailand
o How Can We Optimize Patient Satisfaction After TKA. The 4th IHKS Meeting, Surabaya, 
Indonesia
o Osteoporosis and Osteoarthritis. PEROSI Annual Scientific Meeting, Jakarta, Indone-
sia
Invited speaker
o Patellar Resurfacing, What Are The World Saying? Inaugural World Arthroplasty 
Congress by ICJR 2015, Paris, France
o How to Improve TKR? Patellar Replacement? The Master’s Series at USC Keck School 
of Medicine, Los Angeles, USA
o Patellofemoral Resurfacing in TKA. Combined 7th APKS - 17th THKS - 8th AAA Com-
bined Meeting, Bangkok, Thailand
o The 4th IHKS Meeting, Surabaya, Indonesia
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	 •	 	What	Are	The	Causes	of	Patient	Dissatisfaction	After	TKA?
	 •	 	Measured	Resection	vs	Gap	Balancing	Technique	for	TKR	With	Specific	Reference	
to Final Outcomes
	 •	 	Stability	in	Motion,	New	Advantage	for	TKR	Surgery	(Attune)
	 •	 	Design	Features	&	Early	Experience	With	a	Modern	TKA
	 •	 	Launching	of	Attune	RP	Implants	in	Asia	Pacific
o The 16th APAS Meeting, Delhi, India
	 •	 	New	Technology	in	TKA:	Is	The	Latest	Always	The	Greatest?
	 •	 	Measured	Resection	vs	Gap	Balancing	Technique	for	TKR
	 •	 	Patella	Resurfacing:	What	Are	The	World	Saying?
o The 2nd ICJR SEA Meeting, Penang, Malaysia
	 •	 	Resurfacing	Patella	–	Pro	vs	Against	(Against)
	 •	 	The	Biomechanics	and	Asymmetric	Knees
o The 6th PEROSI Annual Scientific Meeting, Jakarta, Indonesia
	 •	 	Making	the	First	Fracture	the	Last	Fracture:	an	ASBMR	Task	Force	Report
	 •	 	Defining	an	International	Standard	Set	of	Outcomes	Measures	for	Patients	with	
Hip or Knee Osteoarthritis: Consensus of the ICHOM Hip and Knee Osteoarthritis 
Working Group
o Knee Injuries: When to Do Surgery & Does it Guarantee Results? Indonesian Olympic 
Committee (IOC) Sports Medicine Symposium & Course, Jakarta, Indonesia
Instructor
o Cadaveric Workshop on Arthroplasty. Combined 7th APKS - 17th THKS - 8th AAA Meet-
ing, Bangkok, Thailand
Panelist
o The Master’s Series at USC Keck School of Medicine, Los Angeles, USA:
	 •	 	Case	Presentations	for	TKR
	 •	 	Stem	Cells/PRP	Injections	in	Orthopedics
o Measured Resection vs Gap Balancing Technique for TKR With Specific Reference to 
Final Outcomes. The 10th ISAKOS Meeting, Lyon, France
o Case Discussion – Knee: Primary & Difficult Primary. The 2nd ICJR SEA Meeting, Pen-
ang, Malaysia
2014
Keynote speaker and moderator
o The 12th Ranawat Orthopaedic Center Meeting, New Delhi, India
	 •	 	Patella	Replacement	-	Replace	or	not?
	 •	 	Venous	Thromboembolism	Prevention
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o When to Do a Scope in Degenerate Knee? Panelist - Case Challenges for Total Knee 
Replacement: Can the Surgeon Get It Right? The Master’s Series by USC Keck School 
of Medicine, Los Angeles, USA
o The 15th APAS, Cheng Du, China
	 •	 	CAS:	Dreams	or	Facts?	The	Value	of	Daily	Work	in	TKR
	 •	 	Venous	Thromboembolism	Prevention	in	Orthopaedic	Surgery:	Current	Practice	
& Unmet Needs
o THA Dislocation. The 2nd ICJR (International Congress for Joint Reconstruction) Pan 
Pacific, Hawaii, USA
o The 1st ASEAN Insight Meeting, Phuket, Thailand
	 •	 	Crossfire:	Measured	resection	or	Gap	balancing:	What	is	the	key	to	the	knee?
	 •	 	Crossfire:	Femoral/Tibial	Stems	:	Cemented	or	Cementless?	What	works	best?
o The 27th ISTA (International Society for Technology in Arthroplasty), Kyoto, Japan
	 •	 	Hip	Resurfacing,	Bone	&	Joint	Preservation
	 •	 	Bone	&	Joint	Preservation
	 •	 	Hip	Revision	II
o The 2nd ASIA Meeting, Seoul, South Korea
	 •	 	Quality	of	Life	Following	TKR	in	3	Distinct	Patient	Population
	 •	 	Revision	Total	Knee	Replacement
Invited speaker
o Technical Tips for Total Knee Replacement. The Master’s Series by USC Keck School of 
Medicine, Los Angeles, USA
o The 2nd ICJR Pan Pacific, Hawaii, USA
	 •	 	Effective	Methods	to	Prevent	THA	Dislocation
	 •	 	CAS:	Dreams	or	Facts?	The	Value	of	Daily	Work	in	TKR
o Versatility of TKR – Postpone Revision by Doing a Good Primary. ASEAN Insight Meet-
ing, Phuket, Thailand
o The 27th ISTA, Kyoto, Japan
	 •	 	CAS:	Dreams	or	Facts?	The	Value	of	Daily	Work	in	TKR
	 •	 	The	Patella	in	TKA:	To	Resurface	or	Not	is	The	Question
o The 5th PEROSI Congress, Solo, Indonesia
	 •	 	Making	 the	First	Fracture	 the	Last:	 Secondary	Fracture	Prevention	 (Read	by	dr.	
Kiki Novito)
	 •	 	Algorithm	of	Osteoporosis
	 •	 	Osteoarthritis	Management	at	Different	Stages	of	Disease
o Why Total Knees Fail in 2014? – Pitfalls and Pearls for Successful TKR. IHKS Specialty 
Day, 14th IOA National Congress, Jakarta, Indonesia
o Combined 65th POA - 7th AAA - 1st ASSA - AOA Meeting, Cebu, The Philippines
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	 •	 	Patella	Resurfacing	–	Will	This	Ever	End?	I	Don’t
	 •	 	The	New,	The	Bad	&	The	Ugly	Knees
o Patella Resurfacing: Necessary or Not? What Are The World Saying? ICJR India, Delhi, 
India
o The 5th Chandra Knee Foundation Meeting, Ahmedabad, India
	 •	 	Why	TKAs	Fail	in	2014?
	 •	 	Patella	Resurfacing:	Necessary	or	Not?	What	Are	The	World	Saying?
o Development of Arthroplasty in Indonesia. The 1st Symposium & Cadaveric Work-
shop, Bandung, Indonesia
Panelist
o The Master’s Series by USC Keck School of Medicine, Los Angeles, USA
	 •	 	One	Stage	Reimplantation:	Indications	&	Technique
	 •	 	Pain	Management	and	Rapid	Recovery/Discharge	for	Total	Hip	Replacement
	 •	 	Obamacare	&	Your	Practice
2013
Keynote speaker and moderator
o The 3rd IHKS Scientific Meeting, Jakarta, Indonesia
	 •	 	The	Development	and	Current	Status	of	Hip	&	Knee	Surgery	in	Indonesia
	 •	 	Managing	Hip	Fractures	and	their	Sequelae	with	Arthroplasty
	 •	 	Controversial	Issues	of	Hip	&	Knee	Arthroplasty
	 •	 	Eliquis	Lunch	Symposia
	 •	 	ASKOT	Study:	An	Evaluation	of	the	Acceptability	&	Safety	in	Real	Life	Conditions	
of a Viscoelastic Solutions of Hyaluronic Acid in Treatment of Knee Osteoarthritis
	 •	 	Proactive	Knee	Management	of	Knee	OA	-	A	Viscosupplementation	Approach
o Current Approach to Prevent Thromboembolism After Orthopaedic Surgery. The 1st 
Asia Arthroplasty Thromboprophylaxis Survey Working Group Meeting, Hong Kong.
o The Patella in Total Knee Arthroplasty. The 15th THKS Meeting, Bangkok, Thailand
o Proactive Knee Management of Knee OA - A Visco-supplementation Approach. The 
4th Indonesian Osteoporosis Association National Scientific Congress, Palembang, 
Indonesia
o The Patella in Total Knee Arthroplasty - Necessary or Not? Combined 8th COA Con-
gress - 1st ASIA Meeting in Beijing, China
o The 2nd EOA International Meeting, Dubai, United Arab Emirates
	 •	 	Do	We	Need	to	resurface	the	Patella:	What	the	World	is	Saying?
	 •	 	Introduction	to	new	Technology	in	TKA:	Is	the	latest	always	the	greatest?
	 •	 	CAS:	Dreams	or	facts?	The	value	of	daily	work	in	TKA
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Instructor
o Cadaveric Hip & Knee Workshop. The 1st AAA Comprehensive Hip & Knee Course, 
Bangkok, Thailand
Panelist
o What is the preferred bearing surface in THA in young active around the world? The 
2nd EOA International Meeting, Dubai, United Arab Emirates
2012
Keynote speaker and moderator
o The 2nd Indonesia Hip & Knee Society Meeting, Jakarta, Indonesia
	 •	 	The	Development	and	Current	Status	of	Hip	&	Knee	Surgery	in	Indonesia
	 •	 	Unveil	the	Facts	of	COX2	Inhibitor	in	Orthopaedic	Cases	Management
	 •	 	Arthroplasty	Crossfire	Debate
	 •	 	Thrombosis	Management	in	Orthopaedic	Surgery,	Do	We	Need	a	Paradigm	Shift?
o Principles and Roles of Arthroscopy. The 4th Indonesian Osteoporosis Association 
Meeting
o Venous Thromboembolism Prevention (VTEp) in Orthopaedic: Current Practice and 
Unmet Needs. The 14th APAS Meeting, Mumbai, India
o Conventional Polyethylene vs Highly Cross-linked Polyethylene in TKR patients. The 
1st Meeting of Chinese Japanese Korean (CJK) Meeting, Seoul, South Korea
o Varus/Valgus Knee. The 2nd IHKS Instructional Course & Cadaveric Workshop on THA 
and TKA, Malang, Indonesia
Invited speaker
o Venous Thromboembolism Prevention (VTEp) in Orthopaedic: Current Practice and 
Unmet Needs. The 1st Asia Expert Panel Meeting for Better VTE Prevention for Ortho-
paedic Patients, Bali, Indonesia
o Does DVT Exist in Asia? The 59th COE Meeting in Bandung, Indonesia
o Venous Thromboembolism Prevention (VTEp) in Orthopaedic: Current Practice and 
Unmet Needs. The 1st Pacific Rim Orthopaedic Symposium (PROS), Bangkok, Thailand
o 1st ICJR South East Asia Course, Kuala Lumpur, Malaysia
	 •	 	Patellar	Resurfacing	–	Yes	or	No?
	 •	 	Patellar	Tendon	Ripped	Off
o Varus/Valgus Knee. The 2nd IHKS Instructional Course & Cadaveric Workshop on THA 
and TKA, Malang, Indonesia
o Conventional Polyethylene vs Highly Cross-linked Polyethylene in TKR patients. The 
35th Singaporean Orthopaedic Association Meeting, Singapore
169
A
pp
en
di
ce
s
Portfolio
o Surgical Aspect of Osteoporosis Therapy. The 12th Indonesian Osteoporosis Associa-
tion Meeting
o Venous Thromboembolism Prevention (VTEp) in Orthopaedic Patients in Asia: Cur-
rent Practice and Unmet Needs. The 7th COA Meeting in Beijing, China
o The 3rd Chandra Knee Foundation Meeting, Ahmedabad, India
	 •	 	Conventional	 Polyethylene	 vs	 Highly	 Cross-linked	 Polyethylene	 in	 Total	 Knee	
Replacement Patients
	 •	 	Patella	Resurfacing	–	Necessary	or	Not?
	 •	 	Patient	 Specific	 Implants	 vs	 Computer	 Assisted	 Surgery	 ~	 Patient	 Specific	 Im-
plants
2011
Keynote speaker and moderator
o TKA: Uni, High flex and others. Combined 13th APAS - 6th COA Meeting, Beijing, China
o What’s New with Poly in TKR? Combined 41st MOA - 4th AAA Meeting, Kuala Lumpur, 
Malaysia
Invited speaker
o CAS TKA: Is It Still There? Is The Definition of High Flexion The Same for Asian and 
Western Patients? The 13th THKS Meeting, Hua Hin, Thailand
o What’s New in Poly for TKR? Combined 13th APAS - 6th COA Meeting, Beijing, China
Instructor
o Balancing Varus/Valgus Deformities. The 1st IHKS Instructional Cadaveric Course, 
Malang, Indonesia
2010
Keynote speaker and moderator
o CAS TKA: Is It The Best Choice and My Mid to Long term TKA results in ASEAN Coun-
tries? (Indonesia). The 3rd AAA Meeting, Phuket, Thailand
o MIS & CAS: Dreams or Facts? The Value for Daily Work in TKA. The 12th APAS Meeting, 
New Delhi, India
Invited speaker
o MIS & CAS: Dreams or Facts? The Value for Daily Work (Asian Perspective). The 2nd 
EFORT Meeting, Madrid, Spain
o CAS TKA: Is It The Best Choice and My Mid to Long term TKA results in ASEAN Coun-
tries? (Indonesia). The 3rd AAA Meeting, Phuket, Thailand
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o MIS & CAS: Dreams or Facts? The Value for Daily Work in TKA. The 12th APAS Meeting, 
New Delhi, India
o CAS - Dreams or Facts? The Value for Daily Work in TKA. Combined 33rd SOA - 30th AOA 
Meeting, Singapore
o Glucosamine & Hyaluronan for Treatment of Knee OA. The 2nd EFORT Asia Meeting, 
Taipei, Taiwan
2009
Keynote speaker and moderator
o Combined 60th POA - 25th APOA - 2nd AAA Meeting, Manila, Philippines
	 •	 	Current	Management	of	Periprosthetic	Fractures.
	 •	 	MIS	&	CAS:	Dreams	or	Facts?	The	Value	for	Daily	Work	(Asian	Perspective)
Invited speaker
o MIS & CAS: Dreams or Facts? – The Value for Daily Work (Asian Perspective). The 1st 
EFORT ASIA Meeting, Bangkok, Thailand
o Combined 60th POA - 25th APOA - 2nd AAA Meeting, Manila, Philippines
	 •	 	Current	Management	of	Periprosthetic	Fractures.
	 •	 	MIS	&	CAS:	Dreams	or	Facts?	The	Value	for	Daily	Work	(Asian	Perspective)
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